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Abstract 
 
Anopheles funestus is one of three major malaria vectors in Africa.  During 2000 
malaria cases increased in Kwazulu/Natal, South Africa.  This was a result of 
pyrethroid resistance in this vector.  Biochemical studies showed elevated levels of 
Cytochrome P450 (monooxygenases) in the resistant mosquitoes. Monooxygenases 
are one of the three major metabolic based resistance mechanisms used by 
mosquitoes as a defence mechanism against insecticides.  Further studies identified 
one gene in the CYP6 class, CYP6P9, highly overexpressed. Microsomal cytochrome 
P450s were isolated from pyrethroid resistant (FUMOZ-R) larval midguts and 
headless adults.  High enzyme activity of 7-ethoxycoumaorin was noted in both larval 
midguts and adults (FUMOZ-R) compared to susceptible (FANG) strain (3.6 and 6.4 
fold increases respectively).  HPLC analysis further confirmed that microsomal 
cytochrome P450s from FUMOZ-R were involved in permethrin (pyrethroid) 
detoxification.  In order the understand the mode of action of CYP6P9 as a 
metabolizing enzyme, this study aimed to isolate and characterize full length CYP6P9 
as well as develop a suitable expression system in E. coli.  Sequence comparisons of 
full-length cDNA’s between CYP6P9 from resistant and susceptible strains revealed 
several mutations. Redox partners Cytochrome b5 and Cytochrome P450 reductase 
genes were also isolated, sequenced and cloned as these proteins plays an integral 
part in detoxification.  These were almost identical between the two strains analysed. 
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A second cytochrome P450, CYP6P13, was isolated only from FANG genomic 
DNA.  This gene shared a 93.7% identity with that of CYP6P9.  Its absence in 
FUMOZ-R and FANG cDNA indicated that it was not expressed at the protein level. 
This gene is most likely the result of gene duplication.  In order to enzymatically 
characterize the metabolic activity of CYP6P9, recombinant CYP6P9 protein was 
expressed in E. coil.  Expression of CYP6P9 was problematic in E. coli even when 
the expression vector was changed from pIX4.0 to pCWori+ in the presence of a 
bacterial signal sequence (ompA).  Expression was successful when eight of the first 
amino acid sequences were replaced by the 17-α hydroxylase sequence.  This work is 
the first to provide evidence of permethrin detoxification by microsomal P450 from a 
resistant mosquito strain. It is also the first to express An. funestus P450 in E. coli. 
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Valine           Val      V 
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Adenosine        A 
Thymidine        T 
Guanosine        G 
Cytidine        C 
 
 
  
 
1
Chapter one  
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1 General Introduction 
1.1 Importance of Malaria  
Malaria is one of the oldest diseases known to man and was thought to be caused by 
the bad smelling gases from marshy places hence the name mal’ aria, “bad air” 
(Garnham, 1966).  In 1880, Charles Louis Alphonse Laveran first illustrated that 
malaria was caused by a parasite.  This was proven by the presence of parasites in the 
blood of malaria patients (Garnham, 1966; Harrison, 1978).  Human malaria is caused 
by four major Plasmodium species: Plasmodium vivax, P. malariae, P. ovale, and P. 
falciparum.  Plasmodium falciparum is the most severe of all (Garnham, 1966).  The 
parasite is transmitted to the human host by an infected blood feeding Anopheles 
female mosquito.  The transmission of malaria by mosquitoes to man was 
demonstrated by an Italian group, Amico Bignami, Giovanni Battista Grassi and 
Guiseppi Bastianelli in 1898.  They achieved this by allowing infected mosquitoes to 
transmit P. falciparum to a volunteer (Garnham, 1966).  Sir Ronald Ross at the same 
time confirmed this while working on bird malaria which earned him a Nobel Prize in 
1902 (Harrison, 1978). 
 
Literature review 
 
  
 
2
Mosquitoes belong to the order Diptera (they have only one pair of functional wings) 
and undergo a holometabolous life cycle (a three development stage which includes: 
larvae, pupae, adult (imago) (Service, 1980).   
 
In Africa, malaria has a major health impact especially south of the Sahara where it 
influences social and economic growth (WHO, 2001).  The estimated cost to Africa 
alone is over US$ 12 billion per year (WHO, 2001).  At least 300 million global cases 
of malaria are reported with more than a million deaths annually (WHO, 2001).  
Africa south of the Sahara is the most affected region as a result of the high 
prevalence of Plasmodium falciparum as well as the presence of three very efficient 
malaria vector species (WHO, 2001).   
 
1.2 Malaria vectors  
Mosquitoes have 34 genera that belong to three subfamilies, Anophelinae 
(anophelines), Toxorhynchitinae and Culicinae (culicines).  Mosquitoes belonging to 
the genera Anopheles, Culex, Aedes, Mansonia, Haemagogus, Sabethes and 
Psorophora are important due to the fact that they acquire blood meals (Service, 
1980).  The bulk of malaria transmission in Africa is caused by three major vectors, 
An. gambiae s.s, An. arabiensis and An. funestus s.s (Gillies and De Meillon, 1968; 
White, 1974; Gillies and Coetzee, 1987). Anopheles gambiae s.s and An. arabiensis 
are members of the An. gambiae complex while An. funestus s.s is a member of the 
An. funestus group. 
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1.2.1 Anopheles funestus group 
The first classification of An. funestus group was based on morphology.  Species 
were distinguished at various life stages: eggs, larvae and adults.  Based on 
morphological similarities nine species were grouped into the An. funestus group. 
These include: An. funestus Giles, An. vaneedeni Gillies and Coetzee, An. parensis 
Gillies, An. rivulorum Lesson, An. leesoni Evans, An. aruni Sobti, An. brucei Service, 
An. confusus Evans and Leeson and An. fuscivenosus Leeson (Gillies and De Meillon, 
1968; Gillies and Coetzee, 1987).  A new species was identified in Cameroon that 
was very similar to An. rivulorum, hence it was named An. rivulorum-like sp (Cohuet 
et al., 2003).  Species within the group are not easily distinguished morphologically.  
Koekemoer et al (2002) developed a molecular species-specific polymerase chain 
reaction (PCR) assay that identifies five members of the An. funestus group in Africa, 
which are An. funestus, An. vaneedeni, An. rivulorum, An. leesoni and An. parensis.   
 
Re-classification of genus Anopheles was suggested by Harbach (2004).  This 
classification arose as a result of molecular studies.  It involves removal and addition 
of species as well as changes within the hierarchical organization and supraspecific 
group composition.  Classification based on molecular techniques involved sequence 
comparison within species on i) ITS2 (Nuclear ribosomal loci, internal transcribed 
spacer 2), ii) D3 (third domain of the 28S subunit of ribosomal DNA) and iii) COII 
(cytochrome oxidase subunit II) (Garros, et al., 2005a; Garros et al., 2005b; Chen et 
al., 2006; Singh, et al., 2006).  The An. funestus group was subgrouped, An. confuses 
was added to the An. funestus subgroup along with An. aruni, An. funestus, An. 
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parensis and An. vaneedeni.  Anopheles leesoni was added to the Minimus subgroup 
while An. rivulorum, An. rivulorum-like sp, An. brucei and An. fuscivenosus were 
grouped in the An. rivulorum subgroup (Garros, et al., 2005a; Garros et al., 2005b). 
 
Species in the group are small, dark mosquitoes that are known to breed in permanent 
water bodies such as swamps and river systems and are therefore less affected by 
rainfall seasons.  They have low tolerance to saline water and are never found in 
brackish water (Gillies and De Meillon, 1968; Gillies and Coetzee, 1987).  Anopheles 
funestus is a major transmitter of Plasmodium falciparum and in some cases more so 
than An. gambiae (Temu et al., 1998; Cohuet et al., 2004).  In studies carried out by 
Cohuet et al (2004) it was shown that An. funestus was a major transmitter of P. 
falciparum in a village of savannah-forest, Cameroon.  It accounted for a total malaria 
transmission rate of about 88%.  Anopheles funestus was also identified as the major 
malaria vector in an irrigated agricultural area in a sugarcane and savannah village of 
Tanzania (Ijumba et al., 2002).  
 
Anopheles funestus is highly anthropophilic (biting man) and endophilic (resting 
indoors).  This behaviour renders its susceptible to indoor spraying of residual 
insecticides (Gillies and De Meillon, 1968).  Species within the group tend to 
compete for habitats and An. funestus is usually the dominant species.  When An. 
funestus was eliminated from the Pare area in Tanzania by house spraying, An. 
rivulorum population increased.  The same was noted in Kenya coast when An. 
parensis occupied villages that were sprayed to eliminate An. funestus.  Anopheles 
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funestus are slow in re-invading areas they were once eliminated from by house 
spraying (Gillies and De Meillon, 1968).        
 
1.3 Malaria in Southern Africa 
In southern Africa the countries greatly affected by malaria epidemics are Angola, 
Botswana, Malawi, Mozambique, Namibia, South Africa, Swaziland, Zambia and 
Zimbabwe (WHO-SAMC, www.malaria.org.zw). All three major vectors (An. 
arabiensis, An. gambiae s.s and An. funestus s.s.) are found in this region.  
Plasmodium falciparum has been reported as the prevailing malaria parasite with an 
annual death toll of about 200,000 in southern Africa (WHO-SAMC, 
www.malaria.org.zw).  The malaria transmission areas are categorized into three 
classes, which are:  
1. Malaria free – these are areas where malaria transmission does not occur.  
2. Unstable (epidemic-prone) transmission – these are areas in which malaria 
occurs seasonally and there is a high risk of morbidity and mortality if 
measures are not taken to control the outbreak of malaria.  
3. Stable (endemic) transmission – these are areas in which malaria is 
throughout the year and there is a very high morbidity and mortality rate 
(WHO-SAMC, 2002). 
 
South Africa mainly has malaria free zones and a small portion on the border region 
shows unstable seasonal malaria. DDT (Dichloro-Diphenyl-Trichloroethane) was 
introduced for indoor residual spraying (IRS) to combat malaria during the 1940’s. 
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The South Africa malaria control programme changed because: 1) the locals were 
refusing to have their houses sprayed with DDT because of the ugly marks it left on 
walls and it agitates bedbugs to bite more, 2) deltamethrin (pyrethroid) replaced DDT 
because it was as effective and long lived as DDT, 3) environmental concerns 
towards DDT (Attaran and Maharaj, 2000; Coetzee, 2005).   The use of pyrethrum in 
the control of mosquitoes was proven effective as early as the 1930’s (De Meillion, 
1936).  Various factors influence the success of malaria control such as drug 
resistance in the parasites and insecticide resistance in the vectors (WHO-SAMC, 
www.malaria.org.zw).  The impact of insecticide resistance on malaria transmission 
was clearly demonstrated in South Africa (Hargreaves et al., 2000).  In 
Kwazulu/Natal, malaria cases increased from 4,117 in 1995 to 41,786 in 2000 (Figure 
1.1), even though house spraying for malaria control was an ongoing practice. Studies 
conducted in 1999 showed that pyrethroid resistant An. funestus was a major 
contribution factor towards this increase of malaria cases (Hargreaves et al., 2000). 
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Figure 1.1: Malaria cases in Kwazulu/Natal 1995-2006, Department of Health, South Africa. 
 
Pyrethroid resistance in An. funestus from South Africa was reported in the Ndumu 
area of northern Kwazulu/Natal bordering on southern Mozambique.  A total of 5.4% 
of these mosquitoes tested were positive for Plasmodium falciparum 
circumsporozoite protein (Hargreaves et al., 2000).  Resistance was confirmed by 
using three sets of pyrethroid bioassays, firstly the bottle bioassay that was developed 
by Brogdon and McAllister (1998).  This assay uses a diagnostic dosage of 
permethrin (25µg/bottle) to detect resistant mosquitoes.  The second assay used was 
the WHO test kit that uses 1% permethrin impregnated papers.  The third bioassay 
involved residual house spraying using deltamethrin (0.05%) which was detected by 
window exit traps (WT) and pyrethrum knockdown spray catches (PSC).  Brooke et 
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al (2001) used the WHO insecticide susceptibility test and found that An. funestus 
was resistant to pyrethroids (Deltamethrin, 0.05%; Lambdacyhalothrin, 0.05%) as 
well as the carbamate propoxur (0.1%). Biochemical assays concluded that mixed 
function oxidases (MFO) were the main mechanism of resistance (Brooke et al., 
2001).  A drop to 1211 in 2006 was the result of the re-introduction of DDT for house 
spraying in 2000.  The use of pyrethroids as an indoor residual spray (IRS) was 
retained for western-style homesteads while DDT was reintroduced for IRS in 
traditional homesteads (Figure 1.1) (Hargreaves et al., 2003). 
 
1.4 Insecticide resistance 
 
The WHO’s official definition of resistance is the “development of an ability in a 
strain of organism to tolerate doses of toxicant which would prove lethal to the 
majority of individuals in a normal (susceptible) population of species” (cited by 
Zlotkin, 1999).  Brown (1986) defines resistance mechanisms as follows: “Resistance 
is usually due to a detoxification of the insecticide due to mutant enzymes (isozymes) 
engendered by the resistance gene alleles, but some resistance may also be conferred 
by a reduced uptake of the toxicant”.  Resistance is brought about by various factors 
such as the extensive use of agricultural insecticides in malaria areas causing vectors 
to become more resistant to insecticides.  Mosquitoes have developed two main 
mechanisms of resistance: 
1. Target-site insensitivity which results from mutation(s) within the various 
insecticide target sites such as the sodium ion channel (also called knockdown 
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resistance (kdr)), gamma (aminobutyric acid (GABA) receptor and 
acetylcholinesterase (AChE) gene (Mutero et al., 1994; Zhang et al., 1994; 
Martinez-Torres et al., 1998; Ranson et al., 2000; Hemingway et al., 2004; Weill 
et al., 2004).  
2. Metabolic based resistance which involves elevated levels of detoxifying enzymes 
such as esterases, glutathione-S-transferases (GST) and monooxygenases 
(Hemingway and Ranson, 2000; Hemingway et al., 2004).   
 
Below are the classes of insecticides used in malaria control and the target sites and 
enzyme associated in resistance (Figure 1.2).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Cross-resistance between commonly used insecticides as well as the target site they 
affect (Adapted from Brogdon and McAllister, 1998).  
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1.4.1 Target-site insensitivity  
Target-site insensitivity resistance involves mutations within the genes targeted by 
insecticides: sodium-ion channel gene (kdr), the aminobutyric acid (GABA) 
receptor and acetylcholinesterase (AChE) making them less susceptible to 
insecticides. The knockdown resistance (kdr) mutation was first detected in houseflies 
and the German cockroach (Knipple et al., 1994; Williamson et al., 1996; Martinez-
Torres et al., 1997; Liu et al., 2000).  A point mutation of leucine to phenlyalanine 
(TTA → TTT) within the S6 hydrophobic transmembrane segment of domain II gives 
rise to insecticide resistance.  Mutation within this region interferes with the binding 
of pyrethroids or DDT to the voltage-gated sodium channel. This mutation was first 
detected in An. gambiae s.s from West Africa (Martinez-Torres et al., 1998). A 
different mutation (leucine to serine (TTA → TCA)) in the same position was 
described in An. gambiae s.s from East Africa (Ranson et al., 2000). Unlike the 
leucine to phenlyalanine mutation that confers high resistance to both DDT and 
permethrin, the leucine to serine mutation only confers high resistance to DDT and 
low resistance to permethrin (Ranson et al., 2000).   
 
A second mutation methionine to threonine was identified in the common housefly, 
Musca domestica. This mutation is situated within the loop between the S4 and S5 
transmembrane segments of domain II.  In association with the leucine/phelyalanine 
it is referred to as the super-kdr mutation (Williamson et al., 1996; Martinez-Torres et 
al., 1997). 
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   Resistance to dieldrin may arise as a result of a mutation of alanine to serine (GCA 
→ TCA) within the Rdl (resistance to dieldrin) gene that encodes the aminobutyric 
acid (GABA) receptor. This mutation was identified in dieldrin resistant Drosophila 
strains (ffrench-Constant et al., 1991; 1993). Investigations carried out on laboratory 
strains of two dieldrin resistant mosquito species, An. gambiae and An. arabiensis, 
determined that two mutations occurred independently.  Anopheles arabiensis carried 
the alanine to serine mutation, while An. gambiae showed a different mutation of 
alanine to glycine (Du et al., 2005).  
 
In Musca domestica and Drosophila melanogaster five mutations in the 
acetylcholinesterase active site gene were shown to confer resistance to 
organophosphates and carbamates (Mutero et al., 1994; Walsh et al., 2001; Weill et 
al., 2002).  Nabeshima et al (2004) reported the encephalitis vector Culex 
tritaeniorhynchus to have an altered AChE (Ace-2) gene situated on chromosome 2 
associated with organophosphate resistance. Insecticide resistance was also associated 
with a single mutation in the Ace-1 gene of Culex pipiens (Weill et al., 2004).   
  
1.4.2 Metabolic based resistance 
Metabolic based resistance is usually brought about by an alteration within the 
enzyme which in turn affects the detoxification levels and activity (Hemingway et al., 
2004).  Changes may be qualitative or quantitative (Hemingway and Karunaratne, 
1998).  Resistance may involve one or more of three major enzyme classes: 
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carboxylesterases, glutathione-S-transferases and monooxygenases. These enzymes 
may become involved in the sequestration or detoxification of insecticides.  Specific 
enzyme/s involved in resistance are dependent on the class of insecticide they are able 
to hydrolyze (Peiris and Hemingway, 1993).  
 
i) Carboxylesterase 
Carboxylesterases (also known as esterases) are enzymes that hydrolyze carboxylic 
esterase (Hemingway and Karunaratne, 1998).  There are two forms of esterases, the 
A and B forms. The B-esterases are inhibited by paraoxon (organophosphate 
cholinesterase inhibitor) while the A-esterases are not.  Esterases are primarily 
associated with the resistance to organophosphates in a variety of insects.  In Culex 
mosquitoes it was found that one or more esterases may be involved in the 
detoxification of organophosphates.   They are also known to hydrolyze carbamates 
(Hemingway and Karunaratne, 1998).   In Sri Lanka, Culex quinquefasciatus was 
reported to have elevated levels of esterases A2 and B2 in a resistant strain which 
were able to hydrolyze fenitrothion (organophosphate) (Peiris and Hemingway, 
1993).  High esterase levels were also detected in a population of An. gambiae as well 
as Aedes aegypti that was resistant to permethrin (Vulule et al., 1999; Flores et al., 
2005).   
 
Apart from elevation of the enzyme, amino acid alterations have also been 
implemented in resistance.  An amino acid substitution Gly137 to Asp within the 
active site of both house fly and blowfly esterases conferred resistance to 
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organophosphates (Claudianos et al., 1999).  In the blowfly another substitution 
Try251 to Leu was also reported to confer resistance to organophosphates (Campbell 
et al., 1998). 
    
ii) Glutathione-S-transferases 
Glutathione-S-transferases (GST) are a family of enzymes that are involved in the 
detoxification and metabolism of endogenous and xenobiotic compounds (Kavishe et 
al., 2006).  Insects have two GST protein families, GST-1 and GST-2 (Fournier et al., 
1992).  GSTs are dimeric proteins that consist of two binding subunits. A G-site 
which binds glutathione and an H-site which binds substrate (Hemingway et al., 
2004).  In the housefly, GST-1 is found located within the haemolymph cells while 
GST-2 is found in the thorax associated with the flight muscles as well as the central 
nervous system (Franciosa and Bergé, 1995).   Increased levels of GST and esterase 
were detected in Sri Lankan Culex tritaeniorhynchus and Culex gelidus resistant to 
organophosphate, carbamate and pyrethroid insecticides (Karunaratne and 
Hemingway, 2000).  In An. gambiae, GSTs have been shown to be involved in DDT 
resistant mosquitoes (Ranson et al., 2001; Ortelli et al., 2003).  Vontas et al (2001) 
detected elevated levels of GST, which conferred pyrethroid resistance in Nilaparvata 
lugens (brown planthopper). 
 
iii) Monooxygenases 
Monooxygenase, also known as cytochrome P450, are involved in the oxidation of 
many endogenous and exogenous compounds (Nelson et al., 1996). They form an 
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important resistant mechanism for the detoxification of insecticides (Kasai et al., 
2000).  These enzymes will be discussed in detail in the following sections.  
 
In southern Africa An. funestus has been shown to be resistant to pyrethroids 
(Hargreaves et al., 2000; Brooke et al., 2001). In biochemical studies, Brooke et al 
(2001) attributed this resistance to elevated levels of monooxygenases.  Amenya et al 
(2008) were able to demonstrate an increased expression of a single monooxygenase 
P450 enzyme associated with resistance.  The rest of the thesis will be based on this 
particular resistance mechanism and will be discussed further in more detail.  
 
1.5 Monooxygenase (Cytochrome P450)  
1.5.1 Background 
Axelrod (1955) and Brodie et al (1955) carried out the first experimental report that 
suggested an enzyme (Cytochrome P450) was present in the endoplasmic reticulum 
of rabbit liver that was involved in the oxidation of xenobiotic compounds. In 1958 
Garfinkel and Klingenberg separately demonstrated that a pigment within pig and rat 
liver microsomes was able to bind carbon monoxide and had a distinct absorbent 
peak at a wavelength of 450 nm (cited from Omura and Sato, 1964a). Owing to its 
dual properties as an oxidant and reductant this pigment was given the name “mixed 
function oxidase”.  Omura and Sato (1964a) specified that Cytochrome P450 was a 
hemoprotein. They also noted that Cytochrome P450 was associated with another 
hemoprotein (Cytochrome b5) within mammalian (rabbit) liver microsomes (Omura 
and Sato, 1964b).   
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1.5.2 Nomenclature 
Cytochrome P450s are the largest heme-thiolate proteins of a superfamily gene.  They 
are involved in the metabolism of many endogenous (hormones and pheromones) and 
exogenous (insecticides and plant toxins) compounds (Nelson et al., 1996).  Owing to 
the large size of this group of enzymes a naming system has been implemented. The 
root symbol “CYP” from Cytochrome P450 is placed in front of the family number. 
For instance those from family 1 are named CYP1.  A letter represents a subfamily 
e.g. CYP1A.  Following the subfamily is a number that represents the individual 
genes present in the specific subfamily e.g. CYP1A1 or CYP1A2 (Nelson et al., 
1993; Nelson et al., 1996; Feyereisen 1999).   
 
1.5.3 Classification  
P450s are characterized into four main classes according to the nature of the auxiliary 
proteins (Miles et al., 2000). Class I P450 proteins are found in most bacteria and 
embedded in all eukaryotic mitochondrial membranes. This P450 system consists of 
three components, a flavin adenine dinucleotide (FAD) containing reductase, an iron 
sulfur protein and the P450 protein/enzyme. Class II P450 system on the other hand 
only has two components, the NADPH dependent cytochrome P450 reductase 
consisting of a FAD and flavin mononucleotide (FMN) and the P450 protein (Munro 
and Lindsay, 1996).  Class II is found in eukaryotic microsomes, associated with the 
endoplasmic reticulum and is involved in the steroid metabolism and detoxification 
pathways.  Class III P450 system is found in bacteria.  It is similar to that of class II 
however the diflavin reductase peptide is fused to that of the P450 protein forming a 
Literature review 
 
  
 
16
           ER
single polypeptide (Figure 1.3) (Miles et al., 2000; Werck-Reichhart and Feyereisen, 
2000; Roberts et al., 2002). Class IV P450 system was identified by Roberts et al. 
(2002) in bacteria. It consisted of a FMN containing reductase with a ferredoxin- like 
centre fused to the P450 to form a single polypeptide (Figure 1.3).    Table 1.1 
illustrates the differences in which the four classes of P450 acquire their electron 
source. 
  
 
 
Class I       Class II  
 
 
 
 
 
 
 
 
 
 
 
 
 
Class III      Class IV 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Schematic diagrams showing the differences between the four classes of the P450 
systems. Class I system comprises of three separate components, FAD-reductase, Fe-S protein and the 
P450. Class II systems is a membrane bound system composed of a FAD/FMN reductase and the 
P450. Class III system consists of a FAD/FMN reductase fused to the P450 to make a single 
polypeptide.  Class IV system forms a single polypeptide that is composed of a FMN reductase bound 
to ferredoxin-like centre fused to the P450. ER-Endoplasmic Reticulum (Adapted from Roberts et al., 
2002). 
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Table 1.1: Classification of Cytochrome P450 (Werck-Reichhart and Feyereisen, 2000) 
Classes Characterization feature 
I Requires an FAD containing P450 reductase and an iron sulfur redoxin 
 
II 
Requires only FAD/FMN containing P450 reductase for the transfer of 
electrons 
III Self sufficient and does not require an electron donor 
IV Receive electrons directly from NAD(P)H 
 
 
1.5.4 Function and mechanism 
Monoxoygenases have diverse enzymatic activities.  They are known to occur in a 
range of functions including steroid biogenetics, xenobiotic detoxification, drug 
metabolism and many other reactions (Guengerich, 1991). P450s have a general 
catalytic mechanism as described in Figure 1.4 (Porter and Coon, 1991; Hodgson and 
Strobel, 1996).  The reaction requires electrons from NAD(P)H through redox 
partners. The oxygen molecule (O2) is activated which leads to the insertion of one 
oxygen atom into an organic substrate (RH) and the other is reduced to form water. 
 
RH + O2 + NADPH + H+   →   ROH + H2O + NADP+ 
Figure 1.4: Mechanistic reaction of Cytochrome P450:  RH represents substrate. 
 
The reaction is initiated when the substrate binds to the active site of P450.  This 
binding leads to a lowering of the redox potential allowing transfer of an electron 
from redox partners Cytochrome b5 and Cytochrome P450 reductase (CPR). 
Microsomal P450s use Cytochrome P450 reductase that contains FAD and FMN 
P450
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domains as their electron donor (Degtyarenko and Kulikova, 2001).  A change in spin 
state of the heme iron occurs at the active site.  The Fe3+ ion is reduced as a result of 
the first electron transfer (Figure 1.5).  Oxygen (O2) binds rapidly to Fe2+ forming 
Fe2+-O2. This complex slowly forms a stable Fe3+-O2- complex.  A second electron 
transfer occurs, leading to the formation of a superoxide complex (O2-).  The oxygen 
(O2) bond is cleaved resulting in the formation of (Fe-O)3+ complex and water.   
 
The oxygen from Fe-ligand is transferred to the substrate forming a hydroxylated 
compound.  The product is released from the active site and the P450 regains its 
initial state and the cycle repeats itself (Figure 1.5) (Miles et al., 2000; Munro et al., 
2007).  Flow of electrons within the P450 system is as follows:  NAD(P)H → FAD 
→ FMN → Heme (Smith et al., 1994; Wang et al., 1997).  In microsomal P450s the 
membrane (Phospholipid) has been shown to have an influence on the binding of 
substrate to P450 as well as the enzyme activity (Murtazina et al., 2004). 
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Figure 1.5: Catalytic cycle of P450.  RH represents the substrate and ROH is the oxygenated product. 
(Adapted from Miles et al., 2000; Munro et al 2007). 
 
 
1.5.5 Structure  
Poulos et al (1985) determined the first crystal structure of Pseudomonas putida P450 
that was bound to a camphor substrate (P450cam).  It was resolved to a resolution of 
2.6 Å by x-ray crystallography.  The topography of P450 has been shown to have a 
triangular prim shape (Figure 1.6).  Forty percent of the residues make up twelve 
helical segments.  The structure was shown to have five anti-parallel β pairs (Poulos 
et al., 1985).  
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Figure 1.6: Ribbon representation of Cytochrome P450 (human CYP3A4 complexed with 
ketoconazole). The heme molecule is indicated in red and the substrate in black (PDB code: 2ibjA; 
Ekroos and Sjögren (2006). A-L indicate helices, C-terminal and N-terminal are indicated. Model was 
generated using Deep view Swiss-Pdb viewer and PyMOL (Guex and Peitsch, 1997; DeLano, 2002). 
 
 
The heme molecule in all P450s is situated within a cavity surrounded by polar 
residues: four helices (D, E, I, and L) that form a bundle, helices J and K, two sets of 
β sheets and a coil (meander) (Figure 1.6) (Poulos et al., 1985; Werck-Reichhart and 
Feyereisen, 2000). Within the cavity on the proximal face of the heme molecule is a 
highly conserved motif of Pro-Phe-X-X-Gly-X-Arg-X-Cys-X-Gly, which is found 
near the C-terminus. This motif is characteristic of all P450s and is known to bind the 
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heme molecule. The heme molecule is stabilized in position by a cysteine residue that 
forms a fifth ligand to the heme iron (Poulos et al., 1985; Werck-Reichhart and 
Feyereisen, 2000).  The heme cavity structure is stabilized by a conserved motif of 
Glu-X-X-Arg situated within helix K on the proximal side of the heme molecule.  On 
the distal side of the heme molecule is a proton transfer groove that contains a 
conserved region (Ala/Gly/-Gly-X-Asp/Glu/-Thr-Thr/Ser) also known as a P450 
signature and found on helix I (Werck-Reichhart and Feyereisen, 2000). 
 
Substrates have been shown to bind to six regions within the P450 known as substrate 
recognition sites (SRSs) (Figure 1.7 A and B).  These regions occupy 16% of the total 
protein (Gotoh, 1992).  Amino acid mutations occurring within the SRS regions of 
P450 family 2 (CYP2) abolished substrate binding (Gotoh, 1992).  The substrate 
binding and recognition sites are the most variable regions of the proteins (Gotoh, 
1992; Werck-Reichhart and Feyereisen, 2000).  These regions are found near the 
substrate entry and catalytic sites. They are flexible so as to accommodate the binding 
and catalytic reaction of substrates (Werck-Reichhart and Feyereisen, 2000).  The 
active site was identified in mammalian CYP2B4 at a resolution of 1.6 Å where a 
large cleft within the core of the crystal structure was noted.  The opening extended 
from the surface of the protein to the heme molecule.  The cleft was formed by 
helices B' to C and F to G (Figure 1.6) (Scott et al., 2003).  In a substrate free form 
P450cam had a high thermal motion for helices B', F and G suggesting that this 
region was able to move so as to allow substrates in and out of the active site (Poulos 
and Johnson, 2005).   The F and G helices as well as the joining loop (F-G loop) are 
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known to be flexible and were identified to operate as a lid in the opening and closing 
of the active site to allow substrates to enter and leave (Poulos, 2003; Wester, et al., 
2004).  In order to accommodate substrates helices F and G and the F-G loop have 
been identified to reshape around the substrate (Yano et al., 2000).    
 
Most eukaryotic P450s are membrane bound and therefore have a hydrophobic N-
terminus that anchors into the membrane. This region, like that of the substrate 
binding and recognition regions, is highly variable. Next to this region is a hinge that 
consists of Pro-Pro-X-Pro residues that separate the hydrophobic anchor from the rest 
of the molecule (Figure 1.7) (Werck-Reichhart and Feyereisen, 2000).    
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Hyper-variable region          Conserved features 
 
-Membrane-targeting    -Cluster of basic residues 
 hydrophobic segment   
 
-Substrate-recognition site (SRSs)               -Cluster of prolines (often PPGP) 
       
-I-helix groove: distal face of the heme involved 
                          in catalysis 
 
-Glu-X-X-Arg mortif in the K helix 
 
-Heme-binding loop including cysteine 
 coordinated to heme iron 
Features specific to non-ER proteins 
 
-Two positive charges (interaction with ferredoxin) 
 
-Mitochondrial 
 -Chloroplast        targeting sequence 
 
 
Figure 1.7: Primary and tertiary structure of Cytochrome P450. A) Structure of an ER-bound 
Cytochrome P450 protein. B) Structure of various P450 proteins, 1: soluble class I, 2: Mitochondrial 
class II, 3: membrane–bound class III.  Key shows the various functions of the colour-coded domains 
(Adapted from Werck-Reichhart and Feyereisen, 2000).  
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1.5.6 P450 redox partners; Cytochrome P450 reductase and Cytochrome b5 
Cytochrome P450 reductase and cytochrome b5 are important in the P450 system as 
they are the source of electron donors from NADPH to microsomal P450 proteins.  
Without redox partners microsomal P450 enzymes are unable to function 
(Degtyarenko and Kulikova, 2001). 
 
1.5.6.1 Cytochrome P450 reductase (CPR) 
Microsomal NADPH-cytochrome P450 reductase (CPR) (~77 kDa) are membrane 
bound flavoproteins that contain FAD (similar to flavodoxin) and FMN/NADPH 
(similar to ferredoxin-NADP+ reductase) binding domains. The x-ray crystal structure 
of the CPR was resolved at 2.6 Å. The FMN domain is situated at the N-terminus and 
contains a hydrophobic membrane anchor region.  The FAD and NADPH binding 
domains are separated from the FMN domain by a connecting region (Figure 1.8) 
(Wang et al., 1997). CPR is involved in the catalytic transfer of the first electron from 
NADPH. Electrons are accepted from NADPH by the FAD which in turn transfers 
them to FMN that is interacting with the P450 resulting in the reduction of P450 
(Sevrioukova et al., 1999b; Smith et al., 1994; Wang et al., 1997).  Binding of 
eukaryote microsomal P450 to CPR was resolved at a resolution of 2.03 Å. The flavin 
domain was found on the proximal side of the P450 facing the heme molecule 
(Sevrioukova et al., 1999b).  Bridges et al (1998) carried out two mutations on the 
proximal surface of P450 that resulted in a decrease in binding affinity for CPR.   
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Non-membrane bound CPR do not efficiently interact with P450 during electron 
transfer.  Anchoring of the CPR to a membrane creates a suitable orientation for 
efficient transfer of electrons to P450.  CPR is embedded within the membrane in 
such a way that the FMN and FAD/NADPH domains are close to the membrane 
surface so as to have the FMN and P450 in close proximity (Paine et al., 2005).  The 
membrane (Phospholipid) plays an important role in the interaction between P450 
and CPR complex (Müller-Enoch et al., 1984; Paine et al., 2005).   
 
 
 
 
 
 
Figure 1.8: Ribbon representation of Cytochrome P450 reducatse (CPR). A) Liner representation 
of the CPR showing the anchor (Black), FMN (Blue), FAD (Orange) and NAD(P)H (Green) domains 
(Adapted from Wang et al., 1997). B) Ribbon representation of the tertiary structure of CPR. The 
cofactors FMN (Red), FAD (Blue) and NADP+ (Black) are shown in position. N: N-terminal, C: C-
terminal. (PDB code: 1amoA: Wang et al., 1997)  Model was generated using Deep view Swiss-Pdb 
viewer and PyMOL (Guex and Peitsch, 1997; DeLano, 2002). 
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1.5.6.2 Cytochrome b5  (cytb5) 
Cytochrome b5 (cytb5) is a heme containing protein that consists of about 140 amino 
acids (making up a ~17 kDa protein). The crystal structure has been resolved at 2.8 Å 
(Argos and Mathews, 1975). Cytb5 are membrane-bound globular proteins that are 
found within microsomes. They consist of a heme group situated within a 
hydrophobic pocket that is held in position by two histidine residues (Figure 1.9) 
(Rogers and Strittmatter, 1973; Argos and Mathews, 1975). The second electron 
within the P450 reaction has been predicted to come from cytb5. The redox potential 
of cytb5 is +25 mV while P450 is -300 mV.  This suggests that cytb5 may only be 
able to donate the second electron rather than the first (Paine et al., 2005).  In the 
rabbit CYP2B4 system, cytb5 has been shown to transfer electrons faster than CPR 
(Gruenke et al., 1995). In solution cytb5 has two isomer forms, the A and B forms, 
that differ from each other at a rotation of 180º along the heme plane around the α and 
γ meso protons (Arnesano et al., 1999). Cytb5 have been shown to bind to P450 on 
the proximal surface of the P450 heme domain (Bridges et al., 1998; Sevrioukova et 
al., 1999a; Sevrioukova et al., 1999b). Seven mutations on the proximal surface of 
P450 showed a decrease in binding affinity with cytb5 (Bridges et al., 1998).  The 
mechanism of electron transfer from cytb5 to P450 is not clearly understood.  There 
have been suggestions that electrons flow from NADPH → CPR → cytb5 → P450 or 
NADPH → cytb5 reductase → cytb5 → P450 (Paine et al., 2005).  
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Figure 1.9: Ribbon representation of cytochrome b5 (cytb5). The heme group (red) is situated within 
a cleft surrounded by hydrophobic residues (hydrophobic pocket). The two histidines are indicated in 
blue. (PDB code: 1do9A; Banci et al., 2000).  N: N-terminal, C: C-terminal. Model was generated 
using Deep view Swiss-Pdb viewer and PyMOL (Guex and Peitsch, 1997; DeLano, 2002). 
 
1.6 Insect Cytochrome P450 and insecticide resistance 
P450 genes are grouped into clans that are derived from a common ancestor.  The 
clans are named according to the lowest family in the clan (Nelson, 1999).  Insect 
P450 have four clades which are i) CYP2 clade, these are P450s that are involved in 
the physiological function and those that have broader substrate specificity, ii)  CYP3 
clade, these are the insect CYP6 genes which were the first to be cloned and 
characterized within this clade they are closely related to the vertebrate CYP3 and 
CYP15 families.  Insect P450 genes in this clade are the most numerous and are 
mainly found in large clusters. Members in this clade are associated with xenobiotic 
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metabolism as well as insecticide resistance an example is CYP6Z1 that is 
overexpressed in pyrethroid resistant An. gambiae, iii) CYP4 clade, genes from this 
clade are numerous in insects. They are involved in a diversity of functions and are 
inducible metabolizers of xenobiotics such as CYP4C27 in An. gambiae that is 
overexpressed in DDT resistant strain, iv) Mitochondrial clades: in insects there are 
two types one that serves as a physiological function and those that are taxon specific 
paralogous P450s. In Drosophila and Anopheles CYP12 belong to this clade and are 
associated with insecticide resistance (Claudianos et al., 2006; Feyereisen, 2006).        
 
The majority of P450 studies have been carried out in mammalian systems.  It was 
determined however that the structure and mechanisms were conserved from 
prokaryotes (bacteria) to eukaryotes (Drosophila melanogaster) (Feyereisen, 1999).  
In insects P450s are found within all tissues of the insect (Feyereisen, 1999).  P450 
enzymes play an important role in the detoxification of insecticides therefore 
conferring resistance (Bergé et al., 1998; Feyereisen, 1999; Scott, 1999; Hemingway 
and Ranson, 2000). They have been implicated in insecticide resistance mechanisms 
in a number of insect species. For instance, in Drosophila melanogaster it was found 
that three substitution mutations in the P450 gene CYP6A2 conferred resistance.  
These mutations were found on the dorsal side of helix I within the vicinity of the 
substrate recognition valley of the active site.  This region is important for enzyme 
activity (Bergé et al., 1998; Amichot et al., 2004).   
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Rongnoparut et al (2003) reported two novel P450 genes belonging to the CYP6 
family (CYP6AA2 and CYP6P5).  In their findings they noted that CYP6AA2 
mRNA transcription was produced at a greater amount compared to that of CYP6P5 
when carrying out mRNA expression studies on both resistant and susceptible 
mosquitoes. It was therefore concluded that CYP6AA2 was involved in resistance.  
Pyrethroid resistant houseflies were noted to have a high transcription level of 
CYP6D1 mRNA, indicating that CYP6D1 was involved in pyrethroid resistance 
(Kasai and Scott, 2000).  The CYP6 family has been implicated in insecticide 
resistance more often than any other CYP family to date.   
 
Apart from the CYP6 family, three other CYP families (CYP4, CYP9 and CYP12) 
have also been implicated in insecticide resistance (Danileson et al., 1997; Guzov et 
al., 1998; Hemingway and Ranson, 2000; Scharf et al., 2001; Ranson et al., 2002a).  
In studies carried out on western corn rootworms it was noted that mRNA transcript 
signals from CYP4 genes (CYP4AJ1, CYP4G18 and CYP4AK1) were increased in 
insecticide resistant individuals speculating that CYP4 are involved in 
organophosphate resistance (Scharf et al., 2001).   
 
In the tobacco budworm, Helithis virescens CYP9A1 was the first member of the 
CYP9 family to be isolated associated with carbamate resistance. It was found to be 
similar to the insect CYP6 family (Rose et al., 1997).  Reports on housefly CYP12 
showed high levels of CYP12A1 mRNA in insecticide resistant flies. CYP12A1 was 
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expressed and purified from Escherichia coli and was able to metabolize a variety of 
insecticides as well as some xenobiotics (Guzov et al., 1998).  
 
In order to characterize genes differentially expressed in resistant An. gambiae, David 
et al (2005) developed a microarry detoxification chip. This array was able to isolate 
five strongly up-regulated genes present in DDT resistant An. gambiae. Amongst 
these five genes, two were P450s. Of these, CYP6Z1 was previously isolated and 
shown to have a high expression level in resistant mosquitoes (Nikou et al., 2003). 
Up-regulation in the other (CYP325A3) was unexpected as it had never previously 
been implicated in insecticide resistance.  Plant alkaloid detoxification P450s, 
CYP4D1 and CYP4D10 of Drosophila melanogaster and Drosophila mettleri 
respectively were shown to have high amino acid sequence similarity to that of 
CYP325A3.   It is therefore possible that this enzyme might also be involved in 
detoxification.  
 
The An. gambiae genome contains 111, P450 genes of which seven are pseudo genes 
(Ranson et al., 2002b). Only 31, P450 genes have been identified from An. funestus 
(Amenya et al., 2005).  Amenya et al (2005) identified 12 CYP4, 12 CYP6 and 7 
CYP9 partial genes that have a high percentage sequence similarity to that of An. 
gambiae.  Only one of these was unique to An. funestus (CYP9J14) and showed a low 
similarity (55%) to any known An. gambiae CYP9 ortholog.   Amenya et al (2008) 
have further shown that one of these CYP6P9 is overexpressed in a pyrethroid 
resistant An. funestus laboratory colony.   
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1.7 Hypothesis 
Cytochrome P450 (CYP6P9) is involved in the protection of An. funestus exposed to 
pyrethroid insecticides.  Its resistance mode of action is detoxification by hydrolysis 
of pyrethroids.   
 
1.8 Objective 
 The objective of this study is to isolate the full length coding region of CYP6P9 from 
pyrethroid resistant (FUMOZ-R) and susceptible (FANG) strains.  Compare deduced 
amino acid sequences.  Cytochrome P450 heterologous expression systems will be 
investigated to obtain high levels of CYP6P9.  This will be used in metabolic studies 
to determine if cytochrome P450s in the resistant stain are able to hydrolyze 
pyrethroids (permethrin) to its metabolites.   Redox partners (CPR and cytb5) will be 
isolated so as to co-express with CYP6P9 to obtain a functional P450 system.   
 
1.9 Approach 
To achieve the objectives a number of approaches were carried out.  These involved 
isolation and identification of CYP6P9 from An. funestus pyrethroid resistant 
(FUMOZ-R) and susceptible (FANG) strains.  BLAST (Basic Local Alignment 
Search Tool) was used to determine if the correct genes (belonging to cytochrome 
P450, CYP6 family) were isolated.  Cytochrome P450 redox partners (cytochrome 
P450 reductase and cytochrome b5) from An. funestus were also isolated and 
confirmed by BLAST.  Bioinformatic tools such as multiple sequence alignment was 
used to identify deduced amino acid differences between FUMOZ-R and FANG 
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CYP6P9.  Helices and conserved domains were also identified.  A three-dimensional 
structure was generated using homology modeling to visualize structural differences 
between FUMOZ-R and FANG CYP6P9.   
 
Cytochrome P450 expression systems have never been performed in An. funestus.  
We therefore analyzed various techniques.  In Escherichia coli (E. coli) recombinant 
proteins were expressed using the insect pIX4.0 plasmid and pCWori+ plasmid.  Two 
techniques were employed; i) Bacterial leader sequences ompA (Outer Membrane 
Protein A) was attached to the hydrophobic NH2-terminal of CYP6P9 to allow for the 
expression of the full length CYP6P9 in E. coli host without modifying the NH2-
terminus hydrophobic region.  ii) Modification of the NH2-terminus by replacing the 
first eight amino acid sequences with a short bovine steroid 17 -hydroxylase 
(MALLLAVF) amino acids sequence.   
 
Purification was performed using a 6x His tag purification system employing the 
Ni2+-chelating affinity chromatography.  High Performance Liquid Chromatography 
(HPLC) and Mass Spectroscopy (MS) were used to determine metabolic activity of 
pyrethroids (permethrin) by P450.  
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Chapter Two 
 
 
Isolation and characterization of Anopheles funestus total 
microsomal cytochrome P450  
 
 
2.1 Introduction 
2.1.1 Cytochrome P450 enzyme activities 
Cytochrome P450s found within the membrane of microsomes are referred to as 
microsomal P450s and acquire electrons via electron donors (CPR and cytb5) 
(Yamazaki et al., 1999a).  In the presence of electron donors microsomal P450s are 
known to play important roles in the metabolism of many xenobiotics and 
endogenous compounds.  These enzymes are cable of catalyzing several substrates 
and can overlap in substrate specificity (Korytko et al., 2000; Brown et al., 2003).    
 
P450 enzymes are a major cause of insecticide resistance in insects.  In the house fly, 
CYP6A1 and CYP12A1 were shown to metabolize a variety of insecticides such as 
Aldrin, Heptachlor, Diazinon, and Azinphosmethyl, (Guzov et al., 1998; Sabourault 
et al., 2001).  A number of substrate models such as benzo[a]-pyrene, p-chloro-N-
methylaniline, p-nitroanisole, and 7-ethoxycoumarin have been designed to test the 
activity of P450.   Ethoxycoumarin deethylase (ECOD) activity is a widely used P450 
assay which acts as an indicator for oxidative metabolism (Frank, et al., 1997).  
Amichot et al (2004) also demonstrated that CYP6A2 from fruit flies were able to 
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metabolise DDT to dicofol, dichlorodiphenyl-dichloroethane (DDD) and 
dichlorodiphenyl acetic acid (DDA). 
  
2.2 Objective 
Enzyme activity determines the efficiency at which the enzyme is able of catalysing 
substrates.  This is important in insecticide resistance as this relates to the extent to 
which insecticides are hydrolysed by particular enzymes.  Metabolites produced from 
insecticide metabolism further supports the role of the enzyme in detoxification 
resistance.  The broad objective of this study was to compare the enzyme activity of 
total microsomal P450 from pyrethroid resistant and susceptible An. funestus using 7-
ethoxycoumarin as substrate.  Total microsomal P450 activity from An. funestus was 
also compared with those of other insect P450 activity.  Permethrin metabolism was 
conducted using total microsomal P450 from both resistant and susceptible strains.  
The products were analyzed on a reverse phase HPLC.  
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2.3 Materials and Methods 
2.3.1 Mosquito strains 
Two strains of Anopheles funestus colonized at the National Institute for 
Communicable Diseases (NICD) in Johannesburg, South Africa, were used. The 
pyrethroid resistant strain (FUMOZ-R) is derived from material collected in southern 
Mozambique and the insecticide susceptible strain (FANG) is derived from material 
collected in southern Angola. Both strains are kept under standard insectary 
conditions (25 ºC with a relative humidity of 80% and a 12 hour day/night light).  
Selection of pyrethroid resistance in FUMOZ-R was performed by separating newly 
emerged male and female adults into cages supplied with 10% sucrose solution.  This 
ensured that mating did not occur prior exposure so as to select resistant strains.  A 
standard WHO bioassay was carried out by exposing 2-5 day old adults for one hour 
on filter papers treated with 0.1% lamba-cyhalothrin.  Exposure tubes contained 
about 25 adults per exposure. A total of about ten repeats were performed per age for 
each generation.  Survivors after 24 hour post-exposure from both male and female 
were allowed to mate over a period of six days.  Females were supplied daily with 
blood meals in order to produce eggs.  Eggs were reared to adults and resistance to 
lamba-cyhalothrin was performed as above (Hunt et al., 2005).  Selection for 
permethrin resistance was performed as above on resistant adults using 1.5% 
permethrin.  Once resistance was selected the dosage was reduced to the standard 
0.75% permethrin using filter papers supplied by WHO. 
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2.3.2 Determination of permethrin (pyrethroid) resistance 
 
Resistance to permethrin was performed in order to confirm the level of resistance in 
FUMOZ-R compared to susceptible FANG strain.  Three day old mosquitoes (n=25) 
were transferred into a standard WHO holding tube (tubes containing untreated filter 
paper) (Figure 2.1).  The mosquitoes were then transferred into exposure tubes 
(containing 0.75% permethrin paper) and exposed for 1 hour after which the 
knockdown rate was recorded. The mosquitoes were transferred back into holding 
tubes and supplied with 10% sucrose solution (soaked in a cotton wool pad) and left 
for 24 hours (Figure 2.1).  A final mortality was recorded after 24 hours.  Three 
replicates were performed (WHO, 1998).  
 
 
 
 
Figure 2.1:  Standard WHO holding tube. Mosquitoes are first transferred into the holding tube.  
They are then transferred to the exposure tube containing permethrin treated paper by opening a lead 
that separates the two tubes. After one hour exposure mosquitoes are transferred back to holding tube 
for 24 hours and supplied with a pad containing 10% sucrose solution (WHO, 1998).    
 
Movement of lead 
Pad containing 10% sucrose 
solution is placed here 
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2.3.3 P450 inhibition  
 
Synergist bioassays on FUMOZ-R and FANG strains 
Synergists are used to inhibit/block the function of P450 activity.  The assay was 
performed on both resistant and susceptible strains in order to confirm the 
involvement of P450 in permethrin resistance.  Synergist papers were prepared by 
cutting 12 X 15 cm Whatman no. 1 filter papers.  A 4% solution of Piperonyl 
butoxide (PBO) (0.7 ml [4% PBO in olive oil] and 1.2 ml acetone) was pipetted 
evenly onto the filter paper.  A lead pencil was used to mark the treated surface and 
papers were allowed to dry in a fume hood for 24 hours (developed from Hemingway 
PhD thesis, 1981). 
 
Mosquitoes (n=25) were transferred into a standard WHO exposure tube as 
previously described in section 2.3.2.   Mosquitoes were exposed to the synergist (4% 
PBO) for 1 hour before transferring to a tube containing permethrin (0.75%) paper for 
a further 1 hour with 5minute interval recording of knockdown.  The mosquitoes 
were then transferred into holding tubes and supplied with 10% sucrose solution and 
left for 24 hours.  A final mortality was recorded after 24 hours.  Controls included 
exposure to 4% PBO only and to 0.75% permethrin only.  
 
2.3.4 Preparation of microsomes 
Microsomes were prepared from adult mosquitoes (n=100) and larval midguts 
(n=100) which were homogenised in a cold mortar and pestle that was stored at          
-80 ºC.  The mosquitoes or midguts were homogenised in liquid nitrogen to form a 
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powder.  Buffer A (1 ml; 0.1 M Na2HPO4, 1 mM EDTA, 1mM DTT, 200 mM 
sucrose, 1 μg/ml aprotinin, 1 μg/ml leupeptin and 1 mM PMSF) was added to the 
homogenised midguts/mosquitoes and mixed.  Sample was centrifuged at 5,000 x g 
for 5 minutes and supernatant collected.  The supernatant was centrifuged for 20 
minutes at 10,000 x g.  The supernatant was collected and centrifuged at 50,000 x g 
for 1 hour.  The pellet was collected and Buffer # A added (modified from Perry and 
Bucknor, 1970).  Total protein content was measured using the Bradford’s reagent 
and BSA as the standard (Table 2.1). Absorbance reading was measured at 595 nm. 
 
Table 2.1: Protein determination by Bradford’s assay (standard curve) 
BSA(2 mg/ml) 
(Volume, μl) 

μg/μl
Bradford’sreagent 
(20%) (Volume, μl)
0    0 300 
1    2 300 
2    4 300 
4    8 300 
5  10 300 
6  12 300 
8  16 300 
 
Bradford’s reagent (300 µl) was added to microsomal P450 samples (2 µl) in a 
microtitre plate.   
 
2.3.5 P450 Assay  
i) 7-hydroxycoumarin standard curve 
Substrate 7-ethoxycoumarin was used to assay P450 activity.  In the presence of P450 
enzyme, 7-ethoxycoumarin is hydrolysed to 7-hydroxycoumarin.  A standard curve 
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was prepared using 7-hydroxycoumarin. Sodium phosphate buffer pH 7.2 (0.1 M 
Na2HPO4; 1 mM EDTA; 1 mM DTT; 200 mM Sucrose) (Buffer A) was added to 
various concentrations of 7-hydroxycoumarin (Table 2.2).  Readings were measured 
in a fluorospectrophotometer (Varioskan ™, Thermo Electron Corporation, Finland) at an 
emission of 465 nm and excitation of 390 nm and plotted on a graph against 
concentrations of 7-hydroxycoumarin.  
 
Table 2.2: 7-hydroxycoumarin Standard assay 
nmol 7-hydroxycoumarin (μM) Buffer A 
    0     0 100 
    5     5   95 
  10   10   90 
  20   20   80 
  40   40   60 
  60   60   40 
  80   80   20 
100 100     0 
 
ii) P450 assay on An. funestus microsomal P450.  
In a microtitre plate (white walled) total microsomal P450 (50 µl) was added.  Mix A 
(50 µl; Buffer A, 33.5 µl; 20 mM 7-ethoxycoumarin, 2.5 µl; 14 µl of 10 mM 
NADPH) was added to each well to last for the duration of the reaction.  The reaction 
was incubated for 30 minutes at 30 °C.  Mix B (22.5 µl; 30 mM Glutathione Oxidized 
(GS-SG), 10 µl; 0.5 units Glutathione reductase, 0.5 µl; water, 12 µl) was added and 
allowed to incubate for 10 minutes at room temperature.  The reaction was stopped 
with Tris-acetonitrile (27, 5 µl) (50 mM Tris pH 8; 1:1 acetonitrile).  Readings were 
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measured in a fluorospectrophotometer at an emission of 465 nm and excitation of 390 
nm.  Controls included reactions with no NADPH and another with no enzyme 
(buffer only).   
 
2.3.6 Permethrin metabolism  
Total microsomal P450 (50 µl) was mixed as in Table 2.3.  The reaction was 
incubated in the dark for 2 ½ hours.  A sample (50 µl) was removed and the reaction 
stopped with acetonitrile (50 µl) and centrifuged at 16,000 x g for 3 minutes.    
 
Table 2.3 Reaction mixture for permethrin detoxification 
Component Stock
Reaction 
concentration Volume, μl
MgCl2 10 mM 1 mM 10
Glucose-6- phosphate 100 mM 4 mM 4
NADP+ 10 mM 1 mM 10
G6P dehydrogenase* 38.5 U/ml 1 U/ml 2.6
K2HPO4  pH 7.4 500 mM 50 mM 10
Microsomal P450   50
Permethrin 5 mM 0.05 mM 1
Water   12.4
Volume   100
*G6P dehydrogenase (glucose -6-phosphate dehydrogenase) 
 
The supernatant was loaded onto an HPLC (Ultimate 3000, Dionex, UK) with a flow 
rate of 1.0 ml /min and detected at 232 nm over a period of 30 minutes.  Distinctive 
peaks from test samples (FUMOZ-R and FANG) were compared with controls that 
had no enzymes (No microsomal P450).   
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2.3.7 Permethrin extraction from adult mosquito  
Permethrin was extracted from adult mosquitoes previously exposed to 0.75% 
permethrin in order to isolate metabolites produced as a result of detoxification.  
Extraction was performed on three sets of mosquitoes: exposure to 0.75% permethrin 
for one hour, PBO treated and then exposed to permethrin for one hour and 20% 
knockdown (mosquitoes exposed to 0.75% permethrin until 20% knockdown is 
achieved).   Each mosquito was dipped in methanol to rinse off any excess 
permethrin attached to the outer body as a result of exposure.  The mosquito was 
dried on filter paper.   Mosquitoes (n=50) were homogenised in sodium phosphate 
buffer pH 7.2 (0.1 M Na2HPO4; 1 mM EDTA; 1 mM DTT; 200 mM Sucrose).  The 
homogenate was transferred to a glass tube (tube A) and chloroform (2 ml) was 
added.  Chloroform slowly dissolves plastic tubes hence the use of glass tubes.  The 
mix was centrifuged at 3,000 x g for 5 minutes.  The lower organic layer was 
removed using a glass pipette and placed into a clean glass tube (tube B).  Sulphuric 
acid (2 drops) was added to tube A containing homogenate followed by the addition 
of chloroform (2 ml).  The tube was centrifuged at 3,000 x g for 5 minutes and the 
lower organic layer transferred to tube B.  Tubes were placed in a fume hood and 
chloroform was evaporated by passing nitrogen gas over extraction.  The pellet was 
dissolved in 200 µl of acetonitrile.   The sample was loaded onto an HPLC (Ultimate 
3000, Dionex, UK) with a flow rate of 1.0 ml /min and a wavelength of 232 nm over a 
period of 30 minutes. 
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2.4 Results 
2.4.1 Determination of pyrethroid resistance and P450 inhibition 
The role of P450s in resistance was analyzed by carrying out two tests: the 
permethrin resistance and the P450 synergist assays.  Resistant (FUMOZ-R) and 
susceptible (FANG) strains were exposed to permethrin (0.75%) for one hour.  
FUMOZ-R obtained a zero percent knockdown while 100% knockdown was 
observed for FANG after 60 minutes exposure (Figure 2.2A).  A synergist bioassay 
for P450 inhibition using 4% Piperonyl butoxide (PBO) was performed on both 
FUMOZ-R and FANG strains.  Mosquitoes were exposed to PBO for one hour 
followed by a further one hour exposure to 0.75% permethrin during which 
knockdown was measured.  After 30 minutes exposure, FANG had 100% knockdown 
while FUMOZ-R had a knockdown average of 93% (Figure 2.2A).  Mortality rate 
was measured after 24 hours post exposure.  FUMOZ-R (exposed to 0.75% 
permethrin only) had a zero percent mortality while FANG had 100% mortality 
(Figure 2.2B).  Samples treated with PBO then exposed to 0.75% permethrin 
(FUMOZ-R synergized and FANG synergized) had 100% mortality 24 hours post 
exposure (Figure 2.2B).  A 20% knockdown was achieved when FUMOZ-R was 
exposed for three hours to permethrin (0.75%).  FANG only obtained 20% 
knockdown after three minutes exposure to permethrin (0.75%). 
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Figure 2.2: Exposure to 0.75% permethrin and P450 synergist using 4% piperonyl butoxide.   A) 
Mosquitoes (FUMOZ-R and FANG) were exposed for 1 hour to 0.75% permethrin.  Synergist was 
performed by exposing for 1 hour to 4% PBO, and then exposed to 0.75% permethrin for a further 1 
hour during which knockdown was measures. B) Percentage mortality after 24 hours post exposure 
with 0.75% permethrin.  Standard deviation is represented by error bars. 
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2.4.2 Total microsomal P450 enzyme assay 
Total microsomal P450 were isolated from midguts of mosquito larvae (4th instar) 
and headless adult mosquitoes.  Heads were removed from adult mosquitoes as a 
result of the eye pigment (xanthommatin) which is a P450 inhibitor (Danielson and 
Fogleman, 1994).  Cytochrome P450 assay using 7-ethoxycoumarin was performed 
on larvae midguts and adult mosquitoes to investigate and compare the levels of P450 
activity.  Total protein content of P450 was determined using the Bradford’s standard 
curve (Appendix A2).  The P450 spectrum generally used to measure P450 activity 
was not used due to insufficient P450 protein isolated from microsomal.  In the 
presence of P450, 7-ethoxycoumarin is hydrolysed to 7-hydroxycoumarin as seen 
below.  Hydrolysis of 7-ethoxycoumarin to 7-hydroxycoumarin was determined using 
the 7- hydroxycoumarin standard curve (Appendix A3).    
 
       NADPH         P450          NADP+ 
 
7-ethoxycoumarin    7-hydroxycoumarin 
 
FUMOZ-R had a relatively higher P450 activity for both larval midgut and headless 
adult than that of FANG.  Although other proteins such as GSTs are found within the 
microsome fraction, the assay is specific to only detect P450s. The highest total 
microsomal P450 activity was measured in larval midgut of FUMOZ-R (4.127 ± 1.02 
nmol/min/mg P450 protein).  FUMOZ-R headless adult had a slightly higher activity 
(1.573 ± 0.58 nmol/min/mg P450 protein) than the larval midgut of FANG (1.134 ± 
0.58 nmol/min/mg P450 protein).  The lowest activity was measured with FANG 
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headless adult (0.247 ± 0.09 nmol/min/mg P450 protein) (Figure 2.3).  Statistical 
analysis reveled that there was a significant difference (0.0116) between the larval 
midgut P450 activity of FUMOZ-R and FANG.  P450 analysis between headless 
adults of FUMOZ-R and FANG also showed a significant difference (0.0177) using 
the t-test, p < 0.05 (Statistix 7, Analytical software version 7.0). 
 
Mosquitoes that were exposed to 0.75% permethrin, 20% knockdown and P450 
synergized with PBO were also assayed.  Permethrin exposure was carried out in 
order to induce P450 enzymes.  If induction occurred then high P450 activity would 
be expected.  PBO treated mosquitoes served as controls and low or no P450 
activities were expected.  FUMOZ-R again had the highest activity.  FUMOZ-R      
(20% knockdown) which was exposed to 0.75% permethrin for three hours had the 
highest activity (1.036 ± 0.91 nmol/min/mg P450 protein).  Those that were 1 – hour 
exposed (FUMOZ-R) had a slightly lower activity (0.999 ± 0.19 nmol/min/mg P450 
protein) than the 20% knockdown (FUMOZ-R).  FANG, exposed (1hour exposure) 
(0.374 ± 0.13 nmol/min/mg P450 protein) had a relatively low activity compared to 
that of FUMOZ-R.  Both strains which were treated with PBO had low activities 
(0.254 ± 0.11 and 0.0911 ± 0.14 nmol/min/mg P450 protein for FUMOZ-R and 
FANG respectively) indicating that the total P450s were inhibited with PBO. The 
lowest activity was obtained from 20% knockdown FANG (0.016 ± 0.19 
nmol/min/mg P450 protein) which were only exposed for three minutes (Figure 2.4).  
Negative controls included samples with no NADPH and one with no enzymes 
(Buffer only).  These controls showed no activity.  Statistical analysis reveled that 
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there was significant difference (0.0092) between FUMOZ-R and FANG, exposed to 
0.75% permethrin (t-test, p < 0.05).  No significant differences (0.1310) were noted 
between 20 % knockdown FUMOZ-R and FANG (t-test, p > 0.05) and also PBO-
synergized FUMOZ-R and FANG (0.9891) (t-test, p > 0.05) (Statistix 7, Analytical 
software version 7.0). 
 
 
     
Figure 2.3: P450 assay on total microsomal P450. FUMOZ-R had the highest P450 activity.  Larval 
midgut for both strains had a much higher activity than the adult samples. MG-Midgut and HL-
Headless adult. 
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Figure 2.4:  P450 assay on mosquitoes exposed to 0.75% permethrin.  Mosquitoes were exposed to 
0.75% permethrin, 20% knockdown and PBO.  FANG had a relatively higher activity with the exposed 
samples (for 1 hour to permethrin) compared to the 20% knockdown and PBO treated.  FUMOZ-R 
however had the highest activity with the 20% knockdown sample while the exposed sample (1 hour 
exposed) was slightly lower. FUMOZ-R PBO treated was relatively low compared to the other two. 
Ex-exposed to 0.75% permethrin for one hour; 20% knockdown – exposed to 0.75% permethrin until 
20% mortality was achieved; PBO- exposed to PBO for one hour then exposed to 0.75% permethrin 
for one hour. 
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2.4.3 Permethrin metabolism 
Permethrin exists as two isomers, cis and trans, which are detected at about 10.2 and 
10.5 mins respectively (Choi et al., 2002; Nakamura et al., 2007).  Two permethrin 
peaks were observed at retention times 10 and 11.3 when loaded on an HPLC column 
(Figure 2.5A).   Headless adult microsomal P450 were used since they were not 
exposed to permethrin.  The microsomal homogenates were incubated with 
permethrin and analysed after 20 minutes and again 2 ½ hours after incubation.  After 
2 ½ hours, two small peaks were detected within the FUMOZ-R microsomal P450 at 
retention times 5.5 and 6 (Figure 2.5B).  The peak 1 (6 minutes) formed a shoulder 
with an existing peak at retention 6.1.  This peak (shoulder) was not detected after 30 
minute reaction incubation with permethrin.  Peak 2 (5.5 minutes) appeared slightly 
after 30 minutes and increased after 2 ½ hour incubation (Figure 2.5B).  Controls 
containing no microsomal P450 (no enzyme) were included and no peaks were 
detected at retention times 5.5 and 6.  The profile of FANG was similar to that of the 
control with no peaks.   
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Figure 2.5: HPLC elution profile of permethrin metabolites separated in a C-18 reverse phase 
column.  Mobile phase consisted of acetonitrile/water (90:1). A) Two permethrin peaks are detected 
at retention times 10 and 11.3. B) The region between retention times 3 and 8 was magnified in order 
to visualize metabolites produced as a result of the hydrolysis of permethrin.  Arrows show peaks 
formed as a result of permethrin hydrolysis. Metabolites are only present in the FUMOZ-R fraction. S-
Susceptible and R-Resistant. 
A 
B 
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2.4.4 Permethrin metabolism from adult mosquito 
Chloroform extraction was used to extract permethrin metabolites from three sets of 
mosquitoes; i) 0.75% permethrin exposed, ii) PBO treated and iii) 20% knockdown.  
This was performed on both FUMOZ-R and FANG.  However the HPLC used was 
not sensitive enough to detect distinctive metabolites or permethrin peaks.  Presence 
of metabolites would have been evidence of permethrin metabolism within FUMOZ-
R.  The peaks from FUMOZ-R (0.75% permethrin and 20% knockdown) could then 
been compared to determine the effect of each treatment, however this could not be 
done.  A gas chromatography-mass spectrometry (GC-MS), which is sensitive to 
small amounts of compounds, is required to detect the presence of metabolites from 
these samples. Other instruments such as an electrospray mass spectrometry (ESMS) 
and liquid chromatography-electrospray mass spectrometry (LC-ESMS) can also be 
used.  Due to the unavailability of these instruments we were unable to test for 
permethrin metabolites. 
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2.5 Discussion 
 
Pyrethroid resistance in An. funestus was detected in 1999/2000 (Hargreaves et al., 
2000).  Resistance selection (pyrethroid) was performed by Hunt et al (2005) on 
FUMOZ-R.  This colony (FUMOZ-R) as well as the susceptible (FANG) colony was 
used in this study.  Selection pressure has been stopped for eight years and did not 
seem to decrease resistance over the years.  This was noted by a zero percent 
knockdown after one hour post exposure to 0.75% permethrin and a 100% survival 
after 24 hours.  FANG showed a 100% knockdown after 30 minutes post exposure 
and 100% mortality after 24 hours confirming its susceptibility status.  Increased 
P450 enzyme activity was shown by Brooke et al (2001) to be associated with 
permethrin resistance in this strain.  To confirm that P450s are responsible for 
pyrethroid resistance in An. funestus, a widely used P450 synergist assay using 
piperonyl butoxide (PBO) was performed (Young et al., 2005).  Synergist treated 
FUMOZ-R showed a characteristic profile similar to that of FANG indicating that 
P450s were inhibited and were therefore causing the resistant phenotype.  Brooke et 
al (2001) also compared PBO synergized with non- synergiszd mosquitoes in An. 
funestus resistant to pyrethroid.  They found an increase in mortality with mosquitoes 
synergized compared to non-synergized. 
 
Microsomes have been isolated from adults and larval midguts from Culex 
quinquefasciatus showing that guts contain higher levels of P450 activity than any 
other tissues (Kasai et al., 2000).  This was also noted when analysis of larval 
midguts from both FUMOZ-R and FANG showed a relatively higher P450 activity 
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compared to headless adults (4.7 and 2.6 times higher respectively).  However this 
was the opposite for Drosophila P450 which had a 20-fold higher activity for adults 
compared with larvae (Danielson et al., 1994).  Heads from both adults and larvae 
were removed due to the eye pigment ‘xanthommatin’ which is a P450 inhibitor 
(Danielson and Fogleman, 1994).  FUMOZ-R had a much higher activity for both 
larval midgut and adult with 3.6 and 6.4 fold increases respectively compared with 
FANG.   
 
 The role of P450 in resistance was further supported when high levels of P450 
activity were detected in FUMOZ-R in samples exposed to permethrin.  A sub-lethal 
dosage of permethrin (in this study mosquitoes were exposed to 0.75% permethrin 
until 20% knockdown was obtained) was used to induce P450 genes from both 
FUMOZ-R and FANG.  FUMOZ-R (20% knockdown) was exposed to permethrin for 
three hours to achieve 20% knockdown.  The high enzyme activity may result from 
P450 induction after exposure, which may also be due to the prolonged permethrin 
exposure.  FANG 20% knockdown was achieved after only three minutes of exposure 
to permethrin, any longer resulted in an increase in mortality.  Exposure to piperonyl 
butoxide reduced the activity of P450 in both FUMOZ-R and FANG, however low 
activity was still noted in FUMOZ-R with less than 100% knockdown after 60 
minutes.  The low activity may be due to the fact that PBO does not inhibit all P450s.  
This may arise from some mosquitoes not resting on PBO treated papers during 
exposure.    
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The general P450 substrate, 7-ethoxycoumarin is known to have different rates of 
metabolism with different P450s and in some cases no metabolisms at all (Yamazaki 
et al., 1999b).  This phenomenon indicates that results obtained from using 7-
ethoxycoumain as substrate, to be treated with care.  Other substrates such as 
resorufin also need to be tested alongside 7-ethoxycoumarin. 
 
Permethrin metabolism was performed on both FUMOZ-R and FANG total 
microsomal P450.  Permethrin, trans and cis are detected at times 10.2 and 10.5 
minutes respectively on an HPLC (Choi et al., 2002).  Two primary metabolites are 
produced as a result of permethrin metabolism and these are 3-phenoxybenzyl 
alcohol (retention time 3.7 minutes) and 3-phenoxybenzoic acid (retention time 5.9 
minutes). These were however detected in pyrethroid resistant Nilaparvata lugens 
(Vontas et al., 2001).  The two metabolite peaks were detected only in FUMOZ-R at 
5.5 and 6 minutes.  The peak at 6 minutes corresponds to that of 3-phenoxybenzoic 
acid.  FANG however did not produce peaks but had a profile very similar to the 
negative control (no enzyme) indicating the P450s were not able to metabolize 
permethrin.  No permethrin metabolites were noted from permethrin exposed, PBO 
treated and 20% knockdown mosquitoes.  These experiments were designed to 
identify metabolites produced as a result of metabolism by P450 enzymes.  PBO 
treated mosquitoes were expected to produce no metabolites.  PBO is an inhibitor of 
P450 hence resulting in no activity.  Mosquitoes (20% knockdown) were expected to 
have induced P450 hence the presence of metabolites within the mosquitoes.  Due to 
the low sensitivity detection of very small amounts of compounds hence permethrin 
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metabolites were not detected.  The results obtained are not conclusive and further 
anaylsis are required to determine whether FUMOZ-R is capable of metabolizing 
permethrin.   
 
Metabolite standards 3-phenoxybenzyl alcohol and 3-phenoxybenzoic acid were run 
on an HPLC but produced messy results with unclear peaks.  These results however 
could not be used to analyze the peaks produced by FUMOZ-R.  
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Chapter Three 
 
 
Isolation, identification and characterization of Anopheles 
funestus cytochrome P450s, CYP6P9 and redox partners 
 
 
3.1 Introduction 
3.1.1 Up-regulation of CYP6, P450 genes associated with insecticide resistance 
 
Insect cytochrome P450s have been implicated in the metabolism of insecticides such 
as DDT and pyrethroids (Scott, 1999).  High levels of these enzymes have been 
reported in insecticide resistant strains compared to those of the susceptible strains 
(Brooke et al., 2001; Nikou et al., 2003; Rongnoparut et al., 2003).  Up-regulation of 
these cytochrome P450s in association with insecticide resistance is not clearly 
understood (Sabourault et al., 2001; Daborn et al., 2002). 
 
In Drosophila melanogaster CYP6A2 genes in a DDT-resistant strain were expressed 
at higher levels (20-30 folds) than those of the susceptible strain (Waters et al., 1992).  
Daborn et al (2002) also identified CYP6G1 gene to be associated with DDT 
resistance in Drosophila.  Two An. gambiae strains from the same geological locality 
were isolated and one was found to be resistant to pyrethroid while the other was 
susceptible.  Resistance to pyrethroid was due to cytochrome P450, CYP6Z1.  In the 
resistant strain CYP6Z1 was expressed 11 and 4.5 times (male and female 
respectively) higher than the susceptible strain (Nikou et al., 2003).      
Isolation, idetifivcation and characterization of Anopheles funestus cytochrome P450, CYP6P9and redox partners 
  
 
56
In a multi-resistant Musca domestica (Housefly) strain, two P450s associated with 
pyrethroid resistance (CYP6A1 and CYP12A1) were reported to be constitutively 
over-expressed at the transcriptional level.  This was likely due to a trans-regulation 
event (Sabourault et al., 2001).   In the same species however, a different P450, 
CYP6D1 was over-expressed in a pyrethroid resistant housefly (Tomita et al., 1995).  
This increase in mRNA levels of CYP6D1 in a pyrethroid resistant strain was 
correlated with an increase in CYP6D1 proteins implicating an increase in 
transcription.   
 
3.1.2 Mutations associated with resistant cytochrome P450 gene 
Although increased levels of cytochrome P450s are generally associated with insect 
resistance, SNP’s (single nucleotide polymorphisms) in these enzyme genes have 
been associated with resistance.  In Drosophila it was shown that a loss in over-
production did not necessary mean a loss in resistance.  This was demonstrated using 
CYP6A2 genes that are associated with DDT resistance.  In a DDT resistant 
Drosophila strain, CYP6A2 proteins were found expressed 40 times more than the 
susceptible strain (Bergé et al., 1998).  Backcrosses (15 selections) performed on 
resistant (RDDTR) and susceptible D. melanogaster produced a strain capable of 
metabolizing DDT more effectively than susceptible strain.  This strain however did 
not overproduce CYP6A2.  Comparing CYP6A2 from resistant and susceptible 
strains, three amino acid substitutions were noted within the resistant CYP6A2 
sequence (Bergé et al., 1998).  A putative three dimensional model based on bacterial 
CYP102 known crystal structure was produced.  It revealed that the mutations 
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interfered with the active site.  Enzyme activity on wild-type and mutant, CYP6A2 
showed an increase in hydroxylation activity with 7-ethoxycoumarin, 7-
benzoyloxycoumarin and DDT by mutant CYP6A2 to produce a non-insecticidal 
dicofol (Bergé et al., 1998).   Work carried out by Amichot et al (2004) revealed that 
the point mutations (Arg335 to Ser335, Leu336 to Val336 and Val476 to Leu476) observed 
in CYP6A2 were important in the metabolism of DDT.  These mutations were 
clustered within the distal side of helix I close to the substrate recognition cleft.   
  
3.2 Objective 
Monooxygenases are one of the major mechanisms involved in insecticide resistance, 
specifically resistance to pyrethroids.  Despite this, very little is known about this 
complex resistance mechanism.  The broad objectives of this study was to isolate, 
identify and compare conserved amino acids of An. funestus, CYP6P9 with those of 
other insect cytochrome P450s involved in insecticide metabolism using 
bioinformatics tools such as the Basic Local Alignment Search Tool (BLAST) and 
primary sequence alignments to identify structural features of potential functional 
importance.  CYP6P9 from resistant and susceptible strains were compared.  
Anopheles funestus redox partners, cytochrome b5 and NADPH-cytochrome P450 
reductase were also isolated and characterized.  The redox partners are important 
because together with P450 enzymes they form a functional P450 system.  Putative 
three-dimensional structures were generated to allow for the identification of domains 
and predicted orientation of important residues.  These genes were also used for later 
recombinant studies in Chapter 4.     
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3.3 Materials and Methods 
3.3.1 Genomic DNA isolation  
Total genomic DNA was extracted from mosquitoes in order to amplify CYP6P9 
genomic DNA to determine sequence as well as introns present.  In a 1.5 ml 
microcentrifuge tube, mosquitoes (n = 3) were ground in liquid nitrogen and 
resuspended in 200 µl extraction buffer (0.08 mM NaCl, 5.47% sucrose, 0.06 M 
EDTA, 0.5% SDS and 0.1 M Tris-Cl, pH 8.6).  The DNA extract was incubated in a 
water bath (70 ºC) for 30 minutes followed by the addition of potassium acetate (0.01 
M) and incubated on ice for 30 minutes. Supernatant was collected by centrifuging at 
16,000 x g for 10 minutes and 100% ethanol (400 µl) was added.  The supernatant 
was further incubated at -20 ºC for 1 hour followed by centrifuging at 16,000 x g for 
30 minutes.  The pellet was washed in 75% ethanol (200 µl) by centrifuging at 16,000 
x g for 1 minute then air-dry for 5 minutes.  The DNA pellet was then resuspended in 
TE Buffer (30 μL; 1 mM Tris-Cl and 1mM EDTA, pH 8.0).  DNA concentration was 
quantified using a nanodrop and stored at –20 ºC until ready for PCR amplification 
(Collins et al., 1987). 
 
3.3.2 RNA isolation 
RNA was extracted in order to prepare cDNA for the amplification of CYP6P9, 
cytochrome b5 and NADPH-cytochrome P450 reductase genes.  Total RNA was 
extracted from three mosquitoes per 200 l of Tri reagent (Sigma, U.S.A, cat no: 
T9424).  Homogenate was allowed to stand for 5 minutes before adding chloroform 
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(40 l), shaking and standing for a further 5 minutes.  The homogenate was then 
centrifuged at 16,000 x g for 15 minutes at 4 ºC.  The top clear aqueous phase 
containing RNA was transferred into a clean 1.5 ml microcentrifuge tube and 
isopropanol (100 l) was added.  The sample was allowed to stand for 5 minutes at 
room temperature before centrifuging at 16,000 x g for 10 minutes at 4 ºC.  
Supernatant was removed and the RNA pellet was washed in 70% ethanol (200 l) 
by centrifuging at 16,000 x g for 1 minute.  The pellet was then air-dried for 5 
minutes and resuspended in 81l deionized water.  RNA was then DNase treated by 
adding 10x DNase I buffer (8 l), followed by DNase I enzyme (2 L) (Sigma, 
U.S.A, cat no: D5307). The reaction was mixed by vortexing and incubating at 37 ºC 
for 30 minutes. DNase I was heat killed at 70 ºC for 15 minutes. The DNase treated 
RNA was cleaned by using RNeasy MiniElute Cleanup kit (QIAGEN, Germany, cat 
no: 74204). All buffers used in the procedure were supplied as part of the clean up 
kit. RLT buffer (350 l) and 100% ethanol (250 l) were added to the RNA.  The 
RNA was loaded onto an RNeasy column and centrifuged at 16,000 x g for 1 minute. 
The column was then transferred into a new 2 ml collection vial, RPE buffer (750 l) 
(content not supplied) was added and centrifuged at 16,000 x g for 1 minute.  The 
flow through was discarded and RPE buffer (750 l) was again added and centrifuged 
at 16,000 x g for 1 minute. The flow through was discarded and the column was 
centrifuged at 16,000 x g for 1 minute. The column was then transferred to a clean 1.5 
ml microcentrifuge tube and RNase-free water (50 l) added and allowed to stand for 
1 minute at room temperature.  The column was centrifuged at 16,000 x g for 1 
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minute and RNA was collected.  RNA concentration was measured using a nanodrop 
and stored at -80 ºC until ready for use.  
 
3.3.3 Preparation of cDNA for the amplification of open reading frames 
CYP6P9, cytb5 and CPR 
 
Synthesis of cDNA was prepared in order to obtain open reading frame of CYP6P9, 
cytb5 and CPR.  Total RNA was used for synthesizing cDNA.  Oligo (dT) adaptor [5’ 
GACTCGAGTCAT CGATTTTTTTTTTTTTTTVN 3’] and dNTP (10 mM) (Inqaba 
Biotechnical Industries, South Africa) was added to total RNA (2 L) and incubated 
at 65 ºC for 5 minutes followed by chilling on ice for 1 minute.  First strand buffer 
(5X; 8 L), DTT (0.1 M; 2 L) and RNAsin (0.5 L) (All supplied by superscript kit, 
Invitrogen, U.S.A, cat no: 18080-093) were added to the RNA mixture then incubated 
at 50 ºC for 2 minutes.  Superscript III RNase H ¯ reverse transcriptase (0.5 
L)(Invitrogen, U.S.A, cat no: 18080-093) was added to the RNA mixture which was 
then incubated at 55 ºC for 60 minutes and heated to 70 ºC for 15 minutes.  
Synthesized cDNA (1 L) was used for the amplification of CYP6P9, Cytochrome b5 
and NADPH-cytochrome P450 reductase genes.  Gene specific primers were 
designed based on the An. gambiae sequence to amplify genes of interest (Table 3.1).   
The same PCR conditions were used for all genes (Table 3.2 and 3.3). 
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Table 3.1: Primers used for gene amplification 
Primer Sequence  Tm 
CYP6P9 Forward 5' ATG GAG CTA ATT AAC GCG GT 3' 58 ºC 
CYP6P9 Reverse 5' CTA CAA CTT TTC CAC CTT CA 3'  56 ºC 
cytb5  Forward 5’ATG TCG GGA AGT GAA AAC GTA 3'   56 ºC 
cytb5  Reverse 5' TTA CTG GGT GAA GTA GA ACC 3' 58 ºC 
CPR   Forward 5' ATG GAC GCC CAG ACA GAA ACG 3' 66 ºC 
CPR   Reverse 5' TTA GCT CCA CAC GTC CGC CGA GTA T 3' 69 ºC 
 
Table 3.2: PCR protocol (TakaRa Taq ™, Takara Bio Inc, Japan, cat no: R001AM) 
Reagents Volume (l) Final concentration 
10 x Buffer            5                    1x 
dNTP mix (10 mM)            5               1 mM 
MgCl2 (25 mM)            3             1.5 mM 
Forward Primer (3.1 M)            4          0.248 M  
Reverse Primer (3.1 M)            4          0.248 M 
Water variable  
Template DNA variable  50pg-1g/50l 
Taq         0.4               0.4 u/l 
Total volume          50  
 
Table 3.3: PCR conditions 
Stage Cycles Temperature Time 
1   1     94 ºC 2 minutes 
2 30    94 ºC 30 seconds 
    55.1 ºC 1 minute 
       72 ºC 2.5 minutes 
3   1    72 ºC 10 minutes 
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3.3.4 Cloning of CYP6P9, cytb5 and CPR into pGEM-T Easy Vector  
i) Ligation:   
Ligation of gDNA and cDNA into pGEM-T Easy vector was performed in order to 
allow for sequencing as well as subcloning of cDNAs into suitable expression 
vectors.  Amplified PCR products of CYP6P9, cytochrome b5 and NADPH-
cytochrome P450 reductase were separately ligated into pGEM-T Easy Vector 
(Promega, U.S.A, cat no: A1360).  A detail on ligation reaction is provided in Table 
3.4. 
Table 3.4:  pGEM-T Easy vector ligation protocol 
Reagents volume (l) 
2x Rapid Ligation Buffer, T4 DNA Ligase        5 
pGEM-T Easy Vector (50 ng)        1 
PCR Product (200 ng)         3 
T4 DNA Ligase (3 weiss unit/unit)        1 
Total volume      10 
 The reaction was mixed by pipetting and incubated overnight at 4 ºC.  
 
ii) Transformation:  
High efficiency competent cells JM 109 (50 l) were added to ligation reaction (5 l) 
in a sterile 1.5 ml tube on ice. The reaction was mixed by gently flicking the tube and 
storing on ice for 20 minutes.  The cells were heat-shocked at exactly 42 ºC in a water 
bath for 50 minutes and immediately stored on ice for 2 minutes. Luria Bertani (LB) 
(see Appendix A1 for recipe) broth (950 l) was added to cells and incubated at 37 ºC 
for 2 hours with shaking at 200 rpm.  Transformed cells (100 l) were plated onto LB 
plates (see Appendix A1 for recipe) containing ampicillin (AMP) (100 g/ml), 
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isopropyl-1-thio-β-D-galactopyranoside (IPTG) (0.5 mM) and 5-bromo-4-chloro-3-
indolyl-b-D-galactopyranoside (X-Gal) (80 g/ml).  The plates were incubated at    
37 ºC overnight.  Positive clones were selected on the bases of blue and white 
colonies, with the white colonies containing the insert of interest.    
 
3.3.5 Small scale plasmid isolation of CYP6P9, cytb5 and CPR 
Single white colonies were selected and grown in LB Broth (5 ml) containing AMP at 
37 ºC overnight with shaking (200 rpm).  Plasmids were isolated using the QIAGEN 
Plasmid Mini kit (QIAGEN, German, cat no: 2125).  All buffers used in this 
procedure were included in this kit.  Overnight culture (1 ml) was added to a 1.5 ml 
microcentrifuge tube and centrifuged at 16,000 x g for 1 minute. The supernatant was 
discarded and pellet was resuspened in 0.3 ml of Buffer P1 (50 mM Tris.Cl, pH8.0; 
10 mM EDTA; 100 µg/ml RNase A). Buffer P2 (0.3 ml; 200 mM NaOH, 1% SDS) 
was added to cells, gently mixed and incubated at room temperature for five minutes 
in order to lyses cells. Chilled Buffer P3 (0.3 ml; 3.0 mM potassium acetate, pH 5.5) 
was added, gently mixed and incubated on ice for 5 minutes to allow for cell debris 
precipitation and renature of circular DNA. Cells were then centrifuged at 16,000 x g 
for 10 minutes. QIAGEN-tip 20 columns were equilibrated by passing through 1 ml 
of Buffer QBT (750 mM NaCl; 50 mM MOPS, pH 7.0; 15% isopropanol; 0.15% 
Triton® X-100) by gravity flow. Supernatant containing plasmids were carefully 
transferred to equilibrated QIAGEN-tip 20 columns and allowed to enter the resin by 
gravity flow.  DNA bound to the column was washed with 4 ml of Buffer QC (1.0 M 
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NaCl; 50 mM MOPS, pH 7.0; 15% isopropanol). The columns were then transferred 
to sterile 1.5 ml tubes, DNA was eluted with 0.8 ml of Buffer QF (1.25 M NaCl; 50 
mM Tris.Cl, pH 8.5; 15% isopropanol). Isopropanol (0.56 ml) was added to 
precipitate DNA, followed by centrifugation at 16,000 x g for 30 minutes.  DNA 
pellet was washed with 70% ethanol (1 ml) by centrifuging at 16,000 x g for 1 minute 
then air-dried for five minutes. The pellet was resuspended in ultra pure water (30 
µl).  Plasmid concentration was quantified using the nanodrop and stored at -20 ºC till 
ready for use.  Glycerol (30%) was added to plasmids and stored at -70C as backup.  
 
3.3.6 Isolation and identification of open reading frame cDNA sequences of 
CYP6P9, cytb5 and CPR 
 
Isolated plasmids (pGEM-T/CYP6P9, pGEM-T/cytb5 and pGEM-T/CPR) were 
sequenced by Inqaba Biotechnical Industries (South Africa) using pGEM-T Easy 
vector primers T7 and SP6 (Table 3.5).  Once the sequences were known, internal 
primers for CYP6P9 and CPR were designed using inner regions to sequence the 
entire internal regions of CYP6P9 and CPR (Table 3.5).   
 
Table 3.5 Primers used to sequence genes 
Primer Sequence  Tm 
T7 5' TAA TAC GAC TCA CTA TAG GG 3' 48 ºC 
SP6 5' TAT TTA GGT GAC ACT ATA G 3' 50 ºC 
CYP6P9 internal Forward 5' CTG TGC ATT CGG GAT TGA G 3'  60 ºC 
CYP6P9 internal Reverse 5' CCC TTG CCA ACA CTC CC 3' 62 ºC 
CPR internal Forward 5' AAA GTT TTG GCC AAC GGG 3' 57 ºC 
CPR internal Reverse 5' GCA GAC GCG GTA ACA GTT 3' 59 ºC 
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Sequence identity was confirmed by performing a nucleotide-nucleotide BLAST 
search (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi). Genomic DNA was also 
sequenced in order to determine number of introns as well as locations. 
 
3.3.7 Bioinformatics studies 
Sequenced genes were submitted to Genbank database (http://www.ncbi.nlm.nih.gov/ 
Genbank/submit.html) to obtain accession numbers. Multiple sequence alignments 
were performed between protein sequences of interest and those of other organisms 
that were obtained from the protein database (http://www.ncbi.nlm.nih.gov/ 
entrez/query) using ClustalW (http://www.ebi.ac. uk/clustalw/).  Homology models 
were generated using SwissModel First Approach Mode (http://swissmodel.expasy. 
org/SM_FIRST.html) containing known crystal structures as templates that were 
obtained from the protein data bank (http//www.expasy.org/ swissmod/SM_ 
Blast.html). PyMOL programme (DeLano, 2002) was used to visualise the generated 
models. 
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3.4 Results 
3.4.1 Identification of CYP6P9 in Anopheles funestus, FUMOZ-R   
Amplification of An. funestus was achieved using newly designed forward and 
reverse primers based on An. gambiae sequence information on CYP6P3.  A 
fragment of ~1,500bp was amplified using An. funestus cDNA template (Figure 3.1).   
The fragment was cloned into pGEM-T Easy vector and sequenced to verify whether 
it was a P450 gene.  BLAST analysis confirmed that the fragment was 80% identical 
to that of An. gambiae CYP6P3 gene.     
 
     
Figure 3.1: Amplified fragment of CYP6P9 cDNA. A fragment size of 1,530 bp was amplified from 
An. funestus cDNA.  PCR fragments were run on a 1% TAE agarose gel and viewed under UV light. 
 
Sequence analysis showed that CYP6P9 was 1,530 bp in size.  The start (ATG) and 
stop (TAG) codons were identified using GeneRunner sequence analysis programme 
(http:// www. generunner.com) which produced three different reading frames.  The 
correct reading frame was identified by start codon ATG which encodes for 
CYP6P9 cDNA 1500 bp 
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methionine (Met) amino acid.  The stop codon TAG which does not encode for any 
amino acid was identified as the end of the open reading frame.   The open reading 
frame of 1,530 bp encoded for a protein of 509 amino acids in length.  Start and stop 
codons used in An. funestus P450 genes are shown in Table 3.6.   
 
Table 3.6:  Start and stop codons used in An. funestus P450 genes 
 Codon Amino acid 
Start  ATG Met 
Stop TGA End 
 TAG End 
 TAA End 
Generatd using http://bioinformatics.org/sms2/codon_usage.html 
 
In order to determine the differences in nucleotide sequence at mRNA level between 
the resistant (FUMOZ-R) and (FANG) susceptible strains, CYP6P9 cDNA from 
FANG was also isolated.  Both CYP6P9s were characterized as shown in the next 
section. 
    
3.4.2 Sequence comparison between resistant vs susceptible Anopheles 
                funestus CYP6P9  
 
  
  
Sequence comparison between CYP6P9 cDNA from FUMOZ-R and FANG was 
performed in order to identify any nucleotide differences that may affect the amino 
acid sequence.  Only eleven nucleotide differences were noted between the two 
sequences (Figure 3.2).  These differences resulted in four amino acid sequence 
differences which in turn may result in differences that may be associated with 
substrate binding or tertiary structure (Figure 3.3).  Identification of helices (A-L) and 
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substrate recognition sites (SRS 1-6) on the secondary structure were determined by 
sequence aligning CYP6P9 with known crystallographic CYP101A1 sequence as 
template (Poulos et al. 1987; Gotoh, 1992).  Only four amino acid variations were 
found.  The first amino acid variation (position 14, Glu to Val) was found near the 
NH2 terminus.  The second amino acid variation (position 77, Val to Met) was noted 
between helices A and B.  The third variation (position 221, Ile to Phe) was found 
within the F-G loop near SRS-2.  The fourth variation (position 361, Ile to Met) was 
found within helix K.    
 
An. funestus CYP6P9 genomic DNA (FUMOZ-R) was also amplified and sequenced 
to determine number of introns as well as sizes.  One intron was identified which was 
56 bp when aligned with CYP6P9 cDNA sequence.   This intron was situated in helix 
K just before the ETLR domain (Figure 3.3).   
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FUMOZ-R         ATGGAGCTAATTAACGCGGTGTTGGCCGCGTTCATCTTCGTAGTGTCGGCAGTGTACCTT 60 
FANG            ATGGAGCTAATTAACGCGGTGTTGGCCGCGTTCATCTTCGAAGTGTCGGCAGTGTACCTT 60 
                **************************************** ******************* 
 
FUMOZ-R         TTCATTCGGAACAAACATAATTACTGGAAAGACAATGGATTCCCGTATGCGCCGAACCCA 120 
FANG            TTCATTCGGAACAAACATAATTACTGGAAAGACGATGGATTCCCGTATGCGCCGAACCCA 120 
                ********************************* ************************** 
 
FUMOZ-R         CATTTTCTGTTCGGACACGCGAAAGGACAGGCCCAGACAAGGCATGCGGCCGACATCCAT 180 
FANG            CATTTTCTGTTCGGACACGCGAAAGGACAGGCCCAGACAAGGCATGCGGCCGACATCCAT 180 
                ************************************************************ 
 
FUMOZ-R         CTGGAACTGTACAAAAAATTCAAGCAGCGCCGTGAGCGGTACGTTGGTATGAGCCAGTTC 240 
FANG            CTGGAACTGTACAAAAAATTCAAGCAGCGCCGTGAGCGGTACGTTGGTGTGAGCCAGTTC 240 
                ************************************************ *********** 
 
FUMOZ-R         ATGATACCTTCATTGCTCGTGATCGATCCAGAGCTGGTGAAAACGATCCTAGTAAAGGAC 300 
FANG            ATGATACCTTCATTGCTCGTGATCGATCCAGAGCTGGTGAAAACGATCCTAGTAAAGGAC 300 
                ************************************************************ 
 
FUMOZ-R         TTTAATGTATTCCACGATCATGGTGTATTCAATAATGCAAGAGACGACCCGCTGTCCGCA 360 
FANG            TTTAATGTATTCCACGATCATGGTGTATTCAATAATGCAAGAGACGACCCGCTGTCCGCA 360 
                ************************************************************ 
 
FUMOZ-R         CATCTTTTTGCGCTTGAAGGTAACCCATGGCGCTTGTTGCGTCAGAAGCTCACGCCAACG 420 
FANG            CATCTTTTTGCGCTTGAAGGTAACCCATGGCGCTTGTTGCGTCAGAAGCTCACGCCAACG 420 
                ************************************************************ 
 
FUMOZ-R         TTCACCTCAGGTCGCATGAAGCAAATGTTTGGTACACTATGGGATGTAGCACTTGAGCTG 480 
FANG            TTCACCTCAGGTCGCATGAAGCAAATGTTTGGTACACTATGGGATGTAGCACTTGAGCTG 480 
                ************************************************************ 
 
FUMOZ-R         GACAAGTATATGGAAGAAAACTATCGTCAGCCGGATATTGAGATGAAGGATGTGCTAGGT 540 
FANG            GACAAGTATATGGAAGAAAACTATCGTCAGCCGGATATTGAGATGAAGGATGTGCTAGGT 540 
                ************************************************************ 
 
FUMOZ-R         CGGTTTACGACAGATGTGATTGGCACCTGTGCATTCGGGATTGAGTGTAATACGCTTAAG 600 
FANG            CGGTTTACGACAGATGTGATTGGCACCTGTGCATTCGGGATTGAGTGTAATACGCTTAAG 600 
                ************************************************************ 
 
FUMOZ-R         ACACCGGACTCGGAGTTCCGCAAATACGGCAACAAAGCGTTTGAGTTTAATCTGATGATT 660 
FANG            ACACCGGACTCGGAATTCCGCAAATACGGCAACAAAGCGTTTGAGTTTAATCTGATGATT 660 
                ************** ********************************************* 
 
FUMOZ-R         TTTCTAAAAACTTTCTTAGCATCGGCTTATCCGTCACTTGTGCGGAAACTGCGAATGAAG 720 
FANG            ATTCTAAAAACTTTCTTAGCATCGGCTTATCCGTCACTTGTGCGGAAACCGCGAATGAAG 720 
                 ************************************************ ********** 
 
FUMOZ-R         ATAACATTCGACGATGTGGAACAGTTTTTCCTAAAAATTGTTAAGGAAACGGTGGAATAT 780 
FANG            ATAACATTCGACGATGTGGAACAGTTTTTCCTAAAAATTGTTAAGGAAACGGTAGAATAT 780 
                ***************************************************** ****** 
 
FUMOZ-R         CGAGAAAGTAACAACATTAAACGAAACGACTTCATGAACCTGCTGTTGCAGATTAAGAAT 840 
FANG            CGAGAAAGTAACAACATTAAACGAAACGACTTCATGAACCTGCTGTTGCAGATTAAGAAT 840 
                ************************************************************ 
 
FUMOZ-R         AAGGGTAAGCTGGACGACAGCGATGATGGGAGTGTTGGCAAGGGTGAAGTAGGAATGACA 900 
FANG            AAGGGTAAGCTGGACGACAGCGATGATGGGAGTGTTGGCAAGGGTGAAGTAGGAATGACA 900 
                ************************************************************ 
 
FUMOZ-R         CAACGAGAACTTGCGGCACAGGCATTCATTTTCTTCTTGGCCGGTTTCGAGACATCATCC 960 
FANG            CAACGAGAACTAGCGGCACAGGCATTCATTTTCTTCTTGGCCGGTTTCGAGACATCATCC 960 
                *********** ************************************************ 
 
FUMOZ-R         ACGACGCAAAGCTTCTGTCTGTACGAGTTGGCAAAGAACCCTGACATCCAGGAGCGCCTT 1020 
FANG            ACGACGCAAAGCTTCTGTCTGTACGAGTTGGCAAAGAACCCTGACATCCAGGAGCGCCTT 1020 
                ************************************************************ 
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FUMOZ-R         AGACAAGAGATCAACCAAGCAATCGAGGAGAATGACGGCCAGGTGACGTACGATGTCGCC 1080 
FANG            AGACAAGAGATCAACCAAGCAATCGAGGAGAATGACGGCCAGGTGACGTACGATGTCGCC 1080 
                ************************************************************ 
 
FUMOZ-R         ATGAACATACAGTATCTGGACAATGTGATAAACGAAACACTTCGCAAGTACCCACCGGTA 1140 
FANG            ATAAACATACAGTATCTGGACAATGTGATAAACGAAACACTTCGCAAGTACCCACCGGTA 1140 
                ** ********************************************************* 
 
FUMOZ-R         GAATCGTTGAGTCGTGTGCCGTCTGTTGACTATGTCATCCCAGGTACGAAACATGTCATT 1200 
FANG            GAATCGTTGAGTCGTGTGCCGTCTGTTGACTATGTCATCCCAGGTACGAAACATGTCATT 1200 
                ************************************************************ 
 
FUMOZ-R         CCCAAACGAACGTTAGTGCAAATTCCGGTTCACGCCATTCAACATGATCCTGAGCACTAT 1260 
FANG            CCCAAACGAACGTTAGTGCAAATTCCGGTTCACGCCATTCAACATGATCCTGAGCACTGT 1260 
                ********************************************************** * 
 
FUMOZ-R         CCCGATCCAGAACGTTTCGATCCGGATCGCTTCTCACCGGAGGAAGTGAAGAAGCGACAT 1320 
FANG            CCCGATCCAGAACGTTTCGACCCGGATCGCTTCTCACCGGAGGAAGTGAAGAAGCGACAT 1320 
                ******************** *************************************** 
 
FUMOZ-R         CCCTTCACGTTCCTCCCATTCGGTGAGGGGCCACGCGTTTGCATTGGGCTTCGGTTTGGT 1380 
FANG            CCCTTCACGTTCCTCCCATTCGGTGAGGGGCCACGCGTTTGCATTGGGCTTCGGTTTGGT 1380 
                ************************************************************ 
 
FUMOZ-R         GTGATGCAGACGAAGGTAGGATTGATAACGCTGTTGAGAAAGTTCCGCTTCTCACCGTCA 1440 
FANG            GTGATGCAGACGAAGGTAGGATTGATAACGCTGTTGAGAAAGTTCCGCTTCTCACCGTCA 1440 
                ************************************************************ 
 
FUMOZ-R         GCGCGTACACCAGATTGTGTAAAGTTCGATCCGAAAATGATCATTCTGTCACCGATCGCG 1500 
FANG            GCGCGTACACCAGATTGTGTAAAGTTCGATCCGAAAATGATCATTCTGTCACCGATCGCG 1500 
                ************************************************************ 
 
FUMOZ-R         GGTAATTACTTGAAGGTGGAAAAGTTGTAG 1530 
FANG            GGTAATTACTTGAAGGTGGAAAAGTTGTAG 1530 
                ****************************** 
 
Figure 3.2: Nucleotide comparison of CYP6P9 cDNA from resistant and susceptible strains.  
Differences are noted in grey shade and identical nucleotides are represented with asterisk. FUMOZ-R 
(GeneBank accession number: AY729661) and FANG (GeneBank accession number: EU450763) 
(ClustalW,http://www.ebi.ac.uk/clustalw/).   
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FANG        MELINAVLAAFIFEVSAVYLFIRNKHNYWKDNGFPYAPNPHFLFGHAKGQAQTRHAADIH 60 
FUMOZ-R     MELINAVLAAFIFVVSAVYLFIRNKHNYWKDNGFPYAPNPHFLFGHAKGQAQTRHAADIH 60 
 
 
 
FANG        LELYKKFKQRRERYVGVSQFMIPSLLVIDPELVKTILVKDFNVFHDHGVFNNARDDPLSA 120 
FUMOZ-R     LELYKKFKQRRERYVGMSQFMIPSLLVIDPELVKTILVKDFNVFHDHGVFNNARDDPLSA 120 
                 
 
 
FANG        HLFALEGNPWRLLRQKLTPTFTSGRMKQMFGTLWDVALELDKYMEENYRQPDIEMKDVLG 180 
FUMOZ-R     HLFALEGNPWRLLRQKLTPTFTSGRMKQMFGTLWDVALELDKYMEENYRQPDIEMKDVLG 180 
                 
 
 
FANG        RFTTDVIGTCAFGIECNTLKTPDSEFRKYGNKAFEFNLMIILKTFLASAYPSLVRKLRMK 240 
FUMOZ-R     RFTTDVIGTCAFGIECNTLKTPDSEFRKYGNKAFEFNLMIFLKTFLASAYPSLVRKLRMK 240 
                 
 
 
FANG        ITFDDVEQFFLKIVKETVEYRESNNIKRNDFMNLLLQIKNKGKLDDSDDGSVGKGEVGMT 300 
FUMOZ-R     ITFDDVEQFFLKIVKETVEYRESNNIKRNDFMNLLLQIKNKGKLDDSDDGSVGKGEVGMT 300 
                 
 
 
FANG        QRELAAQAFIFFLAGFETSSTTQSFCLYELAKNPDIQERLRQEINQAIEENDGQVTYDVA 360 
FUMOZ-R     QRELAAQAFIFFLAGFETSSTTQSFCLYELAKNPDIQERLRQEINQAIEENDGQVTYDVA 360 
                 
 
 
FANG        INIQYLDNVINETLRKYPPVESLSRVPSVDYVIPGTKHVIPKRTLVQIPVHAIQHDPEHY 420 
FUMOZ-R     MNIQYLDNVINETLRKYPPVESLSRVPSVDYVIPGTKHVIPKRTLVQIPVHAIQHDPEHY 420 
                 
 
 
FANG        PDPERFDPDRFSPEEVKKRHPFTFLPFGEGPRVCIGLRFGVMQTKVGLITLLRKFRFSPS 480 
FUMOZ-R     PDPERFDPDRFSPEEVKKRHPFTFLPFGEGPRVCIGLRFGVMQTKVGLITLLRKFRFSPS 480 
                 
 
 
FANG        ARTPDCVKFDPKMIILSPIAGNYLKVEKL 509 
FUMOZ-R     ARTPDCVKFDPKMIILSPIAGNYLKVEKL 509 
                 
 
 
Figure 3.3: Amino acid comparison of CYP6P9 from resistant and susceptible strains. Helices A-
L are represented by (     ) and substrate recognition sites (SRS) 1-6 are indicated by (      ). Position of 
intron is indicated by (   ). Identical residues are shaded in black while different residues are in white 
(http://searchlauncher.bcm.tmc.edu/multi-align/multi-align.html). 
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SRS-3 
SRS-4
SRS-5
SRS-6 
A-helix 
B-helix
C-helix D-helix
E-helix F-helix
G-helix H-helix
I-helix J-helix K-helix 
L-helix 
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3.4.3 Sequence characterization of Anopheles funestus CYP6P9 
 When aligned with An. gambiae CYP6P3 (the ortholog to CYP6P9) (Ameya et al., 
2005), An. funestus CYP6P9s shared an 84.9% identity.  When CYP6P9 (FUMOZ-R) 
was compared to other insect CYP6 proteins involved in insecticide resistance it 
revealed identities of: 45.5%, 34.0%, 33.5% and 40.8% with CYP6A1, Musca 
domestica  (Feyereisen et al., 1989); CYP6Z1, Anopheles gambiae (Ranson et al., 
2002); CYP6D1, Musca domestica (Tomita et al., 1995) and CYP6F1 Culex pipiens 
pallens (Gong et al., 2005) respectively (Table 3.7).  This is expected since these 
P450 systems are all from different subfamilies.  
  
Table 3.7: Percentage homology amongst various insect CYP6 proteins 
 CYP6D1 CYP6Z1 CYP6F1 CYP6P3 FUMCYP6P9 CYP6A1 FANCYP6P9 
CYP6D1   - 41.7 39.3 32.7 33.5 30.0 33.5 
CYP6Z1 41.7    - 40.1 33.8 34.0 33.7 34.0 
CYP6F1 39.3 40.1    - 39.6 40.8 34.0 40.8 
CYP6P3 32.7 33.8 39.6    - 84.9 45.9 84.9 
FUMCYP6P9 33.5 34.0 40.8 84.9   - 45.5 99.3 
CYP6A1 30.0 33.7 34.0 45.9 45.5    - 45.5 
FANCYP6P9 33.5 34.0 40.8 84.9 99.3 45.5    - 
Data assembled using LASERGENE package (DNASTAR, MegAlign program, Clustal W method)  
 
Amino acid multiple sequence alignments of CYP6P9 against other insect CYP6s 
show that they share the conserved regions characteristic of cytochrome P450 
proteins (Figure 3.4).  These conserved regions are the heme-binding region 
(PFxxGxxxCxG) (position 446-456) (positions are based on FUMOZ-R/FANG 
sequences), which contain the highly conserved cysteine residue that holds the heme-
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group in place; the ExxR motif  (position 372-375) situated within helix K that 
stabilizes the heme cavity structure, an oxygen binding pocket (proton transfer 
groove) ((A/G)Gx(E/D) T(T/S)) (position 314-319), on the distal side of the heme 
group within helix I which is also known as the P450 signature.  The YPDP motif, 
found in the CYP6 family (position 420-423) has an aromatic group (Tyr or Phe) and 
two proline amino acids that are conserved.  A microsomal cytochrome P450 motif 
(PERF) (position 428-431) was found downstream of the YPDP motif.  In the 
CYP6P9s and CYP6P3, Asp429 replaces Glu (Werck-Reichhart and Feyereisen, 
2000).  The N-terminal region constitutes 61% hydrophobic amino acids and is 
involved in membrane anchoring (Rongnoparut et al., 2003).   
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CYP6D1          -----MLLLLLLIVVTTLYIFAKLHYTKWERLGFESDKATIPLGSMAKVFHKERPFGLVM 55 
CYP6Z1          -----MILYTIGLIVTFVFLALKYVYSYWDRQGLPNLRPEIPYGNLRILAQKKESFNVAI 55 
CYP6F1          ---MFAWIICAAAAVPLVYFLIVYQFSYWKRRGITQLTPSFPFGDLGPFFRQRSSLGVVY 57 
FUMCYP6P9       MELINAVLAAFIFVVSAVYLFIRNKHNYWKDNGFPYAPNPHFLFGHAKGQAQTRHAADIH 60 
FANCYP6P9       MELINAVLAAFIFEVSAVYLFIRNKHNYWKDNGFPYAPNPHFLFGHAKGQAQTRHAADIH 60 
CYP6P3          MELINAVLAAFIFAVSIVYLFIRNKHNYWKDNGFPYAPNPHFLFGHAKGQAQTRHGADIH 60 
CYP6A1          MDFGSFLLYALGVLASLALYFVRWNFGYWKRRGIPHE-EPHLVMGNVKGLRSKYHIGEII 59 
                       :      ..         .  *.  *:          .      .         
 
CYP6D1          SDIYDKC--HEK-VVGIYLFFKPALLVRDAELARQILTTDFNSFHDRGLYVDEKNDPMSA 112 
CYP6Z1          NDLYDRS--SER-LVGVYLFFRPAILVRDAHLAKRIMVNDFQHFHDRGVYCNEHSDPMSA 112 
CYP6F1          ADVYRLC--KRLPFVGIYFSLRPMLVVNDPELIKNVLVRDFDHFHDRGLYVNEEKDPLSG 115 
FUMCYP6P9       LELYKKFKQRRERYVGMSQFMIPSLLVIDPELVKTILVKDFNVFHDHGVFNNARDDPLSA 120 
FANCYP6P9       LELYKKFKQRRERYVGVSQFMIPSLLVIDPELVKTILVKDFNVFHDHGVFNNARDDPLSA 120 
CYP6P3          QELYRYFKQRGERYGGISQFIVPSVLVIDPELAKTILVKDFNVFHDHGVFTNAKDDPLTG 120 
CYP6A1          ADYYRKFKGSGP-FAGIFLGHKPAAVVLDKELRKRVLIKDFSNFANRGLYYNEKDDPLTG 118 
                 : *           *:     *  :* * .* : ::  **. * ::*:: : ..**::. 
 
CYP6D1          NLFVMEGQSWRTLRMKLAPSFSSGKLKGMFETVDDVADKLINHLNERLKDGQTHVLEIKS 172 
CYP6Z1          NLFALPGQRWKNLRAKLTPTFTSGQLRHMLPTFLAVGSKLEQYL-ERLAN-EKQIVDMRD 170 
CYP6F1          HLFALGGEQWRHHRSKLTPTFTSGRLKEMFTNLVQIGRVLQDHVAKRAGE----DIEIRD 171 
FUMCYP6P9       HLFALEGNPWRLLRQKLTPTFTSGRMKQMFGTLWDVALELDKYMEENYRQP---DIEMKD 177 
FANCYP6P9       HLFALEGNPWRLLRQKLTPTFTSGRMKQMFGTLWDVALELDKYMEENYRQP---DIEMKD 177 
CYP6P3          HLFALEGQPWRLMRQKLTPTFTSGRMKQMFGTIWDVGIELEKCMEQSYNQP---EVEMKD 177 
CYP6A1          HLVMVEGEKWRSLRTKLSPTFTAGKMKYMYNTVLEVGQRLLEVMYEKLEVSS--ELDMRD 176 
                :*. : *: *:  * **:*:*::*::: *  ..  :.  * . : :         ::::. 
 
CYP6D1          ILTTYAVDIIGSVIFGLEIDSFTHPDNEFRVLSDRLFNPKKSTMLERIRNLSTFMCPPLA 232 
CYP6Z1          IVSRYVLDVVASVFFGFEANCLHDPDDAFRVALRDLNNP--DSFINNIRTAGVFLCPGLL 228 
CYP6F1          VMARYTTDIIASVGFGIENDSINEKGNIFREMGTKVFSP---DLKTILRLTSTFFTPKLN 228 
FUMCYP6P9       VLGRFTTDVIGTCAFGIECNTLKTPDSEFRKYGNKAFEFN---LMIFLKTFLASAYPSLV 234 
FANCYP6P9       VLGRFTTDVIGTCAFGIECNTLKTPDSEFRKYGNKAFEFN---LMIILKTFLASAYPSLV 234 
CYP6P3          ILGRFTTDVIGTCAFGIECNTLKTTDSEFRKYGNKAFELN---TMIMMKTFLASSYPTLV 234 
CYP6A1          ILARFNTDVIGSVAFGIECNSLRNPHDRFLAMGRKSIEVP---RHNALIMAFIDSFPELS 233 
                ::  :  *::.:  **:* : :    . *        .         :        * *  
 
CYP6D1          KLLSRLGAKDPITYRLRDIVKRTIEFREEKGVVRKDLLQLFIQLRNTGKISDDNDKLWHD 292 
CYP6Z1          KFTGINSLSPPMKKFTTEVISSHLHQRETGQVTRKDFIQMLTDLR-------------RK 275 
CYP6F1          ALFGFKFIAQEIEDFIMNVVRETLEYRESNKVVRKDMMQLLMQLRNSGTVSIDDR---WD 285 
FUMCYP6P9       RKLRMKITFDDVEQFFLKIVKETVEYRESNNIKRNDFMNLLLQIKNKGKLDDSDD----- 289 
FANCYP6P9       RKLRMKITFDDVEQFFLKIVKETVEYRESNNIKRNDFMNLLLQIKNKGKLDDSDD----- 289 
CYP6P3          RNLHMKITYNDVERFFLDIVKETVDYREANNVKRNDFMNLMLQIKNKGKLDDSDD----- 289 
CYP6A1          RKLGMRVLPEDVHQFFMSSIKETVDYREKNNIRRNDFLDLVLDLKN----NPESI----- 284 
                           :     . :   :. **   : *:*::::. :::                
 
CYP6D1          VESTAENLKAMSIDMIASNSFLFYIAGSETTAATTSFTIYELAMYPEILKKAQSEVDECL 352 
CYP6Z1          AGSSGE--ETLTDAQCAANVFLFYGAGADTSTGTITFTLHELTHNAEAMAKLQQEVDEMM 333 
CYP6F1          IEVSTNK-KKLSLEQVTAHAFVFFIAAYETSSTTISFCLFELARNPEIQKKVQQEIDQVL 344 
FUMCYP6P9       -GSVGKGEVGMTQRELAAQAFIFFLAGFETSSTTQSFCLYELAKNPDIQERLRQEINQAI 348 
FANCYP6P9       -GSVGKGEVGMTQRELAAQAFIFFLAGFETSSTTQSFCLYELAKNPDIQERLRQEINQAI 348 
CYP6P3          -GSLGKGEVGMTQNELAAQAFVFFLAGFETSSTTQSFCLYELAKNPDIQERLREEINRAI 348 
CYP6A1          -SKLG----GLTFNELAAQVFVFFLGGFETSSSTMGFALYELAQNQQLQDRLREEVNEVF 339 
                          ::    ::: *:*: .. :*:: *  * :.**:   :   : :.*::. : 
 
CYP6D1          QRHGLKPQGRLTYEAIQDMKYLDLCVMETTRKYPGLPFLNRKCTQDFQVPD-TKLTIPKE 411 
CYP6Z1          ERH----HGEITYDNINGMKYLDLCVKETLRIYPALAVLNRECTIDYKVPD-SDTVIRKG 388 
CYP6F1          ASH----NGEITYDNINEMKYLENCIDETLRKYPAVPFLNRECSKDYKIPG-TDTTIEKG 399 
FUMCYP6P9       EEN----DGQVTYDVAMNIQYLDNVINETLRKYPPVESLSRVPSVDYVIPG-TKHVIPKR 403 
FANCYP6P9       EEN----DGQVTYDVAINIQYLDNVINETLRKYPPVESLSRVPSVDYVIPG-TKHVIPKR 403 
CYP6P3          AEN----GGEVTYDVVMNIKYLDNVIDETLRKYPPVESLTRVPSVDYLIPG-TKHVIPKR 403 
CYP6A1          DQFK---EDNISYDALMNIPYLDQVLNETLRKYPVGSALTRQTLNDYVVPHNPKYVLPKG 396 
                        ..::*:    : **:  : ** * **    *.*    *: :*  .. .: *  
 
 
 
 
 
 
Hydrophobic N-Terminal anchor region 
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CYP6D1          TGIIISLLGIHRDPQYFPQPEDYRPERFADE-SKDYDPAAYMPFGEGPRHCIAQRMGVIN 470 
CYP6Z1          TQMIIPLLGISMNEKYFPEPELYSPERFDEA-TKNYDADAYYPFGAGPRNCIGLRQGLLL 447 
CYP6F1          TSLVIPVLGLHRDPDHYPEPDRFIPERFSN--FEDISTKPYLPFGAGPRNCIGLRLGKLQ 457 
FUMCYP6P9       TLVQIPVHAIQHDPEHYPDPERFDPDRFSPEEVKKRHPFTFLPFGEGPRVCIGLRFGVMQ 463 
FANCYP6P9       TLVQIPVHAIQHDPEHYPDPERFDPDRFSPEEVKKRHPFTFLPFGEGPRVCIGLRFGVMQ 463 
CYP6P3          TLVQIPAYAIQRDPDHYPDPERFNPDRFLPEEVKKRHPFTFIPFGEGPRICIGLRFGLMQ 463 
CYP6A1          TLVFIPVLGIHYDPELYPNPEEFDPERFSPEMVKQRDSVDWLGFGDGPRNCIGMRFGKMQ 456 
                * : *.  .:  : . :*:*: : *:**     :.  .  :  ** *** **. * * :  
 
CYP6D1          SKVALAKILANFNI----QPMPRQEVEFKFHSAPVLVPVNGLNVGLSKRW---- 516 
CYP6Z1          SKIALVMMLSRFNF----SATIPRKIKFEPVSI-TLAPKGGLPMRIENRAKH-- 494 
CYP6F1          TKAGLVMMLSKFNVRLADETYASKELALDARSV-VLMPVGGIKVSISERRAS-- 508 
FUMCYP6P9       TKVGLITLLRKFRFS--PSARTPDCVKFDPKMI-ILSPIAGNYLKVEKL----- 509 
FANCYP6P9       TKVGLITLLRKFRFS--PSARTPDCVKFDPKMI-ILSPIAGNYLKVEKL----- 509 
CYP6P3          TKVGLITLLRKFRFS--PSARTPERVEYDPKMI-TIAPKAGNYLKVEKL----- 509 
CYP6A1          SRLGLALVIRHFRFT--VCSRTDIPMQINPESL-AWTPKNNLYLNVQAIRKKIK 507 
                :: .*  :: .*..     .     :  .        *  .  : :.        
 
Figure 3.4: Comparison of the open reading frame amino acid sequence of CYP6P9 with other 
insect CYP6s. The YPDP domain conserved in CYP6 genes only is represented in red, heme-binding 
site (PFxxGxxxCxG) is indicated in grey while the cysteine involved in heme coordination is 
highlighted in bold and underlined. The highly conserved ETLR and PERF domains are shaded in 
black and yellow respectively.  The P450 signature AGxETS is represented in blue. The hydrophobic 
anchor region (N-terminus) is in bold. Identical residues are indicated with asterisks. Musca 
domestica: CYP6D1 (GeneBank accession number: AAC46931), Anopheles gambiae: CYP6Z1 
(GeneBank accession number: AAL93296), Culex pipiens pallens: CYP6F1 (GeneBank accession 
number: AAX47271), Anopheles gambiae: CYP6P3 (GeneBank accession number: AAL93295), 
Anopheles funestus (FUMOZ-R): FUMCYP6P9 (GeneBank accession number: AY729661), 
Anopheles funestus (FANG): FANCYP6P9 (GeneBank accession number: EU450763), Musca 
domestica: CYP6A1 (GeneBank accession number: AAA29293). (ClustalW,http://www.ebi.ac.uk 
/clustalw/).    
 
 
 
3.4.4 Isolation of a CYP6 gene (CYP6P13) from An. funestus (FANG) similar 
               to CYP6P9  
 
Forward and reverse primers for CYP6P9 (Table 3.1) were used to isolate CYP6P9 
from FANG genomic DNA so as to compare intron sequences as well as size with 
that of FUMOZ-R gDNA.  The amplified gene was sequenced and BLAST analysis 
identified it to have an 80% identity to that of CYP6P3.  Comparison revealed the 
presence of a second CYP6P9 gene.  Analysis between FANG cDNA and FANG 
gDNA showed numerous nucleotide differences and a 93.7% identity (Figure 3.5).  
FANG gDNA had one intron which was of 57 bp in length.  When FANG gDNA 
intron was compared with FUMOZ-R gDNA intron, it was one bp longer and had 
Heme binding region 
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numerous differences.  This led to the suggestion that a novel P450 gene similar to 
CYP6P9 had been isolated.  The novel CYP6 gene was sent for naming to the P450 
Nomenclature committee and named CYP6P13.       
 
Sequence alignment was performed at the deduced amino acid level between FANG-
CYP6P9 and FANG-CYP6P13.  A total of 32 amino acid differences were noted 
between FANG-CYP6P9 and FANG-CYP6P13 (Figure 3.6).  The novel FANG-
CYP6P13 had all the characteristics of the CYP6 family.  These were noted by the 
presence of a heme-binding region (PFxxGxxxCxG), ExxR motif that stabilizes the 
heme cavity structure, an oxygen binding pocket (AGxETS) also known as the P450 
signature.  The YPDP motif present only in the CYP6 family and microsomal 
cytochrome P450 motif (PERF).  CYP6P13 was sent together with CYP6P9 for 
naming so as to be classified correctly.  The four amino acid differences noted 
between FANG and FUMOZ-R were compared with CYP6P13. They were found to 
be identical to those in FUMOZ-R-CYP6P9, except for F221 which is substituted with 
M221.   
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CYP6P9        ATGGAGCTAATTAACGCGGTGTTGGCCGCGTTCATCTTCGAAGTGTCGGCAGTGTACCTT 
CYP6P13       ATGGAGCTAATTAACGCGGTGTTGGCCGCGTTCATCTTCGTAGTGTCGGCAGTGTACCTT 
              ****************************************:******************* 
 
CYP6P9        TTCATTCGGAACAAACATAATTACTGGAAAGACGATGGATTCCCGTATGCGCCGAACCCA 
CYP6P13       TTCATTCGGAACAAACATAATTACTGGAAAGACAATGGATTCCCGTATGCGCCGAATCCG 
              *********************************.********************** **. 
 
CYP6P9        CATTTTCTGTTCGGACACGCGAAAGGACAGGCCCAGACAAGGCATGCGGCCGACATCCAT 
CYP6P13       CATTTTCTGTTCGGACACGCGAAAGGACAGGCCCAGACAAGGCATGCGGCCGACATCCAT 
              ************************************************************ 
 
CYP6P9        CTGGAACTGTACAAAAAATTCAAGCAGCGCCGTGAGCGGTACGTTGGTGTGAGCCAGTTC 
CYP6P13       CTGGAACTGTACAAAAAATTCAAGCAGCGCGGTGATCGGTACGTTGGTATGAGCCAGTTC 
              ****************************** **** ************.*********** 
 
CYP6P9        ATGATACCTTCATTGCTCGTGATCGATCCAGAGCTGGTGAAAACGATCCTAGTAAAGGAC 
CYP6P13       ATCATACCATCTGTGTTTGTGATCGATCCAGAGCTGGTGAAAACGATCCTAGTAAAGGAC 
              ** *****:**: ** * ****************************************** 
 
CYP6P9        TTTAATGTATTCCACGATCATGGTGTATTCAATAATGCAAGAGACGACCCGCTGTCCGCA 
CYP6P13       TTTAATGTATTCCACGATCGCGGTATTTTCACTAATGCAAGAGACGATCCACTATCAGGA 
              *******************. ***.*:****.*************** **.**.**.* * 
 
CYP6P9        CATCTTTTTGCGCTTGAAGGTAACCCATGGCGCTTGTTGCGTCAGAAGCTCACGCCAACG 
CYP6P13       CACTTGTTTGCGCTGGAAGGTAACCCATGGCGCTTGTTGCGTCAGAAGCTCACGCCAACG 
              **  * ******** ********************************************* 
 
CYP6P9        TTCACCTCAGGTCGCATGAAGCAAATGTTTGGTACACTATGGGATGTAGCACTTGAGCTG 
CYP6P13       TTCACCTCAGGTCGCATGAAGCAAATGTTTGGTACATTATGGGATGTAGCACTTGAGCTG 
              ************************************ *********************** 
 
CYP6P9        GACAAGTATATGGAAGAAAACTATCGTCAGCCGGATATTGAGATGAAGGATGTGCTAGGT 
CYP6P13       GACAAGTATATGGAAGAAAACTACCATCAGCAGGAGATTGAGATGAAGGATGTGCTAGGT 
              *********************** *.*****.*** ************************ 
 
CYP6P9        CGGTTTACGACAGATGTGATTGGCACCTGTGCATTCGGGATTGAGTGTAATACGCTTAAG 
CYP6P13       CGGTTTACGACCGATGTGATTGGCACGTGCGCATTCGGCATCGAGTGTAATACGCTTAAG 
              ***********.************** ** ******** ** ****************** 
 
CYP6P9        ACACCGGACTCGGAATTCCGCAAATACGGCAACAAAGCGTTTGAGTTTAATCTGATGATT 
CYP6P13       ACACCGGACTCGGAATTCCGCAAATACGGTAACAAAGCGTTCGAGCTGGATCTCCTAATT 
              ***************************** *********** *** * .**** .*.*** 
 
CYP6P9        ATTCTAAAAACTTTCTTAGCATCGGCTTATCCGTCACTTGTGCGGAAACCGCGAATGAAG 
CYP6P13       ATGATGAAGTTTTTCTTTGCATCGGCTTATCCGTCACTTGTGCGGAAACTGCGAATGAAG 
              ** .*.**.: ******:******************************* ********** 
 
CYP6P9        ATAACATTCGACGATGTGGAACAGTTTTTCCTAAAAATTGTTAAGGAAACGGTAGAATAT 
CYP6P13       ATCACATTCGATGATGTGGAAGAGTTTTTCGTAAAAATAGTCCGCGAGACGGTGAACTAT 
              **.******** ********* ******** *******:** .. **.*****..*.*** 
 
CYP6P9        CGAGAAAGTAACAACATTAAACGAAACGACTTCATGAACCTGCTGTTGCAGATTAAGAAT 
CYP6P13       CGTGAAATGAACAATGTAAAACGAAACGACTTCATGAACCTGCTGTTGCAGATCAAGAAT 
              **:****  ***** .*:*********************************** ****** 
 
CYP6P9        AAGGGTAAGCTGGACGACAGCGATGATGGGAGTGTTGGCAAGGGTGAAGTAGGAATGACA 
CYP6P13       AAGGGCAAGCTGGACGACAGTGATGATGGGAGTGTTGGCAAAGGTGAAGTAGGAATGACA 
              ***** ************** ********************.****************** 
 
 
Forward Primer1 
and  
Reverse Primer2 
Forward Primer2
Reverse Primer1
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CYP6P9        CAACGAGAACTAGCGGCACAGGCATTCATTTTCTTCTTGGCCGGTTTCGAGACATCATCC 
CYP6P13       CAACTGGAACTTGCGGCACAAGCGTTCGTTTTCTTCCTGGCTGGTTTCGAGACATCATCC 
              **** .*****:********.**.***.******** **** ****************** 
 
CYP6P9        ACGACGCAAAGCTTCTGTCTGTACGAGTTGGCAAAGAACCCTGACATCCAGGAGCGCCTT 
CYP6P13       ACAACTCAAAGCTTCTGTTTGTACGAGCTGGCAAAGAACCCTGAAATCCAGGAGCGCCTT 
              **.** ************ ******** ****************.*************** 
 
CYP6P9        AGACAAGAGATCAACCAAGCAATCGAGGAGAATGACGGCCAGGTGACGTACGATGTCGCC 
CYP6P13       AGACAAGAGATTAACCAAGCAATCGAGGAGAATGACGGCCAGGTGACGTACGATGTCGCC 
              *********** ************************************************ 
 
CYP6P9        ATAAACATACAGTATCTGGACAATGTGATAAACG-------------------------- 
CYP6P13       ATGAACATACAGTATCTGGACAATGTGATAAACGGTATGATAATGAGTTGTTCATCTGGG 
              **.*******************************                           
 
CYP6P9        -------------------------------AAACACTTCGCAAGTACCCACCGGTAGAA 
CYP6P13       AAGTAGGCATACAATTTTTCTTTTGTTTCAGAAACACTTCGCAAGTACCCACCGGTAGAA 
                                             ***************************** 
 
CYP6P9        TCGTTGAGTCGTGTGCCGTCTGTTGACTATGTCATCCCAGGTACGAAACATGTCATTCCC 
CYP6P13       TCGTTGAGTCGTGTGCCGTCGGTTGACTATGTCATCCCCGGTACGAAACACGTGATTGCC 
              ******************** *****************.*********** ** *** ** 
 
CYP6P9        AAACGAACGTTAGTGCAAATTCCGGTTCACGCCATTCAACATGATCCTGAGCACTGTCCC 
CYP6P13       AAACGAACGTTAGTGCAAATTCCGGTTCACGCCATTCAACATGATCCTGAGCACTATCCC 
              *******************************************************.**** 
 
CYP6P9        GATCCAGAACGTTTCGACCCGGATCGCTTCTCACCGGAGGAAGTGAAGAAGCGACATCCC 
CYP6P13       GATCCAGAACGTTTCGATCCGGATCGCTTCTCACCGGAGGAAGTGAAGAAGCGACATCCC 
              ***************** ****************************************** 
 
CYP6P9        TTCACGTTCCTCCCATTCGGTGAGGGGCCACGCGTTTGCATTGGGCTTCGGTTTGGTGTG 
CYP6P13       TTCACGTTCCTCCCATTCGGCGAGGGGCCACGCGTTTGCATTGGGCTTCGGTTTGGTGTG 
              ******************** *************************************** 
 
CYP6P9        ATGCAGACGAAGGTAGGATTGATAACGCTGTTGAGAAAGTTCCGCTTCTCACCGTCAGCG 
CYP6P13       ATGCAGACGAAGGTAGGATTGATAACGCTGTTGAGAAAGTTCCGTTTCTCACCGTCAGCG 
              ******************************************** *************** 
 
CYP6P9        CGTACACCAGATTGTGTAAAGTTCGATCCGAAAATGATCATTCTGTCACCGATCGCGGGT 
CYP6P13       CGTACACCAGATTGTGTAACGTTTCATCCGAAAATGATCACCTTGTCACCGATCGCGGGT 
              *******************.***  ***************   ***************** 
 
CYP6P9        AATTACTTGAAGGTGGAAAAGTTGTAG 
CYP6P13       AATTACTTGAAGGTGGAAAAGTTGTAG 
              *************************** 
 
Figure 3.5: Nucleotide sequence alignment of FANG-CYP6P9 and FANG-CYP6P13 genomic 
DNAs.  CYP6P9 cDNA aligned with CYP6P13 gene isolated from FANG.  Intron is indicated in red 
and box. Primers were designed based on nucleotides in blue to differentiate the two genes. 
Differences are noted in grey shade and identical nucleotides are indicated with asterisks while similar 
residues are indicated with dot.  CYP6P9 (GeneBank accession number: EU450763) and CYP6P13 
(GeneBank accession number: EF152577) (ClustalW, http://www.ebi.ac.uk/clustalw/).    
 
 
intron 
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CYP6P9       1 MELINAVLAAFIFVESAVYLFIRNKHNYWKDNGFPYAPNPHFLFGHAKGQAQTRHAADIH 
CYP6P13      1 MELINAVLAAFIFVVSAVYLFIRNKHNYWKDNGFPYAPNPHFLFGHAKGQAQTRHAADIH 
 
 
 
CYP6P9      61 LELYKKFKQRRERYVGVSQFMIPSLLVIDPELVKTILVKDFNVFHDHGVFNNARDDPLSA 
CYP6P13     61 LELYKKFKQRGDRYVGMSQFIIPSVFVIDPELVKTILVKDFNVFHDRGIFTNARDDPLSG 
 
 
 
CYP6P9     121 HLFALEGNPWRLLRQKLTPTFTSGRMKQMFGTLWDVALELDKYMEENYRQPDIEMKDVLG 
CYP6P13    121 HLFALEGNPWRLLRQKLTPTFTSGRMKQMFGTLWDVALELDKYMEENYHQQEIEMKDVLG 
 
 
 
CYP6P9     181 RFTTDVIGTCAFGIECNTLKTPDSEFRKYGNKAFEFNLMIILKTFLASAYPSLVRKLRMK 
CYP6P13    181 RFTTDVIGTCAFGIECNTLKTPDSEFRKYGNKAFELDLLIMMKFFFASAYPSLVRKLRMK 
 
 
 
CYP6P9     241 ITFDDVEQFFLKIVKETVEYRESNNIKRNDFMNLLLQIKNKGKLDDSDDGSVGKGEVGMT 
CYP6P13    241 ITFDDVEEFFVKIVRETVNYREMNNVKRNDFMNLLLQIKNKGKLDDSDDGSVGKGEVGMT 
 
 
 
CYP6P9     301 QRELAAQAFIFFLAGFETSSTTQSFCLYELAKNPDIQERLRQEINQAIEENDGQVTYDVA 
CYP6P13    301 QLELAAQAFVFFLAGFETSSTTQSFCLYELAKNPEIQERLRQEINQAIEENDGQVTYDVA 
 
 
 
CYP6P9     361 INIQYLDNVINETLRKYPPVESLSRVPSVDYVIPGTKHVIPKRTLVQIPVHAIQHDPEHY 
CYP6P13    361 MNIQYLDNVINETLRKYPPVESLSRVPSVDYVIPGTKHVIAKRTLVQIPVHAIQHDPEHY 
 
 
 
CYP6P9     421 PDPERFDPDRFSPEEVKKRHPFTFLPFGEGPRVCIGLRFGVMQTKVGLITLLRKFRFSPS 
CYP6P13    421 PDPERFDPDRFSPEEVKKRHPFTFLPFGEGPRVCIGLRFGVMQTKVGLITLLRKFRFSPS 
 
 
 
CYP6P9     481 ARTPDCVKFDPKMIILSPIAGNYLKVEKL 
CYP6P13    481 ARTPDCVTFHPKMITLSPIAGNYLKVEKL 
 
 
Figure 3.6: Amino acid sequence alignment of FANG-CYP6P9 and FANG-CYP6P13. Helices A-
L are represented by (      ) and substrate recognition sites (SRS) 1-6 are indicated by (      ). Identical 
residues are shaded in black while similar residues are in grey shades. 
(http://searchlauncher.bcm.tmc.edu/multi-align/multi-align.html). 
 
 
With the identification of the novel CYP6P13 gene, it was no longer clear whether 
the over-expressed CYP6 gene in FUMOZ-R was that of CYP6P9 or CYP6P13.  
Primers were designed in order to determine whether CYP6P13 was present in both 
FANG and FUMOZ-R.  This was achieved by designing primers based on regions of 
B-helix SRS-1     
C-helix D-helix E-helix
F-helix    SRS-2
A-helix 
SRS-3            G-helix H-helix
SRS-4            I-helix J-helix K-helix
L-helix 
SRS-5
SRS-6
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high differences (Figure 3.5) (Table 3.8).  These primers were used to amplify short 
segments of about 130 bp and 300 bp.  After numerous PCR trials (changing 
annealing temperatures and MgCl2 concentrations) using FUMOZ-R cDNA and 
genomic DNA no fragments were amplified.  A fragment of 300 bp was amplified 
using FANG genomic DNA (Figure 3.7).  This fragment was sequence and found to 
be identical to that of FANG-CYP6P13 gene.  The 130 bp fragment amplified was 
sequenced but sequencing failed.  However no fragment was amplified from FANG 
cDNA. 
  
Table 3.8: Primers used to amplify fragments CYP6P13 gene 
Primers Sequence 
Forward primer1 5’ CTGGATCTCCTAATTATGATGAAGTTTTTC 3’ 
Reverse primer1 5’ GTTCACCGTCTCGCGGACT 3’ 
Forward primer2 5’ACTATCAGGA CACTTG 3’ 
Reverse primer2 5’ GAAAAACTTCATCATAATTAGGAGATCCAG 3’ 
 
A)                                                        B) 
                                        
Figure 3.7:  Amplification of CYP6P13 fragments from cDNA and gDNA.  Two sets of primers 
were used to amplify a 130 bp and 300 bp fragments from CYP6P13. A) Amplification using FANG 
cDNA and gDNA. Lane M: Molecular marker, lanes 1 and 3: FANG cDNA, lanes 2 and 4: FANG 
gDNA. B) FUMOZ-R; Lane M: Molecular marker, lanes 1 and 3: FUMOZ-R cDNA, lanes 2 and 4: 
FUMOZ-R gDNA. DNA was run on a 1% TAE agarose gel and viewed under UV light.  
 
M       1       2        3        4  M       1       2        3        4 
100 bp 
200 bp 
300 bp 
400 bp 
500 bp 
100 bp 
200 bp 
300 bp 
400 bp 
500 bp 
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A phylogenetic tree was generated in order to determine the relationship between 
CYP6P9 sequence (FUMOZ-R and FANG) and CYP6P13.  CYP6P13 intron was 
removed so as to compare sequence information of mRNA although no CYP6P13 
cDNA amplification was obtained.  CYP6P9 from FUMOZ-R and FANG were 
closely related while CYP6P13 fell on a different branch (Figure 3.8).  Anopheles 
gambiae CYP6P3 is a CYP6 gene highly similar to CYP6P9 and was also included in 
the analysis. 
 
 
 
 
Data assembled using LASERGENE package (DNASTAR, MegAlign program, Clustal W method)  
 
Figure 3.8:  Phylogenetic tree of CYP6P9 and CYP6P13.  CYP6P9 sequences from FUMOZ-R and 
FANG were closely related while CYP6P13 sequence was of a different gene.  Anopheles gambiae 
CYP6P3 was included as it is very similar to CYP6P9. 
 
 
 
3.4.5 Homology modelling of An. funestus CYP6P9 
 
Homology modelling was performed so as to visualize the tertiary structure of 
CYP6P9. The known crystal structure of human microsomal CYP3A4 was used to 
model putative structures of An. funestus CYP6P9.  CYP6P9 shares an identity of 
26.7% with CYP3A4. The insect CYP6 family is closely related to those of the 
vertebrate CYP3 family involved in drug metabolism (Danielson et al., 1997) hence 
the use as a model (Figure 3.9A and B).  CYP6P9 (FUMOZ-R and FANG) structures 
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are configurationally the same.  Differences are noted on the amino acid within the 
K-helix (FANG Ile361 to FUMOZ-R Met 361) and F-G loop (FANG Ile221 to FUMOZ-
R Phe 221) (Figure 3.9C and D).  The F-G loop is flexible and has been identified as a 
lid which opens and closes to allow substrates in and out of the active site (Scott et 
al., 2003; Poulos, 2003).  
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Figure 3.9: Ribbon representation of An. funestus CYP6P9s and Human CYP3A4. A) Putative 
structure of An. funestus CYP6P9 B) Crystal structure of Human microsomal P450, CYP3A4, the 
Heme group (red) is situated within the active site (PDB code: 1tqnA; Yano et al., 2004).  C) FANG 
CYP6P9 showing residue ile221 within the F-G loop.  FUMOZ-R CYP6P9 with Phe221 within the F-G 
loop.  CYP6P9 were modeled using known crystal structure of CYP3A4. Substrate entry, catalytic 
sites and Helices A-L are indicated. N: N-terminal, C: C-terminal. Model was generated using Deep 
view Swiss-Pdb viewer and PyMOL (Guex and Peitsch, 1997; DeLano, 2002). 
 
 
 
 
 
 
C
I
L
G′
J
A
A 
B B 
C C 
D 
D 
E E 
F 
G 
H 
I I 
J 
K K 
L 
N N 
C
F′ 
G′ 
Heme molecule 
in catalytic site 
Proximal 
surface
Substrate entry 
F-G loop 
Meander 
A) B)
B′ 
F-G Loop 
Heme molecule 
in catalytic site 
Meander 
Proximal 
surface
A 
B′ 
F 
H 
L 
G′ 
Substrate entry 
C) D)
G′ G′ 
F-G loop F-G loop 
Substrate entry Substrate entry 
Ile221 Phe221 
Isolation, idetifivcation and characterization of Anopheles funestus cytochrome P450, CYP6P9and redox partners 
  
 
84
3.4.6 Identification of Anophele funestus cytochrome b5 sequence 
Anopheles funestus CYP6P9 is a microsomal P450 that requires redox partners for 
electron transfer from NADPH.  As a result of this An. funestus redox partners cytb5 
and CPR were isolated.  Amplification of An. funestus cytb5 (FUMOZ-R) using An. 
gambiae cytb5 primers produced a fragment of approximate 400 bp (Figure 3.10).  
This fragment was cloned into pGEM-T Easy vector in order to sequence and verify 
whether it belonged to the cytb5.  BLAST analysis revealed the fragment to be 90% 
identical to An. gambiae cytb5 cDNA.  Sequencing results showed that cytb5 was of 
387 bp in size.  The start (ATG) and stop (TAA) codons were identified using 
GeneRunner sequence analysis programme. 
 
 
 
 
Figure 3.10: Amplification of An. funestus cytb5.  An. funestus cytb5 (387 bp) was amplified form 
An. funestus cDNA using An. gambiae cytb5 primers. DNA was run on a 1% TAE agarose gel and 
viewed under UV light. 
 
The open reading frame of 387 bp encoded a protein of 128 amino acids in length.  
Sequence alignments revealed high conservation with its counterpart from An. 
An. funestus cytb5 cDNA 400 bp 
200 bp 
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gambiae (Nikou et al., 2003) with a percentage identity of 93.8%.  As expected cytb5 
sequences from An. funestus showed a 59.4% similarity to M. domestica (Guzov et 
al., 1996) and a 64.8% similarity to that of D. melanogaster (Kula et al., 1995) (Table 
3.9).  Multiple sequence alignment showed that An. funestus cytb5 contains all the 
conserved amino acids required for the b5 fold (Trp22, Asp31, His39, Pro40, Gly41, 
Gly42, Ala50, Gly51, Phe58 and His63) (position numbering are based on Anopheles 
funestus cytb5 sequences) and the two histidines (His39 and His63) involved in heme-
coordination (Guzov et al., 1996; Nikou et al., 2003) (Figure 3.11).  The amino acids 
involved in the “b5 fold” are highly conserved in all sequences. The C-terminus 
constitutes 67% hydrophobic amino acid residues indicative of the membrane anchor 
(Vergères and Waskell, 1995).  
 
 
Table 3.9: Percentage identity amongst various insect cytochrome b5 
 Domcytb5 Gamcytb5 Melcytb5 Funcytb5 
Domcytb5    - 57.8 76.1 59.4 
Gamcytb5 57.8    - 62.5 93.8 
Melcytb5 76.1 62.5    - 64.8 
Funcytb5 59.4 93.8 64.8    - 
Data assembled using LASERGENE package (DNASTAR, MegAlign program, Clustal W method) 
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Domesticacytb5        MSSEDVKYFTRAEVAKNNTKDKNWFIIHNNVYDVTAFLNEHPGGEEVLIEQAGKDATEHF 60 
Melanoastercytb5      MSSEETKTFTRAEVAKHNTNKDTWLLIHNNIYDVTAFLNEHPGGEEVLIEQAGKDATENF 60 
Gambiaecytb5          MS--EVKTYSLADVKSHNTNKSTWIVIHNDIYDVTEFLNEHPGGEEVLLEQAGREATEAF 58 
Funestuscytb5         MS--EVKTYSLAEVKSHNTNKSTWIVIHNDIFDVTEFLNEHPGGEEVLLEQAGKEATEAF 58 
                      **  :.* :: *:* .:**:...*::***:::*** ************:****::*** * 
 
Domesticacytb5        EDVGHSSDAREMMKQYKVGELVAEERSNVPEKSEPTWNTEQK-EESSMKSWLMPFVLGLV 119 
Melanoastercytb5      EDVGHSNDARDMMKKYKIGELVESERTSVAQKSEPTWSTEQQTEESSVKSWLVPLVLCLV 120 
Gambiaecytb5          EDVGHSSDAREMMKKFKVGELIEAERKQIPVKKEPDWKMDQQ-DDNQLKQWIVPLILGLL 117 
Funestuscytb5         EDVGHSSDAREMMKKFKVGELIESGRKQVPVKKEPDWKSEQQ-DDNQLKQWIVPLILGLL 117 
                      ******.***:***::*:***: *..:.  *.** *. : *: ::..:*.*::*::***: 
 
Domesticacytb5        ATLIYKFFFGTKSQ 133 
Melanoastercytb5      ATLFYKFFFGGAKQ 134 
Gambiaecytb5          ATILYRFYFTQ--- 128 
Funestuscytb5         ATILYRFYFTQ--- 128  
                      **::*:*:*      
 
Figure 3.11: Comparison of the open reading frame amino acid sequences of insect cytochrome 
b5.  Amino acids involved in the “b5 fold” are indicated in red. The two conserved histidines associated 
with the heme-coordination are highlighted in bold and underlined.  The hydrophobic C-terminal 
anchor region is represented in grey shade and bold. Identical residues are indicated with asterisks. An. 
gambiae: Gambiaecytb5 (GeneBank accession number: AY183376), M. domestica: Domesticacytb5 
(GeneBank accession number: L38464), D. melanoaster: Melanoastercytb5 (accession number: 
NP_610294) and An. funestus: Funestuscytb5 (GeneBank accession number: EF035450).  
(ClustalW, http://www.ebi.ac.uk/clustalw/).    
 
Anopheles funestus cytb5 was modeled using known crystal structure of rat 
microsomal cytb5 (Figure 3.12). The two share an identity of 54.3%.   
 
 
                  
Figure 3.12: Ribbon representation of An. funestus and rabbit microsomal cytochrome b5. A) 
Crystal structure of rabbit microsomal cytb5 with heme group (red) (PDB code: 1do9A; Banci et al., 
2000). B) Putative structure of An. funestus cytb5.  The two Histidine (His39 and His63) involved in 
Heme coordination are shown (Blue). N: N-terminal, C: C-terminal. Model was generated using Deep 
view Swiss-Pdb viewer and PyMOL (Guex and Peitsch, 1997; DeLano, 2002). 
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3.4.7 Identification of Anopheles funestus NADPH-cytochrome P450 
               reductase sequence 
 
Anopheles funestus CPR was amplified from cDNA (FUMOZ-R) synthesized from 
An. funestus RNA.  A 2000 bp fragment was produced when An. gambiae CPR 
primers were used (Figure 3.13).  The fragment was cloned into pGEM-T Easy vector 
and sequenced.  The open reading frame as well as the start (ATG) and stop (TAA) 
codons were identified using GeneRunner sequence analysis programme.   However 
due to its large size internal primers were designed based on sequences obtained from 
forward and reverse.  
 
 
 
Figure 3.13: Amplification of An. funestus CPR.  An. funestus CPR (2040 bp) was amplified form 
An. funestus cDNA using An. gambiae CPR primers. DNA was run on a 1% TAE agarose gel and 
viewed under UV light. 
 
The Anopheles open reading frame of 2040 bp encodes for 679 amino acids.  An 
funestus CPR is very closely related to that of An. gambiae CPR with a percentage 
An. funestus CPR cDNA 
2000 bp 
1500 bp 
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identity of 96.5% (Table 3.10).  A comparison of An. funestus CPR with that of M. 
domestica (Koener et al., 1993) and D. melanoaster (Hovemann et al., 1997), 
revealed highly conserved sequences with identities of 76.3% and 77.5% respectively 
even though they are evolutionary unrelated (Table 3.10).   Anopheles funestus CPR 
contained all conserved regions characteristic of CPRs (Figure 3.14). It had the two 
conserved tyrosine residues (tyr43 and tyr181) (positions are based on Anopheles 
funestus CPR) that are involved in FMN binding as well as the NADPH binding 
residues Ile531, Phe542, Lys625 and Val641.  An. funestus and An. gambiae had two 
substitutes at positions Arg82 and Gly188 that were noted within the FMN domain, 
compared with M. domestica and D. melanoaster that had Ser and Ala at the same 
positions.  In the FAD domain the only substitution observed was at position Glu318 
for both An.  funestus and An.  gambiae while M. domestica and D. melanoaster had 
Asp at this position.  A second substitution within the FAD domain was noted in An.  
gambiae at position His459 while the other CPRs had Tyr at the same position (Figure 
3.14).  The N-terminal region constitutes 52% hydrophobic amino acids and is 
involved in membrane anchoring (Wang et al., 1997). 
 
 
Table 3.10: Percentage identity amongst various insect cytochrome P450 reducatase 
 domCPR gamCPR melCPR funCPR 
domCPR   - 76.0 84.8 76.3 
gamCPR 76.0   - 77.5 96.5 
melCPR 84.8 77.5   - 77.5 
funCPR 76.3 96.5 77.5    - 
Data assembled using LASERGENE package (DNASTAR, MegAlign program, Clustal W method) 
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domCPR          MSAEHVEEVVS-------EEPFLGTLDIALLVVLLVGATWYFMRSRKKEE--APIRSYSI 51 
melCPR          MASEQTIDGAAAIPSGGGDEPFLGLLDVALLAVLIGGAAFYFLRSRKKEE--EPTRSYSI 58 
gamCPR          MDAQTETEVPAGSVS---DEPFLGPLDIVLLVSLLAGTAWYLLKGKKKESQASQFKSYSI 57 
funCPR          MDAQTETEMPTGNVS---DEPFLGPLDIILLVSLLAGTAWYLLKGKKKENQASQFKSYSI 57 
                * ::   :  :       :***** **: **. *: *:::*:::.:***.     :**** 
 
domCPR          QPTTVSTVSTTENSFIKKLKASGRSLVVFYGSQTGTAEEFAGRLAKEGLRYRMKGMVADP 111 
melCPR          QPTTVCTTSASDNSFIKKLKASGRSLVVFYGSQTGTGEEFAGRLAKEGIRYRLKGMVADP 118 
gamCPR          QPTTVNTMTMVENSFIKKLQSSGRRLVVFYGSQTGTAEEFAGRLAKEGIRYQMKGMVADP 117 
funCPR          QPTTVNTMTMVENSFIKKLQSSGRRLVVFYGSQTGTAEEFAGRLAKEGIRYQMKGMVADP 117 
                ***** * :  :*******::*** ***********.***********:**::******* 
 
domCPR          EECDMEELLQMKDIPNSLAVFCLATYGEGDPTDNAMEFYEWITNGEVDLTGLNYAVFGLG 171 
melCPR          EECDMEELLQLKDIDNSLAVFCLATYGEGDPTDNAMEFYEWITSGDVDLSGLNYAVFGLG 178 
gamCPR          EECNMEELLMLKDIDKSLAVFCLATYGEGDPTDNCMEFYDWIQNNDLDMTGLNYAVFGLG 177 
funCPR          EECNMEELLMLKDIDKSLAVFCLATYGEGDPTDNCMEFYDWIQNNDLDMTGLNYAVFGLG 177 
                ***:***** :*** :******************.****:** ..::*::********** 
 
domCPR          NKTYEHYNKVAIYVDKRLEELGATRVFELGLGDDDANIEDDFITWKDRFWPSVCDFFGIE 231 
melCPR          NKTYEHYNKVAIYVDKRLEELGANRVFELGLGDDDANIEDDFITWKDRFWPAVCDHFGIE 238 
gamCPR          NKTYEHYNKVGIYVDKRLEELGANRVFELGLGDDDANIEDYFITWKEKFWPTVCDYFGIE 237 
funCPR          NKTYEHYNKVGIYVDKRLEELGANRVFELGLGDDDANIEDYFITWKEKFWPTVCDFFGIE 237 
                **********.************.**************** *****::***:***.**** 
 
domCPR          GSGEEVLMRQFRLLEQPDVQPDRIYTGEIARLHSMQNQRPPFDAKNPFLASVIVNRELHK 291 
melCPR          GGGEEVLIRQYRLLEQPDVQPDRIYTGEIARLHSIQNQRPPFDAKNPFLAPIKVNRELHK 298 
gamCPR          STGEDVLMRQYRLLEQPDVSADRIYTGEVARLHSLQTQRPPFDAKNPFLAPIKVNRELHK 297 
funCPR          STGEDVLMRQYRLLEQPDVGADRIYTGEVARLHSLQTQRPPFDAKNPFLAPIKVNRELHK 297 
                . **:**:**:******** .*******:*****:*.*************.: ******* 
 
domCPR          GGGRSCMHIELDIDGSKMRYDAGDHIAMYPINDKILVEKLGKLCDANLDTVFSLINTDTD 351 
melCPR          GGGRSCMHIELSIEGSKMRYDAGDHVAMFPVNDKSLVEKLGQLCNADLDTVFSLINTDTD 358 
gamCPR          AGGRSCMHVEFDIEGSKMRYEAGDHLAMYPVNDRDLVERLGRLCNAELDTVFSLINTDTD 357 
funCPR          AGDRSCMHVEFDIEGSKMRYEAGDHLAMYPVNDRDLVERLGKLCNADLETIFSLINTDTD 357 
                .*.*****:*:.*:******:****:**:*:**: ***:**:**:*:*:*:********* 
 
domCPR          SSKKHPFPCPTTYRTALTHYLEITAIPRTHILKELAEYCSDEKDKEFLRNMASITPEGKE 411 
melCPR          SSKKHPFPCPTTYRTALTHYLEITAIPRTHILKELAEYCTDEKEKELLRSMASISPEGKE 418 
gamCPR          SSKKHPFPCPTTYRTALTHYLEITALPRTHILKELAEYCGEEKDKEFLRFISSTAPDGKA 417 
funCPR          SSKKHPFPCPTTYRTALTHYLEITALPRTHILKELAEYCTEEKDKEFLRFISSTAPEGKA 417 
                *************************:************* :**:**:** ::* :*:**  
 
domCPR          KYQNWIQNSSRNIVHILEDIKSCRPPIDHICELLPRLQPRYYSISSSSKLYPTNVHITAV 471 
melCPR          KYQSWIQDACRNIVHILEDIKSCRPPIDHVCELLPRLQPRYYSISSSAKLHPTDVHVTAV 478 
gamCPR          KYQEWVQDSCRNIVHVLEDIPSCHPPIDHVCELLPRLQPRYHSISSSSKLHPTTVHVTAV 477 
funCPR          KYQEWIQDSSRNVVHVLEDIPSCHPPIDHVCELLPRLQPRYYSISSSSKLHPTTVHVTAV 477 
                ***.*:*::.**:**:**** **:*****:***********:*****:**:** **:*** 
 
domCPR          LVQYETPTGRVNKGVATSYMKEKNPSVG--EVKVPVFIRKSQFRLPTKSEIPIIMVGPGT 529 
melCPR          LVEYKTPTGRINKGVATTYLKNKQPQGSE-EVKVPVFIRKSQFRLPTKPETPIIMVGPGT 537 
gamCPR          LVKYETKTGRLNKGVATTFLAEKHPNDGEPAPRVPIFIRKSQFRLPPKPETPVIMVGPGT 537 
funCPR          LVKYETKTGRLNKGVATTFLAEKHPNDGEPLPRVPIFIRKSQFRLPPKPETPVIMVGPGT 537 
                **:*:* ***:******::: :*:*. .    :**:**********.*.* *:******* 
 
domCPR          GLAPFRGFIQERQFLRDGGKVVGDTILYFGCRKKDEDFIYREELEQYVQNGTLTLKTAFS 589 
melCPR          GLAPFRGFIQERQFLRDEGKTVGESILYFGCRKRSEDYIYESELEEWVKKGTLNLKAAFS 597 
gamCPR          GLAPFRGFIQERDHCKQEGKEIGQTTLYFGCRKRSEDYIYEDELEDYSKRGIINLRVAFS 597 
funCPR          GLAPFRGFIQERDFSKQEGKEIGQTTLYFGCRKRTEDYIYEDELEDYSKRGIVNLRVAFS 597 
                ************:. :: ** :*:: *******: **:**..***:: :.* :.*:.*** 
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domCPR          RDQQEKIYVTHLIEQDADLIWKVIGEQKGHFYICGDAKNMAVDVRNILVKILSTKGNMNE 649 
melCPR          RDQGKKVYVQHLLEQDADLIWNVIGENKGHFYICGDAKNMAVDVRNILVKILSTKGNMSE 657 
gamCPR          RDQEKKVYVTHLLEQDSDLIWSVIGENKGHFYICGDAKNMATDVRNILLKVIRSKGGLSE 657 
funCPR          RDQEKKVYVTHLLEQDSDLIWNVIGENKGHFYICGDAKNMATDVRNILLKVIRSKGGLSE 657 
                *** :*:** **:***:****.****:**************.******:*:: :**.:.* 
 
domCPR          SDAVQYIKKMEAQKRYSADVWS 671 
melCPR          ADAVQYIKKMEAQKRYSADVWS 679 
gamCPR          TEAQQYIKKMEAQKRYSADVWS 679 
funCPR          TEAQQYIKKMEAQKRYSADVWS 679 
                ::* ****************** 
 
Figure 3.14: Comparison of the open reading frame amino acid sequence of insect NADPH-
cytochrome P450 reductase. The FMN binding domain is represented in blue, while the tyrosine 
residues involved in the FMN binding are shaded in black. The FAD binding domain is shown in red. 
NADPH binding domain is represented in green and the amino acids involved in the NADPH binding 
are highlighted by gray shade. The hydrophobic anchor region is indicated in bold. An. gambiae: 
gamCPR (GeneBank accession number: AY183375), M. domestica: domCPR (GeneBank accession 
accession number:  L19897), D. melanoaster: MelCPR (GeneBank accession number: X93090) and 
An. funestus: FunCPR (GeneBank accession number: EF152578). Identical residues are indicated with 
asterisks (ClustalW, http://www.ebi.ac.uk/clustalw/). 
 
 
The putative structure of An. funestus CPR was performed using known crystal 
structure of rat microsomal CPR that had an identity of 56.1% with that of An. 
funestus CPR (Figure 3.15). CPR consists of two main regions, a 6-kDa N-terminal 
region that is made up of a hydrophobic membrane anchor and FMN domain. A 72-
kDa C-terminal region that is composed of the FAD and NADP+ domains making up 
the catalytic domain. The tertiary structure of CPR is composed of four domains (I-
IV) (Figure 3.15).  
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Figure 3.15: Ribbon representation of An. funestus and rat CPR.  A) Crystal structure of rat CPR, 
The cofactors are shown as sticks, FMN (gray), FAD (pink) and NADP+ (blue). The four domains are 
also indicated, FMN domain (I), connecting domain (II), FAD domain (III) and the NADP+ domain 
(IV) (PDB code: 1amoA; Wang et al., 1997). B) Putative structure of An. funestus CPR, showing the 
FMN / FAD and NADP+ binding cleft. N: N-terminal, C: C-terminal. Model was generated using Deep 
view Swiss-Pdb viewer and PyMOL (Guex and Peitsch, 1997; DeLano, 2002). 
 
 
3.4.8 CYP6P9 codon usage 
 
The isolated genes were subcloned into a suitable expression vector and proteins 
expressed in E. coli host as seen in the following chapter.  Codon usage plays a 
significant role in the expression of recombinant proteins.  Rare codons present in 
genomic sequences of proteins results in low or no expression.  This may be due to 
early translation termination.  Codon usage however determines the selection of host 
in which the recombinant protein is expressed.  The codon usage in An. funestus 
CYP6P9 was analysed.  It contained only 18 codons that were rare to E. coli (Figure 
3.16).  This however ruled out the possibility of early translation termination or the 
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failing to recognize CYP6P9 codons.  Table 3.11 shows all the codon used in An. 
funsetus CYP6P9.    
 
atggagctaattaacgcggtgttggccgcgttcatcttcgtagtgtcggcagtgtacctt 
M  E  L  I  N  A  V  L  A  A  F  I  F  V  V  S  A  V  Y  L 
ttcattcggaacaaacataattactggaaagacaatggattcccgtatgcgccgaatccg 
F  I  R  N  K  H  N  Y  W  K  D  N  G  F  P  Y  A  P  N  P 
cattttctgttcggacacgcgaaaggacaggcccagacaaggcatgcggccgacatccat 
H  F  L  F  G  H  A  K  G  Q  A  Q  T  R  H  A  A  D  I  H 
ctggaactgtacaaaaaattcaagcagcgcggtgatcggtacgttggtatgagccagttc 
L  E  L  Y  K  K  F  K  Q  R  G  D  R  Y  V  G  M  S  Q  F 
atcataccatctgtgtttgtgatcgatccagagctggtgaaaacgatcctagtaaaggac 
I  I  P  S  V  F  V  I  D  P  E  L  V  K  T  I  L  V  K  D 
tttaatgtattccacgatcgcggtattttcactaatgcaagagacgatccactatcagga 
F  N  V  F  H  D  R  G  I  F  T  N  A  R  D  D  P  L  S  G 
cacttgtttgcgctggaaggtaacccatggcgcttgttgcgtcagaagctcacgccaacg 
H  L  F  A  L  E  G  N  P  W  R  L  L  R  Q  K  L  T  P  T 
ttcacctcaggtcgcatgaagcaaatgtttggtacattatgggatgtagcacttgagctg 
F  T  S  G  R  M  K  Q  M  F  G  T  L  W  D  V  A  L  E  L 
gacaagtatatggaagaaaactaccatcagcaggagattgagatgaaggatgtgctaggt 
D  K  Y  M  E  E  N  Y  H  Q  Q  E  I  E  M  K  D  V  L  G 
cggtttacgaccgatgtgattggcacgtgcgcattcggcatcgagtgtaatacgcttaag 
R  F  T  T  D  V  I  G  T  C  A  F  G  I  E  C  N  T  L  K 
acaccggactcggaattccgcaaatacggtaacaaagcgttcgagctggatctcctaatt 
T  P  D  S  E  F  R  K  Y  G  N  K  A  F  E  L  D  L  L  I 
atgatgaagtttttctttgcatcggcttatccgtcacttgtgcggaaactgcgaatgaag 
M  M  K  F  F  F  A  S  A  Y  P  S  L  V  R  K  L  R  M  K 
atcacattcgatgatgtggaagagtttttcgtaaaaatagtccgcgagacggtgaactat 
I  T  F  D  D  V  E  E  F  F  V  K  I  V  R  E  T  V  N  Y 
cgtgaaatgaacaatgtaaaacgaaacgacttcatgaacctgctgttgcagatcaagaat 
R  E  M  N  N  V  K  R  N  D  F  M  N  L  L  L  Q  I  K  N 
aagggcaagctggacgacagtgatgatgggagtgttggcaaaggtgaagtaggaatgaca 
K  G  K  L  D  D  S  D  D  G  S  V  G  K  G  E  V  G  M  T 
caactggaacttgcggcacaagcgttcgttttcttcctggctggtttcgagacatcatcc 
Q  L  E  L  A  A  Q  A  F  V  F  F  L  A  G  F  E  T  S  S 
acaactcaaagcttctgtttgtacgagctggcaaagaaccctgaaatccaggagcgcctt 
T  T  Q  S  F  C  L  Y  E  L  A  K  N  P  E  I  Q  E  R  L 
agacaagagattaaccaagcaatcgaggagaatgacggccaggtgacgtacgatgtcgcc 
R  Q  E  I  N  Q  A  I  E  E  N  D  G  Q  V  T  Y  D  V  A 
atgaacatacagtatctggacaatgtgataaacgaaacacttcgcaagtacccaccggta 
M  N  I  Q  Y  L  D  N  V  I  N  E  T  L  R  K  Y  P  P  V 
gaatcgttgagtcgtgtgccgtcggttgactatgtcatccccggtacgaaacacgtgatt 
E  S  L  S  R  V  P  S  V  D  Y  V  I  P  G  T  K  H  V  I 
gccaaacgaacgttagtgcaaattccggttcacgccattcaacatgatcctgagcactat 
A  K  R  T  L  V  Q  I  P  V  H  A  I  Q  H  D  P  E  H  Y 
cccgatccagaacgtttcgatccggatcgcttctcaccggaggaagtgaagaagcgacat 
P  D  P  E  R  F  D  P  D  R  F  S  P  E  E  V  K  K  R  H 
cccttcacgttcctcccattcggcgaggggccacgcgtttgcattgggcttcggtttggt 
P  F  T  F  L  P  F  G  E  G  P  R  V  C  I  G  L  R  F  G 
gtgatgcagacgaaggtaggattgataacgctgttgagaaagttccgtttctcaccgtca 
V  M  Q  T  K  V  G  L  I  T  L  L  R  K  F  R  F  S  P  S 
gcgcgtacaccagattgtgtaacgtttcatccgaaaatgatcaccttgtcaccgatcgcg 
A  R  T  P  D  C  V  T  F  H  P  K  M  I  T  L  S  P  I  A 
ggtaattacttgaaggtggaaaagttgtag 
G  N  Y  L  K  V  E  K  L  * 
 
 
Figure 3.16: Codon usage in Anopheles funestus CYP6P9. Highlighted (green) are the codons that 
are rare in E. coli. Lue (cta), Arg, (cgg, aga), Ile (ata).  
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Table 3.11  An. funestus CYP6P9 codon usage  
Amino Acid    Codon                  Number                     /1000                          Fraction  
Ala      GCG        10.00        19.61         0.37  
Ala      GCA        10.00        19.61         0.37  
Ala      GCT         1.00         1.96         0.04  
Ala      GCC         6.00        11.76         0.22 
  
Cys      TGT         4.00         7.84         0.80  
Cys      TGC         1.00         1.96         0.20  
 
Asp      GAT        16.00        31.37         0.52  
Asp      GAC        15.00        29.41         0.48  
 
Glu      GAG        17.00        33.33         0.53  
Glu      GAA        15.00        29.41         0.47 
  
Phe      TTT        10.00        19.61         0.26  
Phe      TTC        29.00        56.86         0.74 
  
Gly      GGG         4.00         7.84         0.15  
Gly      GGA         5.00         9.80         0.19  
Gly      GGT        13.00        25.49         0.50  
Gly      GGC         4.00         7.84         0.15 
 
His      CAT         9.00        17.65         0.69  
His      CAC         4.00         7.84         0.31  
 
Ile      ATA         5.00         9.80         0.17  
Ile      ATT        15.00        29.41         0.50  
Ile      ATC        10.00        19.61         0.33  
 
Lys      AAG        22.00        43.14         0.59  
Lys      AAA        15.00        29.41         0.41  
 
Leu      TTG        12.00        23.53         0.25  
Leu      TTA         2.00         3.92         0.04  
Leu      CTG        15.00        29.41         0.31  
Leu      CTA         6.00        11.76         0.13  
Leu      CTT        10.00        19.61         0.21  
Leu      CTC         3.00         5.88         0.06  
 
Met      ATG        14.00        27.45         1.00  
 
Asn      AAT        11.00        21.57         0.44  
Asn      AAC        14.00        27.45         0.56  
 
Pro      CCG        14.00        27.45         0.47  
Pro      CCA        10.00        19.61         0.33  
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Pro      CCT         3.00         5.88         0.10  
Pro      CCC         3.00         5.88         0.10  
 
Gln      CAG        13.00        25.49         0.65  
Gln      CAA         7.00        13.73         0.35  
 
Arg      AGG         1.00         1.96         0.03  
Arg      AGA         3.00         5.88         0.10  
Arg      CGG         5.00         9.80         0.17  
Arg      CGA         6.00        11.76         0.20  
Arg      CGT         6.00        11.76         0.20  
Arg      CGC         9.00        17.65         0.30  
 
Ser      AGT         3.00         5.88         0.14  
Ser      AGC         3.00         5.88         0.14  
Ser      TCG         4.00         7.84         0.19  
Ser      TCA         8.00        15.69         0.38  
Ser      TCT         1.00         1.96         0.05  
Ser      TCC         2.00         3.92         0.10  
 
Thr      ACG        14.00        27.45         0.54  
Thr      ACA         9.00        17.65         0.35  
Thr      ACT         1.00         1.96         0.04  
Thr      ACC         2.00         3.92         0.08  
 
Val      GTG        17.00        33.33         0.49  
Val      GTA         9.00        17.65         0.26  
Val      GTT         6.00        11.76         0.17  
Val      GTC         3.00         5.88         0.09  
 
Trp      TGG         3.00         5.88         1.00  
 
Tyr      TAT         8.00        15.69         0.47  
Tyr      TAC         9.00        17.65         0.53  
 
End      TGA         0.00         0.00         0.00  
End      TAG         1.00         1.96         1.00  
End      TAA         0.00         0.00         0.00  
Generatd using http://bioinformatics.org/sms2/codon_usage.html. 
 
 
Codons in green are rare to E. coli and blue are most commonly used codons by An. 
funestus CYP6P9. 
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3.5 Discussion  
The first P450 isolated from An. funestus was only recently published (Amenya et al., 
2005).  Amenya and co-workers isolated 12 CYP6, 12 CYP4 and 6 CYP9 genes 
which were named by the P450 nomenclature committee (http://drnelson.utmem.edu/ 
CytochromeP450.html).  The naming was done using partial fragments of genes.  
These fragments were further used to identify gene(s) over-expressed in a pyrethroid 
resistant An. funestus strain.  One of these, CYP6P9 showed high levels of mRNA 
expression (Amenya et al., 2008).  This work was all conducted on a partial sequence 
fragment.  Preliminary microarray analysis between the pyrethroid resistant and 
susceptible colonies shows that multiple genes are differentially expressed, including 
CYP6P9 (Naguran et al. unpublished data).   
 
Wondji et al (2007) chromosomally mapped a quantitative trait locus (QTL) 
associated with pyrethroid resistance using the same An. funestus FUMOZ-R and 
FANG strains. They found that a QTL which accounts for more than 60% of variance 
in susceptibility to permethrin is located between division 9 and 12 of chromosome 
arm 2R. This location coincides with a cluster of CYP6, P450’s mapped by 
fluorescent in situ hybridization, suggesting that resistance is mediated by one or 
more CYP6 genes. One of these is CYP6P9, an ortholog of CYP6P3 in An. gambiae.  
Apart from this gene’s association with resistance nothing else is known about 
CYP6P9.  It is imperative to isolate and sequence CYP6P9 in order to characterize 
the role of this gene in insecticide resistance. 
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The high percentage identity between An. funestus and An. gambiae cytochrome 
P450s (> 75%) enabled the design of primers for An. funestus based on An. gambiae 
sequences (Amenya et al., 2005).  CYP6P9 and CYP6P3 show an identity of 86% 
(Amenya et al., 2005).  These primers were used to amplify and isolate open reading 
frame cDNA sequence of CYP6P9 from An. funestus FUMOZ-R and FANG strains 
as well as genomic sequences.  Sequences from these two strains showed a 99.3% 
amino acid identity. Only four variations were found.  Genomic DNA revealed the 
presence of one intron of 56 bp in size.  An. gambiae CYP6P3 also had one intron of 
56 bp which was found at the same location as An. funestus CYP6P9.   
 
When CYP6P9 was compared with other insect CYP6s involved in insecticide 
resistance it was noted that these sequences shared a very low percentage homology 
(≤ 45%).  The presence of the heme-binding region (PFxxGxxxCxG), ExxR motif, 
ETLR domain and oxygen binding pocket [(A/G)Gx(E/D)T(T/S)] (characteristics of 
a cytochrome P450 protein) were identified in CYP6P9; indicating that it was a P450 
gene.  The characteristic YPDP motif only found in CYP6 families was situated 
upstream of the heme binding region proving that CYP6P9 belonged to the CYP6 
family.   CYP6P9 is a microsomal membrane bound protein containing the highly 
hydrophobic N-terminal region and the PERF motif that is present in all microsomal 
cytochrome P450s.  The evidence is clear, therefore, CYP6P9 belongs to the CYP6 
family and that it is a microsomal membrane bound protein. 
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In FUMOZ-R Ile was replaced with an aromatic Phe within the F-G loop.  The F-G 
loop plays an important role, which operate as a lid in the opening and closing to 
allow substrates in and out of the active site (Scott et al., 2003; Poulos, 2003).   
Amino acids found within the F and G helices are important in substrate specificity 
(Torimoto et al., 2007).  This was proven in human P450 (CYP3A7) where site 
directed mutagenesis was performed by changing CYP3A7 amino acid with those of 
CYP3A4.  A decrease in enzyme activity was noted when compared with the 
CYP3A7 wild-type (Torimoto et al., 2007).  Mutations found in resistant strains have 
been shown to give rise to insecticide resistance.  This was proven by Bergé et al 
(1998) who suggested that mutations in a CYP6A2 gene from a resistant Drosopila 
melanogaster could affect the tertiary structure, therefore having an important role in 
the enzyme activity of the protein.  It was further proven by Amichot et al (2004) 
who determined that the three mutations outside of the conserved regions of CYP6A2 
gene were able to enhance the metabolism of DDT in a resistant strain (RDDTR) as 
opposed to the wild-type strain which was unable to metabolize DDT. Site-directed 
mutagenesis in these regions is required to determine the importance of these residues 
in pyrethroid binding.  
 
A novel P450 gene was isolated from FANG genomic DNA.  This gene shared a 
93.7% identity with that of FUMOZ-R CYP6P9 genomic DNA.  The gene was 
named CYP6P13 by the P450 Nomenclature committee (http://drnelson.utmem. 
edu/CytochromeP450. html).  Deduced amino acid sequence showed 32 variations 
between the two genes.  When primers were designed based on sequence specific 
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regions only fragments from FANG genomic DNA were amplified (130 bp and 300 
bp fragments).  Sequence analysis on the 300 bp fragment revealed that it was 
identical to CYP6P13 sequence.  No fragments were amplified from FANG cDNA or 
FUMOZ-R genomic DNA and cDNA.  This however indicated that CYP6P13 was 
present at the genomic DNA level of FANG.  Phylogenetic analysis showed that 
CYP6P9 from FUMOZ-R and FANG were closely related.  CYP6P13 was on a 
different branch to CYP6P9 supporting the conclusion that this is a different gene.  
The absence of CYP6P13 from FUMOZ-R cDNA, FANG cDNA and FUMOZ-R 
gDNA indicated that the CYP6 gene over-expressed was that of CYP6P9 and not 
CYP6P13.  FUMOZ-R and FANG are from two different geographic locations 
(Mozambique and Angola respectively).  This could explain the presence of CYP6P9 
(2) in FANG and an absence in FUMOZ-R.  It is likely that a duplication of the gene 
could have occurred within FANG, however further studies are required to confirm 
this hypothesis. 
 
The cytochrome P450 redox partners, cytochrome b5 and NADPH-cytochrome P450 
reductase, were also isolated from An. funestus.  Cytochrome b5 are membrane bound 
proteins mainly found within the microsome (Argos and Mathews, 1975).  They are 
16-kDa globular proteins that contain two domains, a hydrophobic C-terminal 
membrane anchor and a hydrophilic heme-binding domain where the redox activity 
takes place (Vergères and Waskell, 1995).  They are believed to be responsible for 
the donation of the second electron to cytochrome P450 during the oxidation of 
substrates (Vergères and Waskell, 1995; Gruenke et al., 1995).  The function of cytb5 
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is not clearly understood.  The function is dependent on P450 isozymes (Zhang et al., 
2005).  However high concentrations of cytb5 have been shown to inhibit the activity 
of CYP2B4 by blocking P450 reductase binding site (Zhang et al., 2008).  To 
understand the function of cytb5 two substrates were used methoxyflurance and 
benzphetamine.  Cytochrome b5 was shown to stimulate CYP2B4 resulting in an 
increase in methoxyflurance metabolism, while the presence of cytb5 had no change 
on benzphetamine metabolism (Gruenke et al., 1995; Zhang et al., 2005).  Anopheles 
funestus cytb5 contains the “b5 fold” and two histidines that are required for heme-
coordination (Guzov et al., 1996; Nikou et al., 2003). The percentage identity of 97% 
with An. gambiae shows that cytb5 function is conserved between the two species.    
 
Cytochrome P450 reductase has four domains, the FMN domain found near the N-
terminus, followed by the connecting domain linking it to the FAD and NADP+ 
domains at the C-terminus (Wang et al., 1997).  Electrons are transferred to the 
FAD/NADP+ domains before being  transferred to cytochrome P450s via the FMN 
domain (Smith et al., 1994; Wang et al., 1997).  CPR donates the first of the two 
electrons to cytochrome P450 (Vergères and Waskell, 1995).  Transfer of electrons to 
cytochrome P450 is through the FMN domain that is known to bind to the proximal 
surface of cytochrome P450 (Sevrioukova et al., 1999a; Sevrioukova et al., 1999b).  
Cytochrome P450 reductase sequences between An. funestus and An. gambiae were 
highly conserved with a percentage identity of 96.5%.  Nikou et al (2003) showed 
that CPRs were highly conserved amongst An. gambiae, housefly and fruitfly 
sequences with percentage homologies of above 75%. The FMN and FAD domains, 
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the conserved NADPH binding residues as well as the two tyrosine residues required 
for the binding of FMN were also found in An. funestus CPR.   
 
Condon usage plays a very important role in heterologous expressing of recombinant 
proteins in E. coli.  Some amino acids are encoded by more than one codon.  This 
results in organisms being biased to their own codon.  A small number of rare codons 
within the genes often does not prevent target protein synthesis.  However in the 
presence of clusters of rare codons or numerous rare codons, heterologous expression 
is very low.  Rare codon may result in translational stalling, premature translation 
termination and translation frame-shifting.  Arginine codon (AGG/AGA) is very 
rarely used in E. coli and is known to cause translational problems (Kane, 1995; 
Kurland and Gallant, 1996).  In CYP6P9, 4 of 509 (0.78%) codons are AGG/AGA. 
The other rare codons are ATA, CTA and CGG.  In total there are 18 out of 509 
codons that are rare in E. coli. Due to the low number and non-clustering of rare 
codons this may result in very low recombinant protein expression levels when 
expressed in E. coli.  
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Chapter Four 
 
 
Protein expression of An. funestus CYP6P9 in E. coli. 
 
 
4.1 Introduction 
4.1.1 Expression systems for recombinant proteins 
Overproduction of recombinant P450 proteins allow for the characterization and 
understanding of the protein/enzyme activity in vitro or in vivo.  This is used for 
instance in the characterization of metabolic insecticide resistance or drug design 
against these resistant enzymes.  In order to fully understand P450 enzymes, different 
host cells are used to express these enzymes in large quantities.  
 
Overproduction of proteins is sometimes problematic and depends on host selection 
or codon usage.  The problem of codon usage arises as a result of low expression or 
no expression levels in the host.  Genes containing rare codons to host cells (e.g. E. 
coli, yeast, insect or mammalian cells) result in translational problems causing a 
reduction in quality and quantity of synthesized protein (Kane, 1995).  When 
expressing wheat P450 in yeast no expression was obtained due to a high GC content, 
which is biased to yeast.  This problem can be resolved by introducing rare tRNAs or 
re-engineering the sequence to suit that of the host (Batard, 2000).  Various 
expression systems have been tested such as yeast, bacteria, mammalian cells and 
insect cells. Each has its limitations as to expressing structural and functional 
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proteins/enzymes (Battula et al., 1987; Guengerich et al., 1993; Waterman et al., 
1995; Grogan et al., 1995).   
 
Expression in Escherichia coli (E. coli) 
Escherichia coli (E. coli) systems are widely used because of their ease and low cost 
of handling (Waterman et al., 1995).  Expression of P450 in an E. coli system is 
mainly achieved by NH2-terminus modified (Waterman et al., 1995).  The first P450 
to be successfully expressed in E. coli was the bovine microsomal CYP17A (Barnes 
et al., 1991).  CYP17A contained a modification by replacing the first eight codons 
with a short amino acid sequence (MALLLAVF).  This short sequence was a 
derivative of bovine steroid 17 -hydroxylase that was placed at the NH2-terminus 
(Barnes et al., 1991).   
 
In order to express an unmodified NH2-terminal microsomal P450, a technique which 
involves fusing a bacterial membrane signal peptide to the NH2-terminal was 
developed by Pritchard et al (1997).  Two bacterial membrane signal peptides were 
used, the ompA (outer membrane Protein A) and pelB (pectate lyase B) leader 
sequences.  This technique was used successfully to express full-length unmodified 
human CYP3A4 (Pritchard et al., 1997).   To achieve optimum expression the 
bacterial signal peptide is cleaved upon expression. This is achieved by introducing 
two amino acids, alanine and proline between the leader sequence and P450 sequence 
to allow for the efficient removal of this leader sequence.  Human CYP3A4 with 
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fused bacterial membrane signal peptides (ompA-3A4 and pelB-3A4) had a much 
higher expression level compared to that with 17 -hydroxylase modification 
described above (17-3A4) (Pritchard et al., 1997).  Other P450s such as human 
CYP2E1 and CYP1A2 as well as An. gambiae CYP6Z2 have successfully been 
expressed in E. coli using the ompA leader sequence (Dong and Porter, 1996; Döhr et 
al., 2001; Mclaughlin et al., 2008). 
 
Expression in yeast 
The first P450 (Rat CYP1A1) was expressed in Yeast (Saccharamyces cerevisiae) 
(Oeda et al., 1985).  Yeast produces its own CPR which acts as electron donor 
making it a good expression host for P450s.  The only limitation is that the 
endogenous CPR and cytb5 are insufficient for microsomal P450 activity and there is 
therefore a need to incorporate exogenous CPR and cytb5 to aid in expression 
(Aoyama et al., 1978; Urban et al., 1990; Cheng et al 2006).  
 
Expression in Mammalian cells 
Mammalian cells (COS cells) are used to express mammalian P450.  These cells are a 
derivative of the African green monkey kidney cell line (COS- 1 cell) (Zuber et al., 
1988).  Expression of P450 in COS cells, first requires the insertion into a vector 
(containing SV40 origin) then transfection into COS-1 or COS-7 cells. After three to 
four days cells are harvested for activity.  The advantage of mammalian P450 
expression in mammalian cells is the presence of efficient electron donors (CPR and 
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cytb5).  No modification is required to the NH2- terminus cDNA (Reviewed in 
Gonzalez and Korzekwa, 1995).  
 
Expression in Insect Cells 
Expression in insect cells involves using a baculovirus-insect cell expression system.  
The system has fewer codon usage problems (Duan and Schuler, 2006).  While 
baculovirus is usually restricted to insect cells, many other human P450s have been 
expressed using this system (Gonzalez and Korzekwa, 1995). The addition of hemin 
(heme precursor) is required in media during expression of P450 in this system.  The 
advantage of this system for insect P450 expression is that exogenous CPR and cytb5 
are not required.  Endogenous CPR is sufficient to achieve high insect P450 activity 
(Wen et al., 2003).  However, expression of human P450 in insect cells requires 
exogenous CPR electron transfer (Grogan et al., 1995; Paine et al., 1996).  
      
4.2 Objective 
E. coli will be used as host cells due to its availability.  An established yeast or insect 
cell system was not available at the NICD or the Liverpool school of Tropical 
Medicine, UK where expression studies were performed. Heterologous expression of 
microsomal P450 in E. coli is extremely difficult without the NH2-terminal 
modification.  The broad objective of this study was to develop a suitable expression 
system in E. coli to over-produce and purify functional CYP6P9.  The following 
procedures were used in completing this objective.  A leader sequence ompA was 
fused to CYP6P9 sequence in order to over-produce the full length enzyme.  The 
Protein expression of An. funestus CYP6P9 in E. coli 
  
 
105
NH2-terminal modification using 17 hydroxylase was also employed.  Anopheles 
funestus cytb5 and CPR were also expressed in E. coli.  Plasmid pIX4.0 and pCWori+ 
plasmid was used to express membrane P450 proteins. Cell induction was achieved 
by the addition of IPTG and ALA (Aminolevulinic acid) to log-phased cells and 
expressed protein was analyzed in a spectrophotometer between wavelengths 400-
500nm. Anopheles gambiae CPR was used instead of An. funestus CPR when 
expression using pCWori+ plasmid was used.  This was due to its availability (An. 
gambiae CPR was a kind gift from Dr M.J.I. Paine).  
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4.3 Materials and Methods 
Two vector systems were set up.  The first was the newly produced insect vector 
system (pIX4.0) and the second was the pCWori+.  The insect vector was used to 
express truncated hydrophobic NH2 terminal P450 enzymes.  The pCWori+ vector 
was used to express NH2 terminal modified P450 (17αP450) and bacterial signal 
peptide fused P450 enzymes (ompA-P450). 
 
4.3.1 E. coli expression of CYP6P9 in insect vector pIX4.0   
4.3.1.1 Construction of pIX4.0/(His)6CYP6P9, pIX4.0/(His)6-cytb5 and 
pIX4.0/(His)6CPR 
 
Three His-tag constructs were generated for this expression system.  Each construct 
contained restriction sites on NH2 and COOH terminals to allow for the cloning in to 
pIX4.0 vector.  For the first construct forward primer (5'CTCGAG CCA TCA TCA 
CCA TCA CCA CAT GGC TGG ACA CGC G 3') (Tm 77.0 ºC) for (His)6-CYP6P9 
was designed by replacing the hydrophobic NH2-terminus (44 amino acids) with XhoI 
restriction site (underline).  A six His-tag (red) was inserted prior to the initial 
methionine (ATG) codon followed by a second codon alanine (GCT) by PCR based 
mutagenesis (Figure 4.1). The same technique was used for the construction of 
(His)6-CPR (5' CCATGG ATC ATC ATC ACC ATC ACC ACA TGG CTA AGG 
GCA AG 3') (Tm 73.7 ºC) except that an NcoI restriction site (underline) was added 
(Figure 4.2). The construction of (His)6-cytb5 (5'CTCGAG CCA TCA TCA CCA 
TCA CCA CAT GGC TAA GGG CAA GAA AAA AG 3') (Tm 72.8 ºC) involved 
the addition of a XhoI restriction enzyme site (underline) followed by a 6xHis tag 
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before the methionine (ATG) start codon and alanine (GCT) as a second codon 
(Figure 4.3). 
 
Reverse primers for (His)6CYP6P9 and (His)6CPR were designed with a BglII 
restriction site (underline) after the stop codons [5'AGATCT CTA CAA CTT TTC 
CAC C 3') (Tm 58.9 ºC) and 5' AGATCT TTA GCT CCA CAC GCC 3' (Tm       
62.6 ºC) respectively], while (His)6-Cytb5 reverse primer were designed with PstI 
restriction site (5'CTGCAG CTA CAA CTT TT CCA CC 3') (Tm 62.6 ºC).  
Amplified cDNAs were ligated into pGEM-T Easy vector as detailed in section 3.3.4.  
Positive clones were cultured in 5 ml LB broth containing AMP and incubated at 
37˚C overnight with shaking. Plasmid DNA was prepared by small scale plasmid 
isolation. A double digest was performed on plasmid DNA using appropriate 
restriction enzymes and allowed to digest overnight at 37˚C (Table 4.1).  
 
Table 4.1: Double digestion reaction procedure for DNA  
Reagents Volume (µl) Concentration 
Water  
 
36  
10x Buffer* 10 2x 
 
DNA 
 
2 
(0.5-1 µg/µl) 
 
Enzyme 1 
 
1 
0.2 units 
 
Enzyme 2 
 
1 
0.2 units 
Total volume 50  
*Tango Buffer: (33 mM Tris-acetate, pH 7.9, 10 mM magnesium acetate, 66 mM potassium acetate, 0.1 mg/ml BSA) was used 
for double digestion (Fermentas, Canada). 
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Figure 4.1: Systematic diagram representing the cloning strategy of CYP6P9 into pIX4.0 insect 
vector. (His)6CYP6P9 was digested from pGEM-T using XhoI and BglII and inserted into a linearized 
pIX4.0 insect vector to produce pIX4.0/(His)6CYP6P9 plasmid. 
PT7 ATG MCS T7 Term LS M13R M13F 
T7 
6x His tag 
    5’ CTCGAG  CAT----CAC ATGGCTGGA --------------/ /------------------AGTTGTAG  AGATCT   3’ 
BglII XhoI (No hydrophobic NH2 terminal)   CYP6P9 (His)6 
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Figure 4.2: Systematic diagram representing the cloning strategy of CPR into pIX4.0 insect 
vector. (His)6CPR was digested from pGEM-T using XhoI and BglII and inserted into a linearized 
pIX4.0 insect vector to produce pIX4.0/(His)6CPR plasmid.
6x His-tag 
T7 
PT7 ATG MCS T7 Term LS M13R M13F 
    5’ CTCGAG  CAT----CAC ATGGCTAAGGG --------------/ /----------- GGAGCTAA  AGATCT   3’ 
BglII XhoI (No hydrophobic NH2 terminal)  CPR  (His)6 
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Figure 4.3: Systematic diagram representing the cloning strategy of cytb5 into pIX4.0 insect 
vector. (His)6Cytb5 was digested from pGEM-T using XhoI and BglII and inserted into a linearized 
pIX4.0 insect vector to produce pIX4.0/(His)6cytb5 plasmid. 
 
PT7 ATG MCS T7 Term LS M13R M13F 
6x His-tag 
T7 
  5’ CTCGAG  CAT----CAC ATGGCTA----------------/ /---------------------AGTTGTAG  CTGCAG   3’ 
PstI XhoI Cytb5 (No hydrophobic COOH)  (His)6 
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The digested fragments were extracted from 1% TAE (Tris-acetate EDTA) agarose 
gel and placed into a preweighed 1.5ml microcentrifuge tube.  The fragments were 
purified using the QIAquick gel Extraction Kit (Qiagen, Germany, cat no: 28704).  
Tube and gel slice were weighed in order to calculate the weight of the gel slice.  
Three volumes of Buffer QG (Guanidine thiocyanate) were added to the gel (100 mg 
~100L) incubated at 50 ºC until the gel was completely dissolved.  Isopropanol (1 
gel volume) was added to the sample and mixed. The sample was added to a 
QIAquick spin column and centrifuged at 16,000 x g for 1 minute to bind DNA to the 
column. Buffer QG (0.5 ml) was added to remove any traces of agarose gel.  The 
sample was centrifuged at 16,000 x g for 1 minute followed by one wash with Buffer 
PE (0.75 ml; containing ethanol) and two spins at 16,000 x g for 1 minute.   
 
The QIAquick column was placed into a clean 1.5 ml microcentrifuge tube and 30 l 
of ultra pure water was added to the centre of the QIAquick membrane, allowed to 
stand for 1 minute then centrifuged at 16,000 x g for 1 minute.  The DNA was stored 
at -20 ºC until ready for use.  The inserts were ligated into insect EasyXpress pIX 4.0 
vector (Qiagen, Germany, cat no: 32713) (Table 4.2 and Figure 4.1- 4.3). 
Transformation and plasmid isolation was performed as detailed in sections 3.3.4 and 
3.3.5. 
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Table 4.2: Ligation procedure for PCR fragment into pIX 4.0 expression vector 
Reagents volume (l) 
2x Rapid Ligation Buffer, T4 DNA Ligase 5 
Insect EasyXpress pIX4.0 vector (0.5 g/l) 1 
PCR Product (200ng) 3 
T4 DNA Ligase (3 weiss unit/unit) 1 
Total volume                          10 
 
 
4.3.1.2 Expression of recombinant P450 proteins 
Competent E. coli BL21 (DE3) (pLysS) cells were used to transform each of the 
expression plasmids.  Overnight culture (5l) E. coli BL21 (DE3) (pLysS) 
[transformants] were diluted into 50 ml LB broth containing AMP and CAM. 
Cultures were grown at 37 ˚C with shaking at 200 rpm until absorbance at 600 nm 
reached 0.6 - 0.9. Samples (1 ml) were collected from the cultures prior to induction 
for sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
analysis. Induction was achieved by the addition of IPTG to a final concentration of 1 
mM.  Samples (1 ml) were collected from the culture every hour over a period of 5 
hours and a final collection after 16 hours.  The induced cell pellets were collected by 
centrifugation at 16,000 x g at room temperature for 60 seconds. The cells were 
resuspended in ice-cold PBS (phosphate buffered saline: 137 mM NaCl, 2.68 mM 
KCl, 10 mM Na2HPO4, 1.76 mM KH2PO4, pH 7.4) to a uniform cell density.  
 
A 2x SDS-PAGE gel-loading buffer (100 mM Tris, pH 6.8, 5% β-mercaptoethanol, 
4% SDS, 0.2% bromophenol blue and 20% glycerol) was added to each induced cell 
suspension and boiled for 5 minutes. The tubes were briefly vortexed and 10 μl of 
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each sample were separated on a discontinuous (0.1%) SDS (12%) PAGE gel 
electrophoresed in Tris-glycine buffer (pH 8.3) (0.12 M Tris-base, 1.26 M glycine 
and 0.1% (w/v) SDS) (Table 4.3 and 4.4).  
 
Table 4.3: Preparation of 12% resolving gel 
Reagents      Volume (ml) 
Final 
concentration
12% Resolving gel    
Water      4.9  
30% Acrylamide mix (Acryl/ Bis, 29:1)       6      12% 
1.5 M Tris (pH 8.8)    3.8 0.38 M 
10% SDS   0.15    0.1% 
10% ammonium persulphate   0.15     0.1% 
TEMED 0.006  
Volume     50  
 
Table 4.4: Preparation of 5% stacking gel 
5% Stacking gel   
Water 4.1  
30% Acrylamide mix (Acryl/ Bis, 29:1)     1 5% 
1.0 M Tris (pH 6.8) 0.75 0.125% 
10% SDS 0.06 0.1% 
10% ammonium persulphate 0.06 0.1% 
TEMED 0.006  
Volume       6  
 
PageRuler™ Prestained Protein Ladder (mixture of 10 recombinant highly purified 
proteins with molecular weights from 10 kDa to 170 kDa) (Fermentas, Canada, cat 
no: SM0671) were used to determine protein size. The gel was electrophoresed at 
200V for 45 minutes, stained in gel staining solution (0.24% Coomassie blue, 50% 
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Methanol, 7.5% Acetic acid) for 3 hours, and destained in destaining solution (20% 
methanol, 7.5% Acetic acid) overnight. 
 
4.3.1.3 Western analysis detection of His-tagged proteins 
Induced cell lysates were run on a (0.1%) SDS (12%) PAGE gel as described in 
section 4.3.1.2.  A PVDF membrane (Polyvinylidene floride) (Millipore, U.S.A cat 
no: IPVH00010) was placed onto the gel prior to soaking in 100% methanol for 15 
seconds and in ultra pure water for 2 minutes (to activate membrane).  Gel and PVDF 
membranes were sandwiched between six layers of 3MM chromatography paper 
(Whatman, England cat no: 3030917) (three on each side), and two sponges pre-
soaked in Transfer buffer (39 mM glycine, 48 mM Tris-base, 20% Methanol).  
Proteins were allowed to transfer from gel to membrane (towards the anodes) for 
1hour at 100 volts in transfer buffer.  The membrane was stained in Ponceau-S for 2 
minutes at room temperature with shaking then destained in water to confirm and 
visualize transferred bands.   
 
Western analysis was performed using the HisDetector™ Western Blot kit, HRP 
Chemiluminescent (KPL, U.S.A cat no: 240002).  The membrane was blocked for 1 
hour in 1% BSA blocking solution (20 ml; 1% BSA in 1X TBST [Tris buffered 
saline: 50 mM Tris, 150 mM sodium chloride, pH 7.5, 1% Tween 200]).  Then 
incubated in HisDetector™ Nickel-HRP conjugate (diluted 1/10 000-1/40 000 in 1% 
BSA blocking solution) for 1 hour at room temperature with gentle agitation.  The 
membrane was washed three times in 1X TBST for 5 minutes each.  
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Chemiluminescent detection was achieved by applying 5 ml, LumiGLO® working 
solution (2.5 ml LumiGLO Substrate A and 2.5 ml LumiGLO Substrate B) to the 
membrane for 1 minute.  The substrate was drained and bands were visualized using 
a G: BOX ChemiHR imaging system (Syngene, UK) for 2 to 10 minutes. 
 
4.3.1.4 Batch purification of recombinant P450 proteins 
A culture (50 ml) of E. coli BL21 (DE3) (pLysS) [transformants] was inducted as in 
section 4.3.1.2.  Cells were harvested two hours after induction by centrifuging at      
4,500 x g for 20 minutes at room temperature.  The pellet was resuspended in 10 ml 
native lysis buffer (50 mM sodium phosphate, pH 8.0, with 300 mM NaCl and 10 
mM imidazole). Protease inhibitor cocktail (Complete, Mini) (Roche, Germany, cat 
no: 1836153) (1X concentration) was added to inhibit protease action and lysozyme 
was also added to a final concentration of 1 mM.  The induced cells were lysed by 
freeze/thawing at -80 °C.   
 
The cells were centrifuged at 4,500 x g for 20 minutes at 4 ºC and the supernatant was 
collected for SDS-PAGE analysis. HIS-Select™ Nickel affinity Gel suspension (1 ml) 
(Sigma, U.S.A. cat no: P6611) was added to the clear lysate. The mixture was gently 
agitated at 4 ºC for 1 hour.  The lysate- HIS-Select™ Nickel affinity Gel suspension 
were centrifuged at 4,500 x g for 5 minutes in order to remove unbound protein.  The 
supernatant was collected for SDS-PAGE analysis.  The lysate- HIS-Select™ Nickel 
affinity Gel suspension was washed three times in 10 gel volumes of wash buffer (50 
mM sodium phosphate, pH 8.0, with 300 mM NaCl and 150 mM imidazole) gently 
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agitated at 4 ºC.  The His-tagged P450 proteins were eluted by adding two gel 
volumes of elution buffer (50 mM sodium phosphate, pH 8.0, with 300 mM NaCl and 
1 M imidazole) then mixing by gently agitated at 4 ºC for 10 minutes followed by 
centrifuging at 4,500 x g for 5 minutes.  Elution was repeated four times, collected 
and analysed by (0.1%) SDS (12%) PAGE. 
 
4.3.2 E. coli expression of CYP6P9 in pCWori+ vector 
4.3.2.1 Construction of pC-ompA+2CYP6P9(His)6 plasmid 
i) Construction of CYP6P9(His)6 cDNA 
Construction of CYP6P9(His)6 cDNA,  forward primer [5' ACCGTAGCGCAG 
GCCGCGCCG ATG GCT GAG CTA ATT AAC GCG GT 3' (Tm 58 ºC)] with end 
sequence of ompA+2  flanking the 5' end (underlined) was designed.  Reverse primer 
[5' GAA TTC TCTAGA TCA GTG GTG GTG GTG GTG GTG CAA CTT TTC 
CAC CTT CAA GTA ATT AC 3' (Tm 74.3 ºC)] designed with a 6x His-tag (red) 
before the stop codon and a XbaI restriction site (underlined) immediately after the 
stop codon  were used to amplify CYP6P9(His)6.  The PCR product was excised from 
a 1% TAE agarose the gel and the gel purified using the QIAquick gel Extraction Kit 
as described in section 4.3.1.1.  Purified PCR products (5l) were analyzed on a 1% 
TAE agarose gel under a UV transilluminator (G: Box ChemiHR imaging system, 
Syngene, U.K). 
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ii) Fusion of bacterial leader sequences ompA+2 to CYP6P9(His)6  cDNA 
 
Bacterial membrane leader sequences ompA+2 (MKKTAIAIAVALAGFATVAQA 
AP) were synthesized by Inqaba Biotechnical Industries (Pty) Ltd (Pretoria, South 
Africa).  In order to fuse ompA+2 leader sequence to CYP6P9(His)6, a forward 
primer (P-1)[5' CATATG AAA AAG ACA GCT ATC 3' (Tm  54.7 ºC)] for ompA+2 
was designed with a NdeI restriction site (underlined). A reverse primer (P-2) [5' 
CAC CGC GTT AAT TAG CTC AGC CAT CGGCGCGGCCTGCGCTACGGT 3' 
(Tm 80.2 ºC)]  was designed with the last 21 nucleotide sequences of ompA+2 
(underlined) fused to the first 24 nucleotide sequences of CYP6P9(His)6 cDNA.  This 
produced a PCR intermediate fragment, see Figure 4.4(i) (Pritchard et al., 1997).  
PCR conditions used are shown in Tables 4.5 and 4.6.  
 
Table 4.5: PCR reaction mix for the amplification of intermediate fragment 
Reagents Volume (l) Final concentration 
10 x Buffer            5                    1x 
dNTP mix (10 mM)            5               1 mM 
MgCl2 (25 mM)            3            1.5 mM 
Primer (1) (3.1 M)            4         0.248 M  
Primer (2) (3.1 M)            4         0.248 M 
Water variable  
DNA variable  50pg-1g/50l 
Taq         0.4              0.4 u/l 
Total Volume          50  
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Table 4.6: PCR cycle conditions for intermediate product 
Stage Cycles Temperature Time 
1   1     94 ºC   2 minutes 
2 30     94 ºC 30 seconds 
    55.1 ºC   1 minute 
       72 ºC 2.5minutes 
3   1    72 ºC 10 minutes 
  
Fusion PCR was used to join and amplify ompA+2CYP6P9(His)6 cDNA by mixing 
the PCR intermediates and CYP6P9 cDNA templates.  Forward primer (P-1) and 
reverse primer (P-3)( 5' GAA TTC TCT AGA TCA GTG GTG GTG GTG GTG 
GTG CAA CTT TTC CAC CTT CAA GTA ATT AC 3') were used to fuse and 
amplify fragment (Figure 4.4 (ii and iii)(Ninomiya et al., 2004). Each fragment was 
analyzed on a 1% TAE agarose gel under an UV transilluminator.  The reaction 
mixture is given in Table 4.5 and PCR conditions in Table 4.7.  
 
Table 4.7: PCR conditions for fusion of ompA leader sequence to CYP6P9 
Stage  Cycles Temperature Time 
1 
 
1 94°C 2 minutes 
2 
 
30 94°C 30 seconds 
 
 
 53°C 1 minutes 
  68°C 5 minutes 
 
3 
 
1 
 
72°C 
 
7 minutes 
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Figure 4.4: Fusion of leader sequences to CYP6P9. i) Primers (P-1) and (P-2) are used to amplify an 
intermediate fragment that contains a partial sequence of CYP6P9 NH2-terminus. ii) Intermediate 
fragment was used as template to amplify and fuse leader sequence to CYP6P9 cDNA using primers 
(P-1) and (P-3). iii) Leader sequence (ompA+2) fused to CYP6P9 cDNA.  
 
iii) Ligation into pCWori+ plasmid 
PCR fragment ompA+2CYP6P9(His)6 was ligated into pGEM-T Easy vector.  
Restriction enzymes NdeI and XbaI were used to excise ompA+2CYP6P9(His)6 from 
pGEM-T Easy vector and prior to ligation into NdeI and XbaI sites of linearized 
pCWori+ plasmid (Figure 4.5).    
OmpA(+2)  
leader sequences 
OmpA(+2)  
leader sequences 
(P-1)
CYP6P9cDNA OmpA(+2)   leader sequences 
PCR intermediate  
First round of PCR between 
primers (P-1) and (P-2) on 
leader sequence template  
Second round of PCR between primers (P-1) 
and (P3) on P450 template in presence of 
limiting concentration of PCR intermediate 
Step 1 
Step 2 
i) 
ii) 
iii) 
(P-2)
(P-1)
(P-3)
CYP6P9 cDNA 
CYP6P9 cDNA 
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Figure 4.5: Systematic diagram representing the cloning strategy of ompA+2CYP6P9(His)6 into 
pCWori+ expression vector. ompA+2CYP6P9 was digested with NdeI and XbaI and inserted into a 
linearized pCWori+ vector to produce pC-ompA+2CYP6P9(His)6 plasmid. 
 
 
 
 
 
ompA+2 
(His)6 
Ptac Ptac 
UV5 
Ptac Ptac 
UV5 
5’  CATATG AAA AAG ACA G------GGCCGCGCCG       ATGGAGCTA-------------/ /--------------- AAAGTTGTAG  CAT-----CAC  TCTAGA  3’ 
ompA+2 XbaI NdeI (His)6 Full-length CYP6P9 (509 aa) 
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4.3.2.2 Construction of pCW-ompA2CYP6P9 plasmid  
 
i) Amplification of CYP6P9 
CYP6P9 was amplified from pGEM-T/CYP6P9 using the forward primer [5' 
GTAGCCGGCATG GAG CTA ATT AAC GCG GTG 3' (Tm 78.8 ºC)] with 
NgoMVI restriction site underlined before the start codon.  The reverse primer [5' 
ATGAATTCT ACA ACT TTT CCA CCT CAAG 3' (Tm 66.6 ºC)] was designed 
with EcoRI restriction site underlined immediately after the stop codon.  KOD HiFi 
DNA polymerase (Cat No: 71085-3, Novagen, U.S.A) was used to amplify CYP6P9 
(Table 4.8 and 4.9).  
 
Table 4.8: PCR mixture for amplification of CYP6P9 
Reagents Volume (L) Final concentration 
KOD 10x Buffer 1            5                    1x 
dNTP mix (2 mM)            5               1 mM 
MgCl2 (25 mM)            2               1 mM 
Forward primer (5 M)            4             0.4 M  
Reverse primer (2) (5 M)            4             0.4 M 
Water variable  
DNA variable  50pg-1g/50l 
KOD Polymerase         0.4              0.4 u/l 
Total volume          50  
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Table 4.9: PCR cycle for the amplification of CYP6P9 
Stage Cycles Temperature Time 
1  1 96 ºC   5 minutes 
2 30 96 ºC 15 seconds 
    50 ºC 15 seconds 
    72 ºC   1 minutes 
3   1 72 ºC   5 minutes 
4   1   4 ºC           Hold 
 
The amplified fragment was cleaned using the QIAquick PCR Purification Kit (Cat 
no: 28104, QIAGEN German).  Buffer PBI (5 volumes; containing guanidine 
hydrochloride and isopropanol) was added to one volume of PCR sample and mixed.  
A QIAquick column was applied to a vacuum pump.  The sample was loaded and 
allowed to pass through.  The DNA was washed with Buffer PE (750 l; containing 
100% ethanol) which was allowed to flow through the sample.  The column was 
transferred into a 2 ml collection tube and centrifuged for 1 minute at 16,000 x g then 
transferred to a clean 1.5 ml centrifuge tube.  Buffer EB (30 L; 10 mM Tris-Cl, 
1mM EDTA, pH 8.0) was added to the column which was allowed to stand for 1 
minute before centrifuging at 16,000 x g to elute the DNA.    A three hour digestion at 
37 ºC with NgoMVI and EcoRI was performed (Table 4.10) and digested fragments 
were excised from a 1% TAE agarose gel run at 100V for 45 minutes.  The fragment 
was gel purified using the QIAquick gel Extraction Kit as described in section 
4.3.1.1.   Purified PCR fragments (5l) were analyzed on a 1% TAE agarose gel 
under a UV transilluminator.  
 
Protein expression of An. funestus CYP6P9 in E. coli 
  
 
123
Table 4.10: CYP6P9 cDNA Digestion 
Reagents Volume (µl) Concentration 
EcoRI (12u/µl) 1 0.34 
NgoMIV (10u/µl) 1 0.30 
BSA (10x) 3.5 1x 
NEB buffer4* 0.4 1x 
DNA 24.1  
Total 30  
*NEB buffer 4: New England BioLabs, U.S.A 
 
ii) Ligation into pCW-ompA2  plasmid 
Digested CYP6P9 cDNA fragments were ligated into NgoMVI and EcoRI sites of the 
pCW-ompA2 plasmid (Figure 4.6) (Table 4.11).  This plasmid was constructed by 
inserting the ompA2 sequence via the NdeI site.  This site is located down stream of 
the Ptactac promoter region.  An NgoMVI site was introduced after the ompA2 so as 
to allow ligation of P450 cDNA.  The plasmid was also digested with EcoRI down 
stream of the ompA2 leader sequence site. 
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Figure 4.6: Diagram representation of CYP6P9 cDNA insertion. CYP6P9 was digested with 
NgoMIV and XbaI and inserted into a linearized pCW-OmpA2 vector to produce pCW-ompA2CYP6P9 
plasmid. 
 
5’  GCCCGGC  ATGGAGCTA-------------/ /--------------- AAAGTTGTAG  TCTAGA  3’ 
EcoRI NgoMIV Full-length CYP6P9 (509 aa) 
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Table 4.11: Ligation into pCW-ompA2 plasmid 
Reagents volume (l) 
Buffer (10x)  4 
pC-ompA2 plasmid  (75 ng/l)  1 
PCR Product (FUMOZ-R: 8.8 ng/ml, FANG: 
16.7 ng/l) 10 
T4 DNA Ligase (400,000 unit/ml)*  1 
Total 16 
* New England BioLabs, Cat No: M0202L, U.S.A 
 
 
iii) Sequence analysis of pCW-ompA2CYP6P9 plasmid 
Plasmid, pCW-ompA2CYP6P9 was sent to Cardiff University, UK (sequencing 
facility) for sequencing.  Forward primer [5' CCA AGC AAT CGA GGA GAA TGA 
C 3' (Tm 69.4 ºC)] that recognises part of the pCW plasmid and ompA2 sequence was 
used to identify the start sequence of CYP6P9.  Reverse primer [5' CAC TCA ATC 
CCG AAT GCA CAG G 3' (Tm 70.7 ºC)] which recognises the pCW plasmid was 
used to identify the end sequence of CYP6P9.  The internal region was sequenced 
using the internal forward primer [5' CAA GAG ACG ACC CGC TCT CC 3' (Tm 
66.6 ºC)]. 
 
4.3.2.3 Construction of pC-17CYP6P9 plasmid  
 
i)  NH2-terminal (17α hydroxylase) modification of CYP6P9 cDNA 
NH2-terminal modification of CYP6P9 using the 17 hydroxylase sequence was 
achieved by PCR.  17 hydroxylase sequence replaced the first eight amino acid 
sequences of CYP6P9 cDNA (Figure 4.7A).  Forward primer [5' TTCATATGGCT 
CTG TTA TTA GCA GTT TTT GC CGC GTT CAT CTT CGT AGT G 3' (Tm   
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66.5 ºC)] contained NdeI site underlined followed by the 17 hydroxylase sequence 
(MALLLAVF) and 21 nucleotides from CYP6P9 cDNA.  Reverse primer [5' 
CGCTCTAGACTA CAA CTT TTC CAC CT TC 3' (Tm 58.7 ºC)] was designed 
with XbaI restriction site underlined used in the amplification of 17CYP6P9 cDNA 
(Figure 4.7B).  17CYP6P9 cDNA was ligated into NdeI and XbaI sites of linearized 
pCW plasmid.  
 
A) 
 
17 hydroxylase     M       A       L       L       L        A         V       F 
               ATG  GCT  CTG   TTA  TTA  GCA   GTT   TTT  
 
B) 
 
 
 
 
 
 
 
Figure 4.7: 17 αhydroxylase NH2-terminal modification.  A) 17 αhydroxylase sequence, alanine 
was place as a second codon, silent mutations were introduced to reduce secondary structure.  B) 
Diagram representation of CYP6P9 with 17 αhydroxylase NH2-terminal modification. Restriction site 
NdeI and XbaI were introduced. 
 
 
 
4.3.2.4 Transformation into DH5competent cells 
On ice DH5 competent cells (50 l) (Invitrogen, U.S.A, cat no: 18263012) were 
transferred into a 1.5 ml centrifuge tube containing DNA (5 l; 1-10 ng).  Cells were 
gently mixed and stored on ice for 30 minutes.  Cells were heat shocked at 42 ºC for 
20 seconds in a water bath without shaking.  Tubes were placed on ice for 2 minutes 
5 ' CATATGGCTCTGTTATTAGCAGTTTTT    GCCGCGTTC--------------/ /------------- AAAGTTGTAG  TCTAGA   3’  
17-α XbaI NdeI Full-length CYP6P9 (501 aa) 
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before the addition of SOC media (see appendix A1 for recipe).  Cells were incubated 
at 37 ºC for 1 hour with shaking (225 rpm).  Transformed cells (200 l) were spread 
onto LB plates containing AMP and incubated overnight at 37 ºC.   
 
4.3.2.5 P450 expression in E. coli 
A starter culture was prepared by picking a single colony from a fresh LB-AMP agar 
plate and inoculating into 5 ml LB-AMP broth.  The culture was allowed to grow 
overnight at 37 ºC with shaking at 200 rpm.  The overnight culture was diluted 1:100 
into Terrific Broth (TB) (see appendix A1 for recipe) containing AMP.  The culture 
was grown at 37 °C for 4 hours after which the OD600 was monitored until it reached 
0.7-1.0. Induction was initiated by the addition of IPTG (1 mM) and ALA (0.5 mM) 
(Aminolevulinic acid).  Induced cells were allowed to grow for 19-24 hours at 
25°C.  
 
4.3.2.6 Cytochrome P450 spectral determination 
Whole cells (2 ml) were collected and centrifuged at 16,000 x g for 2 minutes.  The 
pellet was resuspended in 1X P450 spectrum buffer (2 ml; 100 mM Tris-HCl, pH 7.4, 
containing 10 mM CHAPS, 20% (v/v) glycerol, and 1 mM EDTA).  A few grains of 
sodium hydrosulfite was added and mixed.  The sample was divided equally between 
a pair of matched 1 ml stoppered optical glass cuvets.  A baseline scan from 500 to 
400 nm was performed.  Samples were bubbled with carbon monoxide (CO) for 45-
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60 seconds in a fume hood.  A scan from 500 to 400 nm was repeated.  An expected 
peak at 450nm would indicate P450 expression.  
 
4.3.3 Construction of pACYC-pelBCPR Plasmid 
Plasmid pACYC-pelBCPR was a kind gift from Dr M.J.I. Paine (Liverpool school of 
Tropical Medicine, UK).  This plasmid contained An. gambiae CPR.  Anopheles 
gambiae CPR share an identity of 96.5% with that of An. funestus.  Due to its 
availability it was used in place of An. funestus CPR in recombinant protein 
expression.  Leader sequence pelB was fused to CPR using oligonucleotides 
containing a BamHI site linked to a pelB sequence and 30 bp of the start codon of 
CPR.  The reverse primer contained an EcoRI site and 30 bp of the end sequence of 
CPR.  The fragment produced was ligated into EcoRI and BamHI sites of pCW 
plasmid to produce pCW-pelBCPR.  The pelBCPR was cut out of pCW plasmid with 
the PtacPtac promoter upstream of the pelB sequence using EcoRV and BglII.  This 
fragment was ligated into EcoRV and BamHI sites of pACYC184 plasmid (BamHI 
and EcoRV sites are located within the tetracycline resistant (Tet) gene therefore 
eliminating the Tet resistance) to produce pACYC-pelCPR plasmid (Figure 4.8).  
pACYC184, does not have an IPTG inducible gene hence the insertion of PtacPtac 
promoter from pCW plasmid. 
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Figure 4.8: Construction of pACYC/pelBCPR plasmid. Step1: ligation of pelBCPR into pCW 
plasmid. Step 2: pACYC184 plasmid was linearized with BamHI/EcoRV. Step 3: pelBCPR and Ptactac 
promoter were cut out of pCW plasmid using BglII and EcoRV then ligated into BamHI/EcoRV site of 
linearized pACYA184 to produce pACYC/pelBCPR (Step 4). 
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4.3.4 Construction of pC-cytb5(His)6 plasmid 
Construction of cytb5(His)6 cDNA was carried out using a forward primer [5' CAT 
ATG  GCT TCG GAA GTG AAA ACG TAT TCG CTG G 3' (Tm 69.4 ºC)] that was 
designed with a NdeI restriction site (underlined) flanking the 5' end.  Alanine (GCT) 
that is a preferred second codon by E. coli host was engineered after the methionine 
start codon.  The reverse primer [5' GAAGCTTTT AGT GGT GGT  GGT GGT GGT 
GCT GGG TGA AGT AGA ACC 3' (Tm 75.6 ºC)] was designed with a 6x His-tag 
(red) before the stop codon and a HindIII restriction site (underlined) immediately 
after the stop codon.  The amplified fragment was ligated into pGEM-T Easy vector.  
The insert was cut out using NdeI and HindIII restriction enzymes and ligated into 
pCWori+ plasmid linearized using NdeI and HindIII (Figure 4.9).   
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Figure 4.9: Construction of pc/cytb5(His)6 plasmid.  Cytb5(His)6 was digested with NdeI and HindIII 
and inserted into a linearized pCW vector to produce pC/cytb5 (His)6 plasmid. 
 
 
Ptac Ptac 
UV5 
(His)6 UV5 
Ptac Ptac 
          5’CATATG    ATGGCTA-----------------------/ /-----------------------TCACCCAGCAT--------CAC AAGCTT   3’ 
HindIII NdeI Cytb5 (128 aa)  (His)6 
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4.3.5 Cytochrome b5 spectral determination 
Whole cells (2 ml) were collected and centrifuged at 16,000 x g for 2 minutes.  The 
pellet was resuspended in 1X P450 spectrum buffer (2 ml; 100 mM tris-HCl, pH 7.4, 
containing 10 mM CHAPS, 20% (v/v) glycerol, and 1 mM EDTA).  One sample was 
exposed to air (oxidized) for about 1 hour.  A baseline scan from 650 to 350 nm was 
performed.  The oxidized sample was scanned from 650 to 350 nm.  A few grains of 
sodium hydrosulfite was added and mixed (reduced sample) and the scan from 650 to 
350nm was repeated to indicate the presence of cytb5 expression. 
 
4.3.6 Co-expression of CYP6P9 and CPR 
Plasmids, pC-ompA+2CYP6P9 and pACYC-pelBCPR (10 ng each) were transformed 
into DH5 competent cells as described in section 4.3.2.4.  Cells were grown 
overnight on LB plates containing AMP (resistance conferred to pC-ompA+2CYP6P9 
plasmid) and CAM (resistance conferred to pACYC-pelBCPR plasmid).  Positive 
clones were tested for P450 expression as described in section 4.3.2.7.  
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4.4 Results 
4.4.1 E. coli expression of FUMOZ-R (His)6CYP6P9, (His)6cytb5 and 
(His)6CPR in insect vector pIX4.0 
 
i) Construction of pIX4.0-(His)6CYP6P9, pIX4.0-(His)6-cytb5 and pIX4.0-
(His)6CPR plasmids  
 
Isolated FUMOZ-R cDNAs of CYP6P9, cytb5 and CPR inserted into pGEM-T Easy 
vector were used to attach a six His tag to the NH2 terminus of the cDNAs by PCR 
mutagenesis.  Restriction sites XhoI and BglII were introduced to the 5' and 3' ends of 
(His)6CYP6P9 respectively to give a fragment size of 1,536 bp (Figure 4.10).    The 
fragment was re-cloned into pGEM-T vector.  Insect expression vector pIX4.0, 
containing a bacteriophage T7 promoter which allows for the translation of a cDNA 
insert was used to express recombinant proteins.  Restriction enzymes XhoI and BglII 
were used to digest (His)6CYP6P9 from pGEM-T (Figure 4.10A) vector and ligated 
into XhoI and BglII sites of pIX4.0 vector (Figure 4.10B).  Plasmid 
pIX4.0/(His)6CYP6P9 was sequenced and it contained (His)6CYP6P9 cDNA.  
 
XhoI and NcoI were introduced at the 5' ends of (His)6-cytb5 and (His)6CPR while 
PstI and BglII were inserted at the 3' ends respectively.  Fragment sizes of 393 bp and 
2046 bp were obtained for (His)6-cytb5 and (His)6CPR respectively (Figure 4.11A).   
(His)6-cytb5 was digested with XhoI and PstI from pGEM-T vector and ligated into  
XhoI and PstI sites of pIX4.0 vector (Figure 4.11B), while (His)6CPR was digested 
with XhoI and BglI (Figure 4.11B).  Sequencing was performed on these plasmids 
and inserts were confirmed. 
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Figure 4.10: Construction of pIX4.0-(His)6CYP6P9 plasmid.  A) Lane M: Molecular marker, lane 
1: pGEM-T/(His)6CYP6P9 and lane 2: Double digest of pGEM-T-(His)6CYP6P9 using XhoI and BglII 
restriction enzymes to release (His)6CYP6P9 for subcloning into pIX4.0 vector. B) Lane M: Molecular 
marker, lane 1: pIX4.0-(His)6CYP6P9 and lane 2: Double digest of pIX 4.0-(His)6CYP6P9 using XhoI 
and BglII restriction enzymes to confirm (His)6CYP6P9 insert. DNA was electrophoresed on a 1% 
TAE agarose gel and viewed under UV light.   
 
 
 
 
 
 
(His)6CYP6P9 
pIX4.0-(His)6CYP6P9 
pIX4.0
1 500 bp 
4 000 bp 
3 000 bp 
B) 
(His)6CYP6P9 
pGEM-T A) 
 M     1    2 
 M      1       2 
1 500 bp 
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Figure 4.11: Construction of pIX4.0-(His)6cytb5 and pIX4.0-(His)6CPR plasmids.  A) Lane M: 
Molecular marker, lane 1 Double digestion of pGEM-T/(His)6-cytb5 using XhoI and PstI to release 
(His)6-cytb5 and 2: Double digestion of pGEM-T/(His)6CPR using NcoI and BglII to release 
(His)6CPR. B) Lane M: Molecular marker, lane 1 Double digestion of pIX 4.0-(His)6-cytb5 using XhoI 
and PstI and lane 2: Double digestion of pIX 4.0-(His)6CPR using NcoI and BglII to confirm 
(His)6cytb5 and (His)6CPR inserts respectively. DNA was electrophoresed on a 1% TAE agarose gel 
and viewed under UV light.  
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B) 
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    M        1       2 
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ii) Protein expression of FUMOZ-R (His)6CYP6P9  
Protein expression of (His)6CYP6P9 protein in E. coli BL21 (DE3) (pLysS) and E. 
coli XL1 Blue proved to be extremely difficult.  The hydrophobic N-terminal region 
was eliminated and a preferred second codon, alanine (GCT) was added after the 
methionine (ATG) start codon.  Induction was initiated with the addition of IPTG 
(1mM) when the culture reached OD600 0.7-0.9.  The first sample (1 ml) was 
collected just before induction.  After induction samples were collected every hour 
for four hours with a final collection after 16 hours.  No expression of (His)6CYP6P9 
protein was observed (Figure 4.12).  An expected protein size between 50 – 54 kDa 
was expected for CYP6P9 (Human CYP3A4 an ortholog of insect CYP6 had a size of 
54 kDa (Pritchard et al., 1997)).  Expression of a protein within this region was 
observed.  To determine whether it was CYP6P9 or bacterial protein a control was 
included.  The control was BL21 (DE3) (pLysS) cell containing no plasmids which 
was grown in LB broth and induced with IPTG.  The profile of the E. coli cells were 
compared with those containing CYP6P9 (Figure 4.12).  This clearly showed that 
protein expressed was that of E. coli.  Western analysis was performed on induced 
cells to determine whether CYP6P9 was expressed in low amounts or if there was no 
expression.  The six His tag at the NH2 terminus is detected by His-antibodies which 
in turn are detected during Western analysis giving single bands when exposed to an 
x-ray film or ChemiHR imaging system.  No fragments were detected on a Western 
blot indicating that (His)6CYP6P9 protein was not expressed.  Purification of 
(His)6CYP6P9 was performed using Ni-sepharose beads.  His-tag binds to the Nickel 
beads which are then washed to remove non-specifically bound proteins.  Elution is 
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achieved using imidazole which competed with the His-tag for Nickel binding.  A 
sample of purified protein was run on a SDS PAGE gel and Western analysis was 
performed to detect the presence of (His)6CYP6P9.   No proteins were seen on the 
SDS PAGE gel and no bands were detected on a Western blot.       
 
                 kDa       M     0      1      2      3     4    o/n                               BL21  
                                           
 
 
 
 
Figure 4.12: SDS-PAGE analysis of (His)6CYP6P9.  Lane M: Protein Marker, lane 0: before 
induction with IPTG, lane 1 to 4: samples collected hourly, 1 to 4 hours after induction with IPTG, 
lane o/n: overnight (16 hours) sample, lane BL21: E. coli BL21 (DE3) (pLysS) protein profile. 
  
 
iii) Protein expression of FUMOZ-R (His)6 cytb5 and (His)6CPR 
Recombinant expression was performed on (His)6 cytb5 and (His)6 CPR in E. coli 
BL21 (DE3) (pLysS) and E. coli XL1.  IPTG was used to induce proteins.  No 
protein bands were noted on SDS PAGE gel (Figure 4.13).  The expected protein 
sizes for (His)6 cytb5 and (His)6CPR are 19 kDa and 77 kDa respectively.  This size 
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has been shown in other cytb5 and CPR purified in E. coli (Housefly has a size of 19 
kDa (Guzov et al., 1996) and An. minimus CPR has a size of 77.3 kDa (Kaewpa et 
al., 2007)).  A band was detected in the overnight sample which was in the range of 
cytb5.  Western blot analysis did not detect this band indicating no expression.    
Western blot analysis also did not detect any bands for (His)6CPR, hence no 
expression.  Purification of (His)6 cytb5 and (His)6 CPR also yielded no bands.  No 
(His)6 CPR was detected when inducted and purified.     
 
 
 
 
                           
                    
 
Figure 4.13: SDS-PAGE analysis of (His)6-cytb5 and (His)6CPR.  A) Gel profile for An. funestus 
cytb5. The expected protein band size of (His)6-cytb5 is about 19 kDa. Region of expected protein band 
is indicated by (       ). Lane M: Protein Marker, lane 0: before induction with IPTG, lane 1 to 6: 
samples collected hourly, 1 to 6 hours after induction with IPTG, lane o/n: overnight (16 hours) 
sample. B) Gel profile for An. funestus CPR. The expected protein size was about 77 kDa. Arrow 
indicates position expected for CPR. Lane M: Protein Marker, lane 0: before induction with IPTG, lane 
1 to 4: samples collected hourly, 1 to 4 hours after induction with IPTG, lane o/n: overnight (16 hours) 
sample.   
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4.4.2 E. coli expression of FUMOZ-R CYP6P9 in pCWori+ plasmid 
i) Protein expression using bacterial leader sequence (ompA) 
 
Protein expression of P450 proteins in E. coli is usually successfully achieved using 
the pCWori+ vector.  The hydrophobic N-terminal region of P450 coding sequence is 
modified in order to aid in E. coli expression.  The following experiments were 
conducted at the Liverpool School of Tropical Medicine in UK where the P450 
expression system was available.  Protein expression in E. coli was monitored using a 
spectrophotometer between wavelengths 400 and 500 nm.  Bacterial leader sequences 
(membrane signal peptides) ompA (Outer Membrane Protein A) was attached to the 5' 
end of CYP6P9 sequences by fusion PCR technique.  To allow for subcloning into 
pCWori+ vector, NdeI restriction site was attached to the 5' end. While a 6x His tag 
was attached to the 3' end followed by an XbaI site to give a fragment size of 1,559 
bp (Figure 4.14A).  This plasmid construct was referred to as pC-
OmpA+2CYP6P9(His)6.  The third vector tested for expression of CYP6P9 was a 
pCWori+ that was engineered with an ompA leader sequence (referred to as pCW-
ompA) followed by an NgoMIV site to allow insertion of CYP6P9 cDNA.  This 
plasmid was referred to as pCW-OmpA2CYP6P9.  In contrast to the first construct 
(CYP6-His6) no His tag was included into the construct.  PCR was used to introduce 
restriction sites NgoMIV and EcoRI to 5' and 3' ends of CYP6P9 cDNA respectively 
(fragment size of 1,537 bp).  These restriction sites allowed cloning into pCW-ompA 
vector linearized with NgoMIV and EcoRI (Figure 4.14B).   
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Figure 4.14: Construction of pC-ompA+2CYP6P9(His)6 and pC-ompA2CYP6P9 plasmids.  A) 
Lane M: Molecular marker, lane 1: Double digest of pC-ompA+2CYP6P9(His)6 using NdeI and XbaI 
restriction enzymes to confirm ompA2CYP6P9(His)6 inserts. B) PCR amplification of CYP6P9.  DNA 
was run on a 1% TAE agarose gel and viewed under UV light.  
 
 
 
Protein expression of CYP6P9 proved to be very difficult in E. coli, although the 
preferred E. coli expression vector pCWori+ was used.  The bacterial leader sequence 
was attached at the NH2-terminus of CYP6P9(His)6.  Two amino acids proline and 
alanine were introduced between the ompA and P450 gene.  Bacterial signal peptidase 
cleaves the ompA and P450 at this site.  It is important that ompA is cleaved in order 
to obtain a functional protein.  P450 expression is determined by bubbling cell culture 
(1 ml) with carbon monoxide.  The resulting ferrous ion and carbon monoxide 
complex (Fe2+ - CO) forms a peak at 450nm.  When CYP6P9(His)6 was expressed in 
E. coli, no expression levels were noted (Figure 4.15).  Expression is detected by a 
peak at 450nm.  At least 10 positive clones were selected for expression and they too 
yielded no expression.  When the plasmid was sequenced the ompA sequence and 
A) 
pC vector 
ompA+2- 
CYP6P9(His)6 
5 000 bp 
1 500 bp CYP6P91 500 bp 
B) 
   M      1 
   M    1     2 
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CYP6P9 were in frame ruling out early translational termination.  No insertion or 
deletions were noted within the genes.  Plasmid pCW/ompA2-CYP6P9 yielded very 
low expression levels compared to control (Aedes aegypti CYP9J28) which had a 
peak at 450nm indicating high expression (Figure 4.15).  No expression was detected 
when co-expressed with An. gambiae CPR or An. funestus cytb5.  Protein 
optimization was performed on both CYP6P9 constructs (pC-OmpA+2CYP6P9(His)6 
and pCW/ompA2-CYP6P9).     
 
 
Figure 4.15:  CO - difference spectra.  CYP9J28 (Aedes aegypti) (control) shows an absordant peak 
at 450 nm indicating P450 expression in E.coli (blue line). Expression of CYP6P9(His)6  showing no 
expression (no peak at 450 nm) (green)  and CYP6P9 (no His-tag) showing very low expression at 450 
nm (red). 
 
After induction with IPTG and ALA incubation temperatures were reduced to 25 °C, 
28 °C and 30 °C to obtain optimum expression.  Shaking was kept at 150 rpm.  Cells 
were allowed to grow for 3 days.  Samples were collected every 24 hours and 
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randomly within the 3 days.  Culture (1 ml) was bubbled with carbon monoxide 
(CO). P450 expression was measured immediately and also allowed to stand for 10 – 
20 minutes to allow Fe2+ - CO complex to form.   
 
Growth conditions according to Saribas et al (2001) were performed.  This involved 
addition of ALA (0.5 mM) to media after inoculation with overnight culture.  Cells 
were grown at room temperature (25 °C) with shaking at 120 rpm.  When the cells 
reached an OD600 between 4 -6 they were induced with IPTG (0.7 mM).  Cells were 
allowed to grow for 94 hours. Samples were collected every 24 hours for CYP6P9 
expression.   With the change in growth conditions no CYP6P9 expression was noted.  
This led us to try the 17α hydroxylase modification which involved replacing the first 
eight amino acids with those of MALLLAVF.    
 
ii) Expression using the 17α hydroxylase NH2-terminal modification 
 
A number of membrane bound P450s have been successfully expressed in E. coli.  
Expression in E. coli required the modification of the NH2-terminus.  The first 8 to 18 
nucleotides are replaced with the 17α hydroxylase, a derivative of the bovine 17-
hydroxylase P450 (CYP17A).  Replacement of the amino acid is predicted to have no 
effects on protein structure because this region is anchored into the membrane of E. 
coli allowing for CYP6P9 activity to occur on the membrane surface. The sequence 
consists of eight amino acids (MALLLAVF) which have been shown to improve 
expression of many P450s in E. coli.   The second codon was changed to alanine 
(GCT) however, this is a preferred second codon by E. coli for expression of protein. 
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Silent mutations were introduced to make the codon usage similar to that of E. coli.  
This involved making it AT rich to reduce secondary structure (Figure 4.16A).  When 
the first eight amino acids of CYP6P9 were aligned with those of the 17α 
hydroxylase, four (50%) of them matched, indicating a similarity (Figure 4.16B).  
The NH2-terminus modified CYP6P9 was inserted into pCW vector via the NdeI and 
XbaI sites (Figure 4.16C).    
 
A) 
 
Native 17   M        T        L       L        L       A        V       F 
    ATG      TGG     CTG     CTC      CTG     GCT       GTC     TTT  
 
Modified 17     M       A       L        L       L       A        V       F 
     ATG    GCT   CTG    TTA    TTA   GCA    GTT    TTT  
 
 
B) 
 
CYP6P9       MELINAVLAAFIFVVSAVYLFIR--(remainder of CYP6P9 sequence)  
17-alpha     MALLLAVF---------------------                  
           * *: **: 
 
C)                                                  M    1    2     3    4  
 
 
Figure 4.16: Construction of 17αCYP6P9 plasmid.  A) Sequence of 17α hydroxylase showing 
native and modified sequences, silent mutations were introduced so as to reduce secondary structure 
(red). B) Alignment of CYP6P9 NH2-terminus with 17α hydroxylase (ClustalW, http://www.ebi.ac.uk 
/clustalw/). C) Lane M: Molecular marker, lane 1: pCW/OmpA+2-CYP6P9(His)6, lane 2:  
pCW/OmpA+2-CYP6P9(His)6 digested with NdeI and XbaI, lane 3: pCW/17αCYP6P9, lane 4:  
pCW/17αCYP6P9 digested with NdeI and XbaI. DNA was run on a 1% TAE agarose gel and viewed 
under UV light. 
5 000 bp 
1 500 bp 17αCYP6P9 
pCW vector 
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Due to the lack of expression detection facilities, the plasmid (17αCYP6P9) was 
shipped to the Liverpool School of Tropical Medicine, UK to continue with 
expression studies.  Sequence analysis (Cardiff University, Sequencing facility) 
confirmed the presence of the 17α hydroxylase sequence at the NH2 terminus.  
Expression of  17αCYP6P9 recombinant protein was performed in DH5α cells.  Cells 
were grown in Terrific-AMP broth at 37°C.  When the culture reached an OD600 of 
about 0.7 the cells were induced with IPTG and ALA.  P450 expression is sensitive to 
temperature therefore the culture media was reduced to 25 °C.  Expression of 
recombinant protein was checked after 24 hours post induction using a 
spectrophotometer between 400-500 nm.  High expression levels were successfully 
achieved using the 17α hydroxylase approach.  No expression was noted in the first 
24 hours post induction.  Cultures were allowed to continue to grow.  Expression was 
noted on day two with a protein concentration of 1 µM of P450 in the culture.  The 
concentration increased on day three to 2.7 µM of P450 in the culture.  A CO-
difference spectrum for CYP6P9 was measured over a 2 minute interval after binding 
with CO.  Saturation of CO to CYP6P9 was achieved after 25 minutes (Figure 4.17).   
This however was in contrast to An. gambiae’s CYP6M2 and CYP6Z2 recombinant 
proteins which are saturated after three minutes.  
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Figure 4.17:  CO - difference spectra.  Expression of 17αCYP6P9 was achieved after three days.  
Peaks represent measurements carried out every two minutes until a maximum (CO-P450 saturation) 
was achieved after 25 minutes. AU-absorption units. (expression was performed courtesy of Dr 
Bradley Stevenson, Liverpool School of Tropical Medicine, UK). 
 
 
4.4.3 Expression of An. funestus cytb5 in E. coli 
 
Cytb5 has a C-terminal hydrophobic region hence it does not require a bacterial leader 
sequence for expression.  Construction of pC/cytb5(His)6 involved the insertion of 
NdeI to the 5' end and a 6x His tag followed by a HindIII at the 3' end of Cytb5.  The 
fragment was ligated into NdeI / HindIII linearized pCWori+ vector (Figure 4.18).   
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Figure 4.18: Construction of pC-cytb5(His)6.  Double digest of pC-cytb5(His)6  using NdeI and 
HindIII restriction enzymes to confirm cytb5(His)6 insert. DNA was run on a 1% TAE agarose gel and 
viewed under UV light. 
 
 
Expression of cytb5(His)6 was achieved in E. coli.  A peak at about 420-430 nm was 
observed when reduced with sodium hydrosulphite (Figure 4.19).  This peak is 
characteristics of cytb5 expression.  
   M      1 
pCWori+ vector 
cyt b5(His)6 
5 000 bp 
1 500 bp 
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Figure 4.19:  Absorbance of reduced CO - difference P450 spectrum.  Cytb5 expression is detected 
at an absorbance of about 420 nm.   
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4.5 Discussion 
 
 
CYP6P9 is the first  An. funestus protein to be expressed.  No other protein studies in 
this species has ever been undertaken.  The insect expression system developed by 
Qiagen was used to express An. funestus CYP6P9 in E. coli cells XL1 blue and BL21 
(DE3) (pLysS).  pIX4.0 was used as an expression vector in E. coli, due to the 
presence of the T7 promotor that is recognized by T7 RNA polymerase encoded in 
some E. coli (for instance E. coli BL21 strain).  Protein expression under T7 
promotor is achieved in the presence of inducer IPTG.  Expression of CYP6P9 was 
unsuccessful even after the hydrophobic NH2-terminus was truncated.  Truncation of 
the hydrophobic region was done to improve expression.  Expression of hydrophobic 
amino acids in E. coli is extremely difficult resulting in low or no expression.  
Attaching a His tag was performed in order to detect protein expression as well as for 
purification.  No expression levels were detected on a Western blot and as a result, 
the expression vector was changed to a high regulated promotor (tac) expression 
plasmid, pCWori+.  This vector has been used successfully in expressing other insect 
P450s in E. coli such as cockroach CYP15A1 (Helvig et al., 2004). 
 
Modifications of the NH2- terminus is performed on the P450 sequence to enhance 
expression levels in E. coli.  This system has been shown to express P450s in E. coli 
(Barnes et al., 1991).  In this current work we employed the ompA (outer membrane 
protein A) leader sequence, a derivative of a bactieral membrane protein (Pritchard et 
al., 1997).  This bacterial signal peptide is fused to the NH2- terminus of a P450 and 
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assists in the expression of hydrophobic NH2- terminus P450s.  Cleavage of the ompA 
is important for the expression of recombinant proteins.  The addition of alanine (Ala) 
and proline (Pro) between the ompA and P450 gene allows for bacterial proteases to 
cleave at this site.  The leader sequence ompA improves expression but reduces the 
catalytic activity of the P450 (Pritchard et al., 2006).  Pritchard et al (1997) used this 
method on human CYP3A4 and found it to have a much higher expression level 
compared to other techniques that use the 17α hydroxylase NH2- terminal 
modification.  This method, however,  was not successful in expressing CYP6P9 in 
E. coli.  A very low expression was noted for non-His tagged FUMOZ-R CYP6P9 
when using the pCW-ompA2 vector.  This vector has a Ala and Gly instead of the 
Ala/Pro.  It is not clear whether this site is cleaved by bacterial signal peptidase.  
Growth conditions were optimized but with no success.  Heme precursor (ALA) was 
added before cell inoculation so as to form heme molecules before induction to assist 
in P450 formation.  This did not result in expression of CYP6P9.  Sequcence analysis 
revealed that the ompA  and P450 cDNA were in frame.  This was important because 
it allowed translation to occur from the start codon (ATG) of ompA right through to 
the stop codon of CYP6P9 (TAG).  A mismatch will result in early translational 
termination and hence no expression.  Codon usage analysis reavealed only 18 out of 
509 codons were rare in E. coli.  This could result in low protein expression.   
 
The ompA technique was successful in expressing CYP9J28 (Aedes aegypti) and An. 
gambiae’s CYP6M2 and CYP6Z2 (Stevenson et al., Unpublished data).  As a result 
of  unsuccessful expression of CYP6P9, the 17α hydroxylase method which was first 
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used in E. coli to produce bovine CYP17A by Barnes et al (1991) was employed. The 
first 8-18 amino acids depending on similarities are replaced with the 17α 
hydroxylase sequence (MALLLAVF) which is favoured by E. coli for protein 
expression.   A second codon Ala (GCT) was used as it is the preferred codon by E. 
coli for the expression of proteins (Guzov et al., 1996).  Replacement of the first eight 
amino acids of CYP6P9 with 17α hydroxylase sequence produced high expression 
levels in E. coli.  The first 24 hours after induction with IPTG and ALA produced no 
expression.  The first expression was noted after 48 hours with the highest expression 
after 3 days.  Expression after 48 hours may be due to the N-terminal modification 
(MALLLAVF) on CYP6P9, this was in contrast to the ompA sequence used in An. 
gambiae’s CYP6M2 and CYP6Z2.  Optimization of the N-terminal codons of P450 
were shown to vary in P450 expression between 24-48 hours with varying P450 
expression levels (Wu et al., 2006a; Wu et al., 2006b; Stark et al., 2008).  Saturation 
of carbon monoxide to CYP6P9 was achieved after 25 minutes.  This however was in 
contrast to An. gambiae’s CYP6M2 and CYP6Z2 which are saturated after three 
minutes (Stevenson et al., Unpublished data). 
 
Expression of cytb5 was not problematic, this is due to the fact that the hydrophobic 
region is at the C-terminus rather than the NH2-terminus.  No expression was noted 
using the Qiagen pIX4.0 insect expression vector.  Expression was observed when the 
pCWori+ expression vector was used.  
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Expression of An. funestus CPR was not attemped due to its lengthly preparation 
which involves insertion of a pelB leader sequence and subcloning into pCWori+ 
then into pACYC184 vectors.  Anopheles gambiea CPR construct that was previously 
proven to express in E. coli was available and were used to eliminate unnecasary cost 
and time delays . 
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Chapter Five 
 
 
General discussion and conclusions  
 
 
5.1 Microsomal P450 activity (7-ethoxycoumarin assay) 
 
Resistance to permethrin by FUMOZ-R was confirmed.  This was shown by a zero 
percent knockdown within the first hour and 100% survival rate 24 hours post 
exposure.  FANG however was susceptible to permethrin with 100% knockdown 
within the first hour and 100% mortality after 24 hours.  Permethrin resistance in An. 
funestus FUMOZ-R was brought about by a metabolic based enzyme, cytochrome 
P450 (Brooke et al., 2001).  To further confirm that P450s were involved as a 
resistance mechanism, a P450 synergist (piperonyl butoxide (PBO)) was used that 
inhibits P450 activity (Kasai et al., 1999; Young et al., 2005).  Exposure to PBO 
inhibited P450s in FUMOZ-R as shown by a 93% knockdown rate within the first 
hour of permetrhin exposure and 100% mortality after 24 hours.   
 
To determine the levels of P450 activity in both FUMOZ-R and FANG, microsomal 
P450 was isolated.  Microsomes were isolated from adults as well as larval midguts.  
Heads from both adults and larvae were removed so as to prevent P450 inhibitor 
‘xanthommatin’ (found within eye pigment) from coming into contact with 
microsomal extract (Danielson and Fogleman, 1994).  Three day old, non blood fed 
adults were selected.  Larval midguts were isolated and food content removed (food 
also inhibits P450 activity).  In both strains larval midgut P450 had a higher activity 
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than those of headless adults.  Kasai et al (2000) also observed that guts contained the 
highest P450 activity than any other tissues.  However in Drosophila, P450 activity in 
adults was 20 times higher than in larvae (Danielson et al., 1994).  The highest P450 
activity was noted in FUMOZ-R larval midguts (4.127 ± 1.02 nmol/min/mg P450 
protein).  This was 3.6 times higher than that of FANG larval midguts (1.134 ± 0.58 
nmol/min/mg P450 protein).  FUMOZ-R headless adult P450 activity (1.573 ± 0.58 
nmol/min/mg P450 protein) was 6.4 times higher than FANG headless adults (0.247 
± 0.09 nmol/min/mg P450 protein).  The fold increase found in adult P450 from An. 
funestus was relatively higher compared with An. gambiae (2 fold increase) (Etang et 
al., 2007), Culex quinquefasciatus (1.6 and 2.5 fold increases for female and male 
adults respectively) (Chandre et al., 1998) and Aedes aegypti (4 fold increase) 
(Prapanthadara et al., 2002) but lower than that in the German cockroach (23 fold 
increase) (Siegfried and Scott 1992).  The data presented here support the results of 
Brooke et al (2001) and go further in quantifying the fold expression. 
 
5.2 HPLC analysis 
Detoxification of permethrin by An. funestus microsomal P450 was further confirmed 
using an HPLC to detect the presence of metabolites produced.  Two metabolites 
were detected at retention times 5.5 and 6 minutes from FUMOZ-R (headless adults) 
when incubated with 0.05 mM permethrin.  Detoxification of permethrin produces 
two metabolites, 3-phenoxybenzyl alcohol (retention time 3.7 minutes) and 3-
phenoxybenzoic acid (retention time 5.9 minutes) (Vontas et al., 2001; Choi et al., 
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2002).  No metabolites were detected from FANG (headless adults).  Extraction of 
permethrin from exposed mosquitoes (1-hour exposure and 20% knockdown) was not 
achieved due to the low sensitivity of the HPLC used.  A gas chromatography-mass 
spectrometry (GC-MS) which is sensitive to small amounts of compounds is required 
to detect the presence of metabolites from these samples.  Other instruments that may 
be used are electrospray mass spectrometry (ESMS) and liquid chromatography-
electrospray mass spectrometry (LC-ESMS).  Due to the unavailability these 
instruments were not used. 
 
5.3 Analysis of Anopheles funestus CYP6P9   
Amenya et al (2005) isolated the first partial P450 genes from An. funestus.  One 
particular gene, CYP6P9 showed high levels of mRNA expression in FUMOZ-R 
(Amenya et al., 2008).  Preliminary microarray analysis performed on FUMOZ-R 
and FANG showed an over-expression of CYP6P9 in FUMOZ-R (Naguran et al. 
unpublished data).  Chromosomal mapping of a quantitative trait locus (QTL) 
associated with pyrethroid resistance in An. funestus (FUMOZ-R and FANG) was 
found to account for more than 60% of variance in susceptibility to permethrin.  This 
QTL was situated between division 9 and 12 of chromosome arm 2R.  This location 
however was seen to coincide with a cluster of CYP6 P450s which were mapped by 
fluorescent in situ hybridization.  These results suggested that resistance was 
mediated by one or more CYP6 genes.  CYP6P9 was found within this region 
(Wondji et al., 2007). 
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From the above results, CYP6P9 was obviously a major candidate for pyrethroid 
resistance.  Isolation and characterization of the full length CYP6P9 was needed to 
fully understand the mode of action. Full length CYP6P9 genes were isolated using 
specific primers designed using An. gambiae CYP6P3.  CYP6P3 was shown to have 
an identity of 86% with that of CYP6P9 (Amenya et al., 2005).  An open reading 
frame cDNA sequence of CYP6P9 was isolated from both FUMOZ-R and FANG.  
Genomic DNA was also isolated.  CYP6P9 amino acid sequence from FUMOZ-R 
and FANG shared a 99% identity with only four amino acid differences.  Genomic 
DNA had only one intron that was of 56 bp in length.  Multiple sequence alignment 
of CYP6P9 with other insect CYP6 genes showed a low percentage identity (≤ 45%).  
CYP6P9 contained all the characteristic features of a P450 which include:  the heme-
binding region (PFxxGxxxCxG), ExxR motif, ETLR domain and oxygen binding 
pocket [(A/G)Gx(E/D)T(T/S)] (characteristics of a cytochrome P450 protein).  The 
presence of the YPDP motif indicated that it belonged to the CYP6 family (this motif 
is found only in CYP6 family).  CYP6P9 is a membrane bound P450 as noted by the 
hydrophobic N-terminal region.  The presence of the PERF motif also indicated that 
it was a microsomal P450.  This motif is found in all microsomal cytochrome P450s.  
The major differences between FUMOZ-R and FANG CYP6P9 were noted in the F-
G loop.  Amino acid, Ile361 was replaced with an aromatic Phe361.  In other P450s the 
F-G loop operates as a lid, opening and closing to allow the entry and exit of 
substrates to the active site (Scott et al., 2003; Poulos, 2003).  The changes found in 
FUMOZ-R and FANG CYP6P9 may result in the efficiency of the enzyme to bind 
and detoxify permethrin.  In Drosophila melanogaster three mutational changes 
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found in CYP6A2 gene from a resistant strain were shown to cause DDT resistance 
when compared with a susceptible strain (Bergé et al., 1998; Amichot et al., 2004).  
In order to determine the significance of the four changes noted in FUMOZ-R 
compared to FANG, site-directed mutagenesis is required in these regions to 
determine whether they cause resistance in FUMOZ-R.    
      
While isolating CYP6P9 from FANG a novel CYP6 gene (CYP6P13) similar to that 
of CYP6P9 was isolated.  This gene was mistaken for CYP6P9 but sequence 
alignment with FANG-CYP6P9 (from cDNA) showed a 93.7% identity.  
Phylogenetic analysis revealed that FUMOZ-R and FANG CYP6P9s were closely 
related while FANG CYP6P13 was on a different branch indicating that it was a 
different gene.  Amino acid sequence alignment revealed a total of 32 differences.  
The novel gene was given the name CYP6P13 by the P450 Nomenclature Committee 
(http://drnelson.utmem.edu/CytochromeP450.html).  CYP6P13 also had one intron 
which was 57 bp, this was 1 bp longer than CYP6P9.  CYP6P13 was only found in 
FANG genomic DNA.  The two strains FUMOZ-R and FANG were originally from 
two different geological locations (FUMOZ-R from Mozambique and FANG from 
Angola) and this could account for the differences seen (e.g. CYP6P13 could be a 
duplication in FANG, but is not expressed).   
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5.4 Analysis of Anopheles funestus Cytb5 and CPR   
Anopheles funestus redox partners, cytochrome b5 and NADPH-cytochrome P450 
reductase were also isolated.  Anopheles funestus cytb5 was shown to have a 97% 
identity with that of An. gambiae cytb5.  Multiple sequence alignment with other 
insect P450s showed that An. funestus cytb5 contained all the features of a cytb5 
protein which are the “b5 fold” and two histidines that are required for heme-
coordination (Guzov et al., 1996; Nikou et al., 2003).  A hydrophobic C-terminal was 
noted which acts as a membrane anchor.  
 
Anopheles funestus CPR was also isolated and it was found to have a 96.5% identity 
with that of An. gambiae CPR. It had all the characteristic features for CPR which 
includes:  the FMN and FAD domains, the conserved NADPH binding residues as 
well as the two tyrosine residues required for the binding of FMN.  Electrons are 
catalyzed within the FAD/NADP+ domains of CPR and then transferred to 
cytochrome P450s via the FMN domain (Smith et al., 1994; Wang et al., 1997).  The 
first of the two electrons donated to P450 by redox partners is from CPR (Vergères 
and Waskell, 1995).  Electrons are transferred to cytochrome P450 via the FMN 
domain that has been shown to bind to the proximal surface of cytochrome P450 
(Sevrioukova et al., 1999a; Sevrioukova et al., 1999b).  The presence of a 
hydrophobic N-terminal indicates that CPR is membrane bound.    
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5.5 Escherichia coli expression of CYP6P9 
This current work is the first to report on the expression of CYP6P9 protein.  No An. 
funestus proteins have ever been expressed before.  The insect expression vector pIX 
4.0 developed by Qiagen was used for the expression of CYP6P9.  Expression was 
performed in E. coli cells XL1 Blue and BL21 (DE3)(pLSs).  However, expression 
was unsuccessful even after the hydrophobic NH2-terminus was truncated.  A six His 
tag was attached to detect the expression of proteins when analyzed using the 
Western blot analysis.  No protein fragments were detected on the Western blot 
indicating that expression was not achieved.  Expression vector pIX 4.0 was not a 
suitable expression system for the expression of P450 proteins.  Many or all P450s 
are succesfully expressed using a high regulated tac promotor expression plasmid, 
pCWori+.  Eukaryotes and prokaryotes P450 proteins have been expressed using this 
plasmid (Barnes et al., 1991; Helvig et al., 2004).   
 
 Expression of membrane P450 proteins is only achieved by modification of the NH2-
terminus (Barnes et al., 1991).  This involves replacing the first amino acids with that 
of 17α hydroxylase sequence (MALLLAVF).  Pritchard et al (1997) developed a 
technique that involved fusing a bacterial leader sequence at the NH2-terminus of the 
P450 gene.  The bacterial leader sequence aided in expressing P450 proteins in E. coli 
without the need of modifying the NH2-terminus.  Bacterial leader sequences used are 
the ompA (outer membrane protein A) and pelB (pectate lyase B).  It was important to 
add two amino acids Ala and Pro between the bacterial leader sequence and P450 
gene so as to allow bacterial proteases to cleave the leader sequence from P450 
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during expression.  Human CYP3A4 has been successfully expressed in E. coli using 
this technique (Pritchard et al., 1997).  CYP9J28 in Aedes aegypti and CYP6M2 and 
CYP6Z2 in An. gambaie have recently been expressed in E. coli under the control of 
‘ompA’  (Stevenson et al., Unpublished data). 
 
The bacterial leader sequence ‘ompA’ was attached to CYP6P9 and expressed in E. 
coli DH5α cells.  No expression was observed.  Redox partners cytb5 and CPR were 
co-expressed with CYP6P9 to assist in expression but still no expression was 
observed.  Low levels of expressions were noted in pCW-ompA2CYP6P9. This 
plasmid was constructed by attaching ompA leader sequence and introducing a 
NgoMVI restriction site (Ala and Gly) adjacent to the leader sequence to allow 
cloning of P450 genes.  A second construct was produced which had a six His tag 
attached to the C-terminal and fusing the ompA leader sequence to the NH2 terminal 
of CYP6P9 before ligating into pCWori+ plasmid.  No expression was detected using 
this construct.  Western blot analysis detected no protein fragments indicating that no 
proteins were expressed.  Escherichia coli expression was optimized by varying 
growth conditions.  This included temperature change (25-30 ºC), addition of ALA 
before cell inoculation to allow for the formation of heme molecule to increase the 
chases of CYP6P9 expression and allowing induction to occur for three days. No 
expression was achieved.  Sequence analysis indicated that the ompA sequence was in 
frame and that the gene contained no insertions or deletions that may result in 
translational termination.  Rare codon usage in E. coli was checked and only 3.5% of 
the total gene was rare to E. coli usage.  This indicated that rare codon usage was not 
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the major reason for the lack of expression.  Due to the failure of expression using the 
bacterial leader sequence (ompA), expression was changed to the 17 α hydroxylase 
technique.  No expression was obtained after the first 24 hours post induction with 
IPTG and ALA.  Expression of 17α-CYP6P9 was finally noted after two days and the 
highest expression on day three.  Carbon monoxide stauration was achieved after 25 
minutes.  This however was in contrast to An. gambiae’s CYP6M2 and CYP6Z2 
which are saturated after three minutes (Stevenson et al., Unpublished data).  These 
results showed that expression of An. funestus CYP6P9 in E. coli was problematic.  
Bacterial leader sequence (ompA) did not impove the expression of CYP6P9.  
Expression of CYP6P9 was only achieved using the 17 α hydroxylase technique, 
however induction was slow.  This was noted with a low expression on day two and 
high expression on day three post induction with IPTG and ALA.  P450 induction is 
usually one to two days long (Pritchard et al., 2006).   
 
Based on results above it seems that CYP6P9 might have a higher affinity for its 
substrate (permethrin) therefore resulting in better detoxification of permethrin. The 
fact that this same gene is also overexpressed and indirectly implicating increase 
enzyme levels might be significant and shoud be further investigated.  Having both 
types of gene alterations will make this an extremely effective system.  However, 
such a system has never been reported.    
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Expression of cytb5 was not achieved using insect expression vector pIX4.0 but was 
achieved using pCWori+ expression vector. Unlike CYP6P9, expression was not 
problematic. An expression peak was observed at around 420 nm.  This peak is 
characteristic of cytb5 expression.  House fly cytb5 was shown to have three 
characteristic peaks, A large peak at 420nm and two small peaks at 527 and 557 nm 
(Guzov et al., 1996).  Anopheles funestus CPR did not express using insect 
expression vector pIX4.0.   CPR is usually expressed in the pACYC184 plasmid but 
due to time constraints it was not constucted.  Anopheles gambiae CPR (pACYC-
pelBCPR) was available and was used in co-expression with CYP6P9.  Anopheles 
gambiae and An. funestus CPRs share a 96.5 % identity. 
 
5.6 Future work 
 
Further investigation is required to extract metabolites formed as a result of 
permethrin detoxification in exposed FUMOZ-R. Detection can be performed using a 
gas chromatography-mass spectrometry (GC-MS) which is sensitive to small 
amounts of compounds.  These finding will determine the compounds formed during 
permethrin detoxification by FUMOZ-R.  Enzyme activity of FUMOZ-R and FANG 
CYP6P9 are required to compare the levels of activities as well as enzyme kinetics 
such as Vmax, Km and kcat.  Site directed mutagenesis on the four amino acid 
differences noted in FUMOZ-R CYP6P9 and FANG CYP6P9 is required to 
determine their effects in CYP6P9 enzyme activity.  These results will indicate which 
amino acid is important during enzyme detoxification of permethrin.  Antibodies 
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targeted against CYP6P9 proteins can be produced and used to compare and 
determine elevated expression levels of CYP6P9 protein from both FANG and 
FUMOZ-R.  Gene knockdown using RNAi technique could be employed.  This 
technique is used to target genes of interest (CYP6P9) by inhibiting gene expression 
at the translation stage or blocking the transcription of specific genes.  In the case of 
CYP6P9, this will result in the pyrethroid resistant strain, FUMOZ-R being 
susceptible which will indicate that CYP6P9 plays a major role in pyrethroid 
resistance. These types of studies have been done in Anopheles gambiae P450 
reducase (Lycett et al., 2006).   
 
In conclusion, this study has advanced our knowledge of resistance mechanism in An. 
funestsus by understanding the role of cytochrome P450s in the detoxification of 
permethrin.  Work carried out by Amenya et al (2005 and 2008) provided evidence 
that CYP6P9 was the major candidate associated with insecticide resistance.  
Mutational changes found between CYP6P9 from resistant and susceptible strains 
may account for the differences in enzyme activity.  However, this needs to be 
investigated further.  Understanding of the mechanism of P450 enzyme detoxification 
will contribute towards the understanding of insecticide resistance and ultimately in 
the development of novel improved methods of vector control. 
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Appendix 
A1: Recipe for media preparations 
 
1. Luria Bertani Broth (1 litre) 
 
             10g Bacto-tryptone 
               5g Bacto-Yeast extract 
             10g NaCl 
             Adjust to 1L with distilled water and autoclave 
 
2. Luria Bertani Agar (1 litre) 
 
           10g Bacto-tryptone 
             5g Bacto-Yeast extract 
           10g NaCl 
           15g Bacto-Agar 
           Adjust to 1L with distilled water and autoclave  
 
           Pour to plates when cooled. 
 
3. SOC Media (1 Litre) 
 
           20g  Bacto Tryptone,  
             5g,  Bacto Yeast Extract  
           2ml 5M NaCl  
           2.5ml    1M KCl  
           10ml 1M MgCl2  
           10ml 1M MgSO4  
           20ml 1M glucose  
           Adjust to 1L with distilled water and autoclave.  
 
4. Terrific Broth (1 Litre) 
 
            12g  bacto-tryptone;  
            24g  bacto-yeast extract,  
              2g  bacto-peptone;  
              4ml  glycerol in  
            Adjust to 900ml with distilled water 
 
            Add 100 ml of a sterile 10x phosphate solution before use  
 
            10x phosphate solution (0.17 M KH2PO4 and 0.72 M K2HPO4)  
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A2: Protein standard curve 
 
 
 
 
 
 
 
 
 
 
Figure A2.1: Protein standard curve. Bradford’s reagent was use to detemine the concentration of 
P450 Protein. The curve had an R2 value of 0.966 and the equation used was  y= 0.069x. 
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A3:  7- hydroxycoumarin Standard curve 
 
 
 
 
 
 
 
 
 
 
 
Figure A3.1: The 7-hydroxycoumarin standard curve. The 7-hydroxycoumarin standard curve was 
used to detemine the concentration of 7-hydroxycoumarin formed from the hydrolysis of 7-
ethoxycoumarin by microsomal P450 Proteins. The curve had an R2 value of 0.990 and the equation 
used was  y= 1.188x. 
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A4: Nucleotide and Amino acid sequences of CYP6P9 
 
  
CTCGAGCATCATCACCATCACCACATGGCTGGACACGCGAAAGGACAGGCCCAGACAAGGCATGCGGC
CGACATCCATCTGGAACTGTACAAAAAATTCAAGCAGCGCCGTGAGCGGTACGTTGGTATGAGCCAGT
TCATGATACCTTCATTGCTCGTGATCGATCCAGAGCTGGTGAAAACGATCCTAGTAAAGGACTTTAAT
GTATTCCACGATCATGGTGTATTCAATAATGCAAGAGACGACCCGCTGTCCGCACATCTTTTTGCGCT
TGAAGGTAACCCATGGCGCTTGTTGCGTCAGAAGCTCACGCCAACGTTCACCTCAGGTCGCATGAAGC
AAATGTTTGGTACACTATGGGATGTAGCACTTGAGCTGGACAAGTATATGGAAGAAAACTATCGTCAG
CCGGATATTGAGATGAAGGATGTGCTAGGTCGGTTTACGACAGATGTGATTGGCACCTGTGCATTCGG
GATTGAGTGTAATACGCTTAAGACACCGGACTCGGAGTTCCGCAAATACGGCAACAAAGCGTTTGAGT
TTAATCTGATGATTTTTCTAAAAACTTTCTTAGCATCGGCTTATCCGTCACTTGTGCGGAAACTGCGA
ATGAAGATAACATTCGACGATGTGGAACAGTTTTTCCTAAAAATTGTTAAGGAAACGGTGGAATATCG
AGAAAGTAACAACATTAAACGAAACGACTTCATGAACCTGCTGTTGCAGATTAAGAATAAGGGTAAGC
TGGACGACAGCGATGATGGGAGTGTTGGCAAGGGTGAAGTAGGAATGACACAACGAGAACTTGCGGCA
CAGGCATTCATTTTCTTCTTGGCCGGTTTCGAGACATCATCCACGACGCAAAGCTTCTGTCTGTACGA
GTTGGCAAAGAACCCTGACATCCAGGAGCGCCTTAGACAAGAGATCAACCAAGCAATCGAGGAGAATG
ACGGCCAGGTGACGTACGATGTCGCCATGAACATACAGTATCTGGACAATGTGATAAACGAAACACTT
CGCAAGTACCCACCGGTAGAATCGTTGAGTCGTGTGCCGTCTGTTGACTATGTCATCCCAGGTACGAA
ACATGTCATTCCCAAACGAACGTTAGTGCAAATTCCGGTTCACGCCATTCAACATGATCCTGAGCACT
ATCCCGATCCAGAACGTTTCGATCCGGATCGCTTCTCACCGGAGGAAGTGAAGAAGCGACATCCCTTC
ACGTTCCTCCCATTCGGTGAGGGGCCACGCGTTTGCATTGGGCTTCGGTTTGGTGTGATGCAGACGAA
GGTAGGATTGATAACGCTGTTGAGAAAGTTCCGCTTCTCACCGTCAGCGCGTACACCAGATTGTGTAA
AGTTCGATCCGAAAATGATCATTCTGTCACCGATCGCGGGTAATTACTTGAAGGTGGAAAAGTTGTAG
TCTAGA 
 
L E H H H H H H Met A G H A K G Q A Q T R H A A D I H L E L Y K K F K Q R R E R Y V G 
Met S Q F Met I P S L L V I D P E L V K T I L V K D F N V F H D H G V F N N A R D D P L S A 
H L F A L E G N P W R L L R Q K L T P T F T S G R Met K Q Met F G T L W D V A L E L D K Y 
Met E E N Y R Q P D I E Met K D V L G R F T T D V I G T C A F G I E C N T L K T P D S E F R 
K Y G N K A F E F N L Met I F L K T F L A S A Y P S L V R K L R Met K I T F D D V E Q F F L 
K I V K E T V E Y R E S N N I K R N D F Met N L L L Q I K N K G K L D D S D D G S V G K G 
E V G Met T Q R E L A A Q A F I F F L A G F E T S S T T Q S F C L Y E L A K N P D I Q E R L 
R Q E I N Q A I E E N D G Q V T Y D V A Met N I Q Y L D N V I N E T L R K Y P P V E S L S R 
V P S V D Y V I P G T K H V I P K R T L V Q I P V H A I Q H D P E H Y P D P E R F D P D R F S 
P E E V K K R H P F T F L P F G E G P R V C I G L R F G V Met Q T K V G L I T L L R K F R F S 
P S A R T P D C V K F D P K Met I I L S P I A G N Y L K V E K L Stop S R 
 
 
Figure A4.1: Sequences of (His)6CYP6P9.  Restriction enzymes are underlined, XhoI (before start 
codon) and XbaI (After stop codon).  A 6 x His-tag is in blue. Hydrophobic amino acids were 
removed.  Alanine was added as a second codon  
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CATATGAAAAAGACAGCTATCGCGATTGCAGTGGCACTGGCTGGTTTCGCTACCGTAGCGCAGGCCGC
GCCGATGGAGCTAATTAACGCGGTGTTGGCCGCGTTCATCTTCGTAGTGTCGGCAGTGTACCTTTTCA
TTCGGAACAAACATAATTACTGGAAAGACAATGGATTCCCGTATGCGCCGAACCCACATTTTCTGTTC
GGACACGCGAAAGGACAGGCCCAGACAAGGCATGCGGCCGACATCCATCTGGAACTGTACAAAAAATT
CAAGCAGCGCCGTGAGCGGTACGTTGGTATGAGCCAGTTCATGATACCTTCATTGCTCGTGATCGATC
CAGAGCTGGTGAAAACGATCCTAGTAAAGGACTTTAATGTATTCCACGATCATGGTGTATTCAATAAT
GCAAGAGACGACCCGCTGTCCGCACATCTTTTTGCGCTTGAAGGTAACCCATGGCGCTTGTTGCGTCA
GAAGCTCACGCCAACGTTCACCTCAGGTCGCATGAAGCAAATGTTTGGTACACTATGGGATGTAGCAC
TTGAGCTGGACAAGTATATGGAAGAAAACTATCGTCAGCCGGATATTGAGATGAAGGATGTGCTAGGT
CGGTTTACGACAGATGTGATTGGCACCTGTGCATTCGGGATTGAGTGTAATACGCTTAAGACACCGGA
CTCGGAGTTCCGCAAATACGGCAACAAAGCGTTTGAGTTTAATCTGATGATTTTTCTAAAAACTTTCT
TAGCATCGGCTTATCCGTCACTTGTGCGGAAACTGCGAATGAAGATAACATTCGACGATGTGGAACAG
TTTTTCCTAAAAATTGTTAAGGAAACGGTGGAATATCGAGAAAGTAACAACATTAAACGAAACGACTT
CATGAACCTGCTGTTGCAGATTAAGAATAAGGGTAAGCTGGACGACAGCGATGATGGGAGTGTTGGCA
AGGGTGAAGTAGGAATGACACAACGAGAACTTGCGGCACAGGCATTCATTTTCTTCTTGGCCGGTTTC
GAGACATCATCCACGACGCAAAGCTTCTGTCTGTACGAGTTGGCAAAGAACCCTGACATCCAGGAGCG
CCTTAGACAAGAGATCAACCAAGCAATCGAGGAGAATGACGGCCAGGTGACGTACGATGTCGCCATGA
ACATACAGTATCTGGACAATGTGATAAACGAAACACTTCGCAAGTACCCACCGGTAGAATCGTTGAGT
CGTGTGCCGTCTGTTGACTATGTCATCCCAGGTACGAAACATGTCATTCCCAAACGAACGTTAGTGCA
AATTCCGGTTCACGCCATTCAACATGATCCTGAGCACTATCCCGATCCAGAACGTTTCGATCCGGATC
GCTTCTCACCGGAGGAAGTGAAGAAGCGACATCCCTTCACGTTCCTCCCATTCGGTGAGGGGCCACGC
GTTTGCATTGGGCTTCGGTTTGGTGTGATGCAGACGAAGGTAGGATTGATAACGCTGTTGAGAAAGTT
CCGCTTCTCACCGTCAGCGCGTACACCAGATTGTGTAAAGTTCGATCCGAAAATGATCATTCTGTCAC
CGATCGCGGGTAATTACTTGAAGGTGGAAAAGTTGCATCATCACCATCACCACTAGTCTAGA 
 
H Met K K T A I A I A V A L A G F A T V A Q A A P Met E L I N A V L A A F I F V V S A V Y 
L F I R N K H N Y W K D N G F P Y A P N P H F L F G H A K G Q A Q T R H A A D I H L E L Y 
K K F K Q R R E R Y V G Met S Q F Met I P S L L V I D P E L V K T I L V K D F N V F H D H G 
V F N N A R D D P L S A H L F A L E G N P W R L L R Q K L T P T F T S G R Met K Q Met F G 
T L W D V A L E L D K Y Met E E N Y R Q P D I E Met K D V L G R F T T D V I G T C A F G I 
E C N T L K T P D S E F R K Y G N K A F E F N L Met I F L K T F L A S A Y P S L V R K L R 
Met K I T F D D V E Q F F L K I V K E T V E Y R E S N N I K R N D F Met N L L L Q I K N K G 
K L D D S D D G S V G K G E V G Met T Q R E L A A Q A F I F F L A G F E T S S T T Q S F C L 
Y E L A K N P D I Q E R L R Q E I N Q A I E E N D G Q V T Y D V A Met N I Q Y L D N V I N E 
T L R K Y P P V E S L S R V P S V D Y V I P G T K H V I P K R T L V Q I P V H A I Q H D P E H 
Y P D P E R F D P D R F S P E E V K K R H P F T F L P F G E G P R V C I G L R F G V Met Q T 
K V G L I T L L R K F R F S P S A R T P D C V K F D P K Met I I L S P I A G N Y L K V E K L H 
H H H H H Stop S R 
 
Figure A4.2: Sequences of ompA-CYP6P9(His)6.  Restriction enzymes are underlined, NdeI (before 
start codon) and XbaI (After stop codon).  Bacterial leader sequence (ompA) is highlighted in red.  The 
two amino acids alanine and proline (site for bacterial proteases) are in green.  A 6 x His-tag is in blue.   
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CATATGAAAAAGACAGCTATCGCGATTGCAGTGGCACTGGCTGGTTTCGCTACCGTAGCGCAGGCCGC
GCCGATGGAGCTAATTAACGCGGTGTTGGCCGCGTTCATCTTCGTAGTGTCGGCAGTGTACCTTTTCA
TTCGGAACAAACATAATTACTGGAAAGACAATGGATTCCCGTATGCGCCGAACCCACATTTTCTGTTC
GGACACGCGAAAGGACAGGCCCAGACAAGGCATGCGGCCGACATCCATCTGGAACTGTACAAAAAATT
CAAGCAGCGCCGTGAGCGGTACGTTGGTATGAGCCAGTTCATGATACCTTCATTGCTCGTGATCGATC
CAGAGCTGGTGAAAACGATCCTAGTAAAGGACTTTAATGTATTCCACGATCATGGTGTATTCAATAAT
GCAAGAGACGACCCGCTGTCCGCACATCTTTTTGCGCTTGAAGGTAACCCATGGCGCTTGTTGCGTCA
GAAGCTCACGCCAACGTTCACCTCAGGTCGCATGAAGCAAATGTTTGGTACACTATGGGATGTAGCAC
TTGAGCTGGACAAGTATATGGAAGAAAACTATCGTCAGCCGGATATTGAGATGAAGGATGTGCTAGGT
CGGTTTACGACAGATGTGATTGGCACCTGTGCATTCGGGATTGAGTGTAATACGCTTAAGACACCGGA
CTCGGAGTTCCGCAAATACGGCAACAAAGCGTTTGAGTTTAATCTGATGATTTTTCTAAAAACTTTCT
TAGCATCGGCTTATCCGTCACTTGTGCGGAAACTGCGAATGAAGATAACATTCGACGATGTGGAACAG
TTTTTCCTAAAAATTGTTAAGGAAACGGTGGAATATCGAGAAAGTAACAACATTAAACGAAACGACTT
CATGAACCTGCTGTTGCAGATTAAGAATAAGGGTAAGCTGGACGACAGCGATGATGGGAGTGTTGGCA
AGGGTGAAGTAGGAATGACACAACGAGAACTTGCGGCACAGGCATTCATTTTCTTCTTGGCCGGTTTC
GAGACATCATCCACGACGCAAAGCTTCTGTCTGTACGAGTTGGCAAAGAACCCTGACATCCAGGAGCG
CCTTAGACAAGAGATCAACCAAGCAATCGAGGAGAATGACGGCCAGGTGACGTACGATGTCGCCATGA
ACATACAGTATCTGGACAATGTGATAAACGAAACACTTCGCAAGTACCCACCGGTAGAATCGTTGAGT
CGTGTGCCGTCTGTTGACTATGTCATCCCAGGTACGAAACATGTCATTCCCAAACGAACGTTAGTGCA
AATTCCGGTTCACGCCATTCAACATGATCCTGAGCACTATCCCGATCCAGAACGTTTCGATCCGGATC
GCTTCTCACCGGAGGAAGTGAAGAAGCGACATCCCTTCACGTTCCTCCCATTCGGTGAGGGGCCACGC
GTTTGCATTGGGCTTCGGTTTGGTGTGATGCAGACGAAGGTAGGATTGATAACGCTGTTGAGAAAGTT
CCGCTTCTCACCGTCAGCGCGTACACCAGATTGTGTAAAGTTCGATCCGAAAATGATCATTCTGTCAC
CGATCGCGGGTAATTACTTGAAGGTGGAAAAGTTGTAGTCTAGA 
 
H Met K K T A I A I A V A L A G F A T V A Q A A P Met E L I N A V L A A F I F V V S A V Y 
L F I R N K H N Y W K D N G F P Y A P N P H F L F G H A K G Q A Q T R H A A D I H L E L Y 
K K F K Q R R E R Y V G Met S Q F Met I P S L L V I D P E L V K T I L V K D F N V F H D H G 
V F N N A R D D P L S A H L F A L E G N P W R L L R Q K L T P T F T S G R Met K Q Met F G 
T L W D V A L E L D K Y Met E E N Y R Q P D I E Met K D V L G R F T T D V I G T C A F G I 
E C N T L K T P D S E F R K Y G N K A F E F N L Met I F L K T F L A S A Y P S L V R K L R 
Met K I T F D D V E Q F F L K I V K E T V E Y R E S N N I K R N D F Met N L L L Q I K N K G 
K L D D S D D G S V G K G E V G Met T Q R E L A A Q A F I F F L A G F E T S S T T Q S F C L 
Y E L A K N P D I Q E R L R Q E I N Q A I E E N D G Q V T Y D V A Met N I Q Y L D N V I N E 
T L R K Y P P V E S L S R V P S V D Y V I P G T K H V I P K R T L V Q I P V H A I Q H D P E H 
Y P D P E R F D P D R F S P E E V K K R H P F T F L P F G E G P R V C I G L R F G V Met Q T 
K V G L I T L L R K F R F S P S A R T P D C V K F D P K Met I I L S P I A G N Y L K V E K L 
Stop S R 
  
 
Figure A4.3: Sequences of ompA-CYP6P9.  Restriction enzymes are underlined, NdeI (before start 
codon) and XbaI (After stop codon).  Bacterial leader sequence (ompA) is highlighted in red.  The two 
amino acids alanine and proline (site for bacterial proteases) are in green.   
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CATATGGCTCTGTTATTAGCAGTTTTTGCCGCGTTCATCTTCGTAGTGTCGGCAGTGTACCTTTTCAT
TCGGAACAAACATAATTACTGGAAAGACAATGGATTCCCGTATGCGCCGAACCCACATTTTCTGTTCG
GACACGCGAAAGGACAGGCCCAGACAAGGCATGCGGCCGACATCCATCTGGAACTGTACAAAAAATTC
AAGCAGCGCCGTGAGCGGTACGTTGGTATGAGCCAGTTCATGATACCTTCATTGCTCGTGATCGATCC
AGAGCTGGTGAAAACGATCCTAGTAAAGGACTTTAATGTATTCCACGATCATGGTGTATTCAATAATG
CAAGAGACGACCCGCTGTCCGCACATCTTTTTGCGCTTGAAGGTAACCCATGGCGCTTGTTGCGTCAG
AAGCTCACGCCAACGTTCACCTCAGGTCGCATGAAGCAAATGTTTGGTACACTATGGGATGTAGCACT
TGAGCTGGACAAGTATATGGAAGAAAACTATCGTCAGCCGGATATTGAGATGAAGGATGTGCTAGGTC
GGTTTACGACAGATGTGATTGGCACCTGTGCATTCGGGATTGAGTGTAATACGCTTAAGACACCGGAC
TCGGAATTCCGCAAATACGGCAACAAAGCGTTTGAGTTTAATCTGATGATTATTCTAAAAACTTTCTT
AGCATCGGCTTATCCGTCACTTGTGCGGAAACTGCGAATGAAGATAACATTCGACGATGTGGAACAGT
TTTTCCTAAAAATTGTTAAGGAAACGGTGGAATATCGAGAAAGTAACAACATTAAACGAAACGACTTC
ATGAACCTGCTGTTGCAGATTAAGAATAAGGGTAAGCTGGACGACAGCGATGATGGGAGTGTTGGCAA
GGGTGAAGTAGGAATGACACAACGAGAACTTGCGGCACAGGCATTCATTTTCTTCTTGGCCGGTTTCG
AGACATCATCCACGACGCAAAGCTTCTGTCTGTACGAGTTGGCAAAGAACCCTGACATCCAGGAGCGC
CTTAGACAAGAGATCAACCAAGCAATCGAGGAGAATGACGGCCAGGTGACGTACGATGTCGCCATGAA
CATACAGTATCTGGACAATGTGATAAACGAAACACTTCGCAAGTACCCACCGGTAGAATCGTTGAGTC
GTGTGCCGTCTGTTGACTATGTCATCCCAGGTACGAAACATGTCATTCCCAAACGAACGTTAGTGCAA
ATTCCGGTTCACGCCATTCAACATGATCCTGAGCACTATCCCGATCCAGAACGTTTCGATCCGGATCG
CTTCTCACCGGAGGAAGTGAAGAAGCGACATCCCTTCACGTTCCTCCCATTCGGTGAGGGGCCACGCG
TTTGCATTGGGCTTCGGTTTGGTGTGATGCAGACGAAGGTAGGATTGATAACGCTGTTGAGAAAGTTC
CGCTTCTCACCGTCAGCGCGTACACCAGATTGTGTAAAGTTCGATCCGAAAATGATCATTCTGTCACC
GATCGCGGGTAATTACTTGAAGGTGGAAAAGTTGTAGTCTAGA  
 
H M A L L L A V F A A F I F V V S A V Y L F I R N K H N Y W K D N G F P Y A P N P H F L F 
G H A K G Q A Q T R H A A D I H L E L Y K K F K Q R R E R Y V G M S Q F M I P S L L V I D 
P E L V K T I L V K D F N V F H D H G V F N N A R D D P L S A H L F A L E G N P W R L L R 
Q K L T P T F T S G R M K Q M F G T L W D V A L E L D K Y M E E N Y R Q P D I E M K D V 
L G R F T T D V I G T C A F G I E C N T L K T P D S E F R K Y G N K A F E F N L M I I L K T F 
L A S A Y P S L V R K L R M K I T F D D V E Q F F L K I V K E T V E Y R E S N N I K R N D F 
M N L L L Q I K N K G K L D D S D D G S V G K G E V G M T Q R E L A A Q A F I F F L A G F 
E T S S T T Q S F C L Y E L A K N P D I Q E R L R Q E I N Q A I E E N D G Q V T Y D V A Met 
N I Q Y L D N V I N E T L R K Y P P V E S L S R V P S V D Y V I P G T K H V I P K R T L V Q I 
P V H A I Q H D P E H Y P D P E R F D P D R F S P E E V K K R H P F T F L P F G E G P R V C I 
G L R F G V Met Q T K V G L I T L L R K F R F S P S A R T P D C V K F D P K M I I L S P I A G 
N Y L K V E K L Stop S R 
 
 
 
 
Figure A4.4: Sequences of 17α-CYP6P9.  Restriction enzymes are underlined, NdeI (before start 
codon) and XbaI (After stop codon).  The 17 α hydroxylase nucleotide and amino acid sequence are 
indicated in red. 
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A5: Nucleotide and Amino acid sequences of cytb5 
 
CTCGAGCATCATCACCATCACCACATGGCTGAAGTGAAAACGTATTCGCTGGCGGAGGTGAAATCCCA
CAACACCAACAAATCGACCTGGATCGTAATTCACAACGATATCTTCGACGTGACGGAGTTTCTGAACG
AGCATCCTGGCGGAGAAGAAGTGCTGCTAGAGCAGGCCGGTAAGGAAGCAACGGAAGCATTCGAGGAT
GTGGGCCACAGCAGCGATGCCCGCGAGATGATGAAGAAGTTTAAAGTGGGCGAACTGATCGAATCCGG
ACGCAAACAGGTCCCGGTAAAGAAGGAACCGGATTGGAAATCGGAGCAGCAGGATGATAATCAACTAA
AGCAATGGATAGTGCCACTTATCCTGGGTCTGCTCGCAACCATCCTCTATCGGTTCTACTTCACCCAG
TAACTGCAG 
 
 
L E H H H H H H Met A E V K T Y S L A E V K S H N T N K S T W I V I H N D I F D V T E F L 
N E H P G G E E V L L E Q A G K E A T E A F E D V G H S S D A R E Met Met K K F K V G E L 
I E S G R K Q V P V K K E P D W K S E Q Q D D N Q L K Q W I V P L I L G L L A T I L Y R F Y 
F T Q Stop L Q 
 
 
Figure A5.1: Sequences of (His)6cytb5.  Restriction enzymes are underlined, XhoI (before start 
codon) and PstI  (After stop codon).  Six His –tag is indicated in blue.  
 
 
  
 
CATATGGCTGAAGTGAAAACGTATTCGCTGGCGGAGGTGAAATCCCACAACACCAACAAATCGACCTG
GATCGTAATTCACAACGATATCTTCGACGTGACGGAGTTTCTGAACGAGCATCCTGGCGGAGAAGAAG
TGCTGCTAGAGCAGGCCGGTAAGGAAGCAACGGAAGCATTCGAGGATGTGGGCCACAGCAGCGATGCC
CGCGAGATGATGAAGAAGTTTAAAGTGGGCGAACTGATCGAATCCGGACGCAAACAGGTCCCGGTAAA
GAAGGAACCGGATTGGAAATCGGAGCAGCAGGATGATAATCAACTAAAGCAATGGATAGTGCCACTTA
TCCTGGGTCTGCTCGCAACCATCCTCTATCGGTTCTACTTCACCCAGCATCATCACCATCACCACTAA
AAGTT 
 
 
H Met A E V K T Y S L A E V K S H N T N K S T W I V I H N D I F D V T E F L N E H P G G E E 
V L L E Q A G K E A T E A F E D V G H S S D A R E Met Met K K F K V G E L I E S G R K Q V 
P V K K E P D W K S E Q Q D D N Q L K Q W I V P L I L G L L A T I L Y R F Y F T Q H H H H 
H H Stop K 
 
Figure A5.2: Sequences of cytb5(His)6.  Restriction enzymes are underlined, NdeI (before start 
codon) and HindIII (After stop codon).  Six His –tag is indicated in blue.  
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A6: Nucleotide and Amino acid sequences of CPR 
 
CCATGGCATCATCACCATCACCACAAGGGCAAGAAAAAAGAAAACCAAGCTAGTCAGTTCAAATCCTA
CTCGATCCAACCGACCACGGTAAACACGATGACAATGGTGGAGAATTCGTTCATCAAGAAGCTGCAAT
CCTCTGGTCGTCGTTTGGTGGTGTTCTACGGTTCTCAAACAGGCACGGCAGAGGAATTTGCCGGTCGT
CTGGCAAAGGAAGGAATCCGCTACCAGATGAAGGGCATGGTAGCCGATCCGGAGGAGTGCAATATGGA
AGAACTACTGATGTTGAAAGACATCGACAAATCGTTGGCTGTGTTTTGCTTAGCAACGTACGGTGAGG
GCGATCCGACGGACAACTGTATGGAGTTTTACGACTGGATTCAAAATAACGATCTGGATATGACCGGT
TTAAATTATGCGGTGTTTGGCCTGGGCAATAAAACGTACGAGCATTACAACAAGGTCGGCATCTATGT
TGACAAGCGGTTAGAGGAACTCGGAGCAAACCGAGTGTTTGAGCTAGGATTAGGCGACGATGATGCGA
ACATTGAGGATTACTTCATTACGTGGAAGGAAAAGTTTTGGCCAACGGTGTGCGATTTCTTCGGCATT
GAAAGTACGGGCGAGGATGTGTTGATGCGACAGTATCGTCTGTTGGAGCAACCGGATGTCGGTGCGGA
CCGTATATACACCGGTGAGGTGGCCCGGCTACACTCACTGCAGACGCAGCGCCCACCGTTCGATGCCA
AGAACCCGTTCCTAGCCCCCATCAAGGTAAACCGGGAGCTGCACAAGGCCGGGGACCGTTCCTGCATG
CACGTCGAGTTCGATATCGAGGGCTCGAAGATGCGGTACGAGGCCGGTGATCATTTGGCCATGTACCC
GGTGAACGATCGGGATCTGGTCGAGCGGCTCGGCAAGCTGTGCAACGCGGATCTGGAAACGATATTCT
CGCTGATCAACACCGACACGGACAGCAGCAAAAAGCATCCATTCCCCTGCCCGACCACCTACCGGACG
GCTTTGACGCACTACCTCGAGATAACGGCGCTACCCCGGACGCACATCCTGAAGGAGCTGGCCGAGTA
CTGCACGGAGGAGAAGGACAAAGAGTTCCTGCGGTTCATCTCGTCTACCGCGCCGGAAGGAAAGGCAA
AGTACCAGGAGTGGATACAGGACAGCAGCCGCAACGTGGTGCACGTGCTGGAGGATATCCCGTCCTGC
CATCCACCGATCGATCACGTGTGCGAACTGTTACCGCGTCTGCAGCCGCGCTACTATTCCATCTCCTC
CTCGTCCAAGCTCCACCCGACGACGGTACACGTGACGGCGGTGCTGGTGAAGTACGAGACGAAAACGG
GCCGATTGAACAAGGGTGTCGCTACGACATTCCTTGCCGAAAAGCACCCGAACGATGGGGAACCGTTG
CCGCGCGTACCTATCTTCATTCGCAAGAGCCAGTTCCGTTTGCCACCGAAACCGGAAACGCCCGTAAT
CATGGTCGGTCCTGGTACCGGGCTGGCACCGTTCCGTGGCTTCATACAGGAGCGTGACTTCTCCAAGC
AGGAGGGCAAGGAAATAGGGCAGACGACGCTATACTTTGGCTGCCGAAAGCGTACAGAGGACTACATA
TACGAAGACGAACTGGAGGATTATTCCAAACGTGGCATCGTTAACCTGCGCGTTGCCTTTTCGCGTGA
CCAAGAGAAGAAGGTGTACGTGACGCATCTGCTCGAGCAAGATAGCGACCTGATATGGAACGTTATCG
GCGAGAATAAGGGACACTTTTACATCTGCGGTGATGCGAAAAATATGGCCACCGATGTGCGAAACATT
CTGCTTAAAGTCATACGCTCAAAAGGTGGTTTAAGCGAAACGGAAGCACAGCAGTACATAAAAAAGAT
GGAAGCCCAAAAACGATACTCGGCGGACGTGTGGAGCTAAAGATCT 
 
 
P W H H H H H H K G K K K E N Q A S Q F K S Y S I Q P T T V N T Met T Met V E N S F I K 
K L Q S S G R R L V V F Y G S Q T G T A E E F A G R L A K E G I R Y Q Met K G Met V A D P 
E E C N Met E E L L Met L K D I D K S L A V F C L A T Y G E G D P T D N C Met E F Y D W I 
Q N N D L D Met T G L N Y A V F G L G N K T Y E H Y N K V G I Y V D K R L E E L G A N R 
V F E L G L G D D D A N I E D Y F I T W K E K F W P T V C D F F G I E S T G E D V L Met R Q 
Y R L L E Q P D V G A D R I Y T G E V A R L H S L Q T Q R P P F D A K N P F L A P I K V N R 
E L H K A G D R S C Met H V E F D I E G S K Met R Y E A G D H L A Met Y P V N D R D L V 
E R L G K L C N A D L E T I F S L I N T D T D S S K K H P F P C P T T Y R T A L T H Y L E I T 
A L P R T H I L K E L A E Y C T E E K D K E F L R F I S S T A P E G K A K Y Q E W I Q D S S 
R N V V H V L E D I P S C H P P I D H V C E L L P R L Q P R Y Y S I S S S S K L H P T T V H V 
T A V L V K Y E T K T G R L N K G V A T T F L A E K H P N D G E P L P R V P I F I R K S Q F 
R L P P K P E T P V I Met V G P G T G L A P F R G F I Q E R D F S K Q E G K E I G Q T T L Y F 
G C R K R T E D Y I Y E D E L E D Y S K R G I V N L R V A F S R D Q E K K V Y V T H L L E 
Q D S D L I W N V I G E N K G H F Y I C G D A K N Met A T D V R N I L L K V I R S K G G L S 
E T E A Q Q Y I K K Met E A Q K R Y S A D V W S Stop R S 
 
 
 
Figure A6.1: Sequences of (His)6CPR.  Restriction enzymes are underlined, NcoI (before start codon) 
and BglIII (After stop codon).  Six His –tag is indicated in blue. 
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